{
  "LinkDataSet": {
    "LinkData": [
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 134436906
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Selpercatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 346,
            "CooccurrenceScore": 1137151,
            "Article": [
              {
                "PCLID": 13600687,
                "RelevanceScore": 2080473,
                "PMID": 34099825,
                "DOI": "10.1038/s41698-021-00188-x",
                "PublicationDate": "2021-06-07",
                "IsReview": false,
                "Title": "The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib",
                "Author": "Tao Shen, Xueqing Hu, Xuan Liu, Vivek Subbiah, Blaine H. M. Mooers, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "loxo-292; selpercatinib"
              },
              {
                "PCLID": 19676353,
                "RelevanceScore": 2080473,
                "PMID": 33161056,
                "DOI": "10.1016/j.annonc.2020.10.599",
                "PublicationDate": "2021-02-01",
                "IsReview": false,
                "Title": "Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations",
                "Author": "V. Subbiah, T. Shen, S.S. Terzyan, X. Liu, X. Hu, K.P. Patel, M. Hu, M. Cabanillas, A. Behrang, F. Meric-Bernstam, P.T.T. Vo, B.H.M. Mooers, J. Wu",
                "Journal": "Annals of oncology : official journal of the European Society for Medical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "loxo-292; selpercatinib"
              },
              {
                "PCLID": 29773356,
                "RelevanceScore": 2080473,
                "PMID": 32416592,
                "DOI": "10.1016/j.jchromb.2020.122131",
                "PublicationDate": "2020-06-15",
                "IsReview": false,
                "Title": "Quantitative bioanalytical assay for the selective RET inhibitors selpercatinib and pralsetinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry",
                "Author": "Rahime Şentürk, Yaogeng Wang, Alfred H. Schinkel, Jos H. Beijnen, Rolf W. Sparidans",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "selpercatinib"
              },
              {
                "PCLID": 34847774,
                "RelevanceScore": 2080473,
                "PMID": 36941218,
                "DOI": "10.1002/bmc.5628",
                "PublicationDate": "2023-04-12",
                "IsReview": false,
                "Title": "Development and validation of an HPLC–MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2‐EDTA plasma",
                "Author": "Judith L. Gulikers, Ard J. van Veelen, Elishia M. J. Sinkiewicz, Yvo M. de Beer, Mariëlle Slikkerveer, Leo M. L. Stolk, Vivianne C. G. Tjan‐Heijnen, Lizza E. L. Hendriks, Sander Croes, Robin M. J. M. van Geel",
                "Journal": "Biomedical chromatography : BMC",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "selpercatinib"
              },
              {
                "PCLID": 34950047,
                "RelevanceScore": 2080473,
                "PMID": 36572992,
                "DOI": "10.1177/10781552221147500",
                "PublicationDate": "2022-12-26",
                "IsReview": true,
                "Title": "An overview of the role of selpercatinib and pralsetinib in RET-fusion-positive non-small cell lung cancer (NSCLC)",
                "Author": "Vanessa Quang Nguyen, Marc Geirnaert",
                "Journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "selpercatinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 25102847
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Cabozantinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 152,
            "CooccurrenceScore": 297767,
            "Article": [
              {
                "PCLID": 34364823,
                "RelevanceScore": 1200128,
                "PMID": 36768635,
                "DOI": "10.3390/ijms24032312",
                "PublicationDate": "2023-01-24",
                "IsReview": true,
                "Title": "Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect",
                "Author": "Linnea Højer Wang, Markus Wehland, Petra M. Wise, Manfred Infanger, Daniela Grimm, Michael C. Kreissl",
                "Journal": "International Journal of Molecular Sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "cabozantinib"
              },
              {
                "PCLID": 13614015,
                "RelevanceScore": 1043589,
                "PMID": 34118198,
                "DOI": "10.1016/s2213-8587(21)00120-0",
                "PublicationDate": "2021-08-01",
                "IsReview": false,
                "Title": "Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study",
                "Author": "Vivek Subbiah, Mimi I Hu, Lori J Wirth, Martin Schuler, Aaron S Mansfield, Giuseppe Curigliano, Marcia S Brose, Viola W Zhu, Sophie Leboulleux, Daniel W Bowles, Christina S Baik, Douglas Adkins, Bhumsuk Keam, Ignacio Matos, Elena Garralda, Justin F Gainor, Gilberto Lopes, Chia-Chi Lin, Yann Godbert, Debashis Sarker, Stephen G Miller, Corinne Clifford, Hui Zhang, Christopher D Turner, Matthew H Taylor",
                "Journal": "The lancet. Diabetes & endocrinology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "cabozantinib"
              },
              {
                "PCLID": 38533325,
                "RelevanceScore": 782692,
                "PMID": 40084047,
                "DOI": "10.1530/eo-24-0077",
                "PublicationDate": "2025-02-18",
                "IsReview": true,
                "Title": "Overview of management and therapeutic advances in medullary thyroid cancer",
                "Author": "Mark A Jara, Luciana Audi Castroneves",
                "Journal": "Endocrine oncology (Bristol, England)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "cabozantinib"
              },
              {
                "PCLID": 5424281,
                "RelevanceScore": 782692,
                "PMID": 34733735,
                "DOI": "10.21037/gs-21-469",
                "PublicationDate": "2021-09-01",
                "IsReview": false,
                "Title": "Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma",
                "Author": "Jia Ma, Baosheng Wang, Erhong Meng, Xiangpeng Meng",
                "Journal": "Gland Surgery",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "cabozantinib"
              },
              {
                "PCLID": 36227874,
                "RelevanceScore": 626154,
                "PMID": 38009200,
                "DOI": "10.1089/thy.2023.0363",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study",
                "Author": "Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schuler, Viola W. Zhu, Julien Hadoux, Giuseppe Curigliano, Lori Wirth, Justin F. Gainor, Guzman Alonso, Douglas Adkins, Yann Godbert, Myung-Ju Ahn, Philippe A. Cassier, Byoung Chul Cho, Chia-Chi Lin, Alena Zalutskaya, Teresa Barata, Peter Trask, Astrid Scalori, Walter Bordogna, Sebastian Heinzmann, Marcia S. Brose",
                "Journal": "Thyroid : official journal of the American Thyroid Association",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "cabozantinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 3081361
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Vandetanib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 128,
            "CooccurrenceScore": 296607,
            "Article": [
              {
                "PCLID": 34364823,
                "RelevanceScore": 1290420,
                "PMID": 36768635,
                "DOI": "10.3390/ijms24032312",
                "PublicationDate": "2023-01-24",
                "IsReview": true,
                "Title": "Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect",
                "Author": "Linnea Højer Wang, Markus Wehland, Petra M. Wise, Manfred Infanger, Daniela Grimm, Michael C. Kreissl",
                "Journal": "International Journal of Molecular Sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "vandetanib"
              },
              {
                "PCLID": 13614015,
                "RelevanceScore": 1122104,
                "PMID": 34118198,
                "DOI": "10.1016/s2213-8587(21)00120-0",
                "PublicationDate": "2021-08-01",
                "IsReview": false,
                "Title": "Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study",
                "Author": "Vivek Subbiah, Mimi I Hu, Lori J Wirth, Martin Schuler, Aaron S Mansfield, Giuseppe Curigliano, Marcia S Brose, Viola W Zhu, Sophie Leboulleux, Daniel W Bowles, Christina S Baik, Douglas Adkins, Bhumsuk Keam, Ignacio Matos, Elena Garralda, Justin F Gainor, Gilberto Lopes, Chia-Chi Lin, Yann Godbert, Debashis Sarker, Stephen G Miller, Corinne Clifford, Hui Zhang, Christopher D Turner, Matthew H Taylor",
                "Journal": "The lancet. Diabetes & endocrinology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "vandetanib"
              },
              {
                "PCLID": 34579877,
                "RelevanceScore": 841578,
                "PMID": 36582799,
                "DOI": "10.3389/fonc.2022.1033484",
                "PublicationDate": "2022-12-13",
                "IsReview": true,
                "Title": "Targeted therapy of RET fusion-positive non-small cell lung cancer",
                "Author": "Zixiong Shen, Binxu Qiu, Lin Li, Bo Yang, Guanghu Li",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "vandetanib"
              },
              {
                "PCLID": 38533325,
                "RelevanceScore": 841578,
                "PMID": 40084047,
                "DOI": "10.1530/eo-24-0077",
                "PublicationDate": "2025-02-18",
                "IsReview": true,
                "Title": "Overview of management and therapeutic advances in medullary thyroid cancer",
                "Author": "Mark A Jara, Luciana Audi Castroneves",
                "Journal": "Endocrine oncology (Bristol, England)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "vandetanib"
              },
              {
                "PCLID": 5424281,
                "RelevanceScore": 841578,
                "PMID": 34733735,
                "DOI": "10.21037/gs-21-469",
                "PublicationDate": "2021-09-01",
                "IsReview": false,
                "Title": "Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma",
                "Author": "Jia Ma, Baosheng Wang, Erhong Meng, Xiangpeng Meng",
                "Journal": "Gland Surgery",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "vandetanib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 6057
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "L-Tyrosine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 132,
            "CooccurrenceScore": 253887,
            "Article": [
              {
                "PCLID": 34173152,
                "RelevanceScore": 341961,
                "PMID": 35689816,
                "DOI": "10.1210/clinem/dgac352",
                "PublicationDate": "2022-06-11",
                "IsReview": false,
                "Title": "A Novel Germline Deletion of p.C630 inRETCauses MTC and Promotes Cell Proliferation and Sensitivity to Pralsetinib",
                "Author": "Xiao Ma, Xiuli Ma, Lihan Chin, Zhen Zhu, Haibo Han",
                "Journal": "The Journal of clinical endocrinology and metabolism",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tyrosine"
              },
              {
                "PCLID": 13600687,
                "RelevanceScore": 315657,
                "PMID": 34099825,
                "DOI": "10.1038/s41698-021-00188-x",
                "PublicationDate": "2021-06-07",
                "IsReview": false,
                "Title": "The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib",
                "Author": "Tao Shen, Xueqing Hu, Xuan Liu, Vivek Subbiah, Blaine H. M. Mooers, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tyrosine"
              },
              {
                "PCLID": 19676353,
                "RelevanceScore": 315657,
                "PMID": 33161056,
                "DOI": "10.1016/j.annonc.2020.10.599",
                "PublicationDate": "2021-02-01",
                "IsReview": false,
                "Title": "Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations",
                "Author": "V. Subbiah, T. Shen, S.S. Terzyan, X. Liu, X. Hu, K.P. Patel, M. Hu, M. Cabanillas, A. Behrang, F. Meric-Bernstam, P.T.T. Vo, B.H.M. Mooers, J. Wu",
                "Journal": "Annals of oncology : official journal of the European Society for Medical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tyrosine"
              },
              {
                "PCLID": 25150569,
                "RelevanceScore": 315657,
                "PMID": 34702125,
                "DOI": "10.1080/17460441.2022.1995351",
                "PublicationDate": "2021-10-27",
                "IsReview": true,
                "Title": "Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancer",
                "Author": "Pietro Locantore, Roberto Novizio, Andrea Corsello, Rosa Maria Paragliola, Alfredo Pontecorvi, Salvatore Maria Corsello",
                "Journal": "Expert Opinion on Drug Discovery",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tyrosine"
              },
              {
                "PCLID": 34037745,
                "RelevanceScore": 315657,
                "PMID": 35587858,
                "DOI": "10.1007/s40265-022-01720-4",
                "PublicationDate": "2022-05-19",
                "IsReview": true,
                "Title": "Pralsetinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Yahiya Y. Syed",
                "Journal": "Drugs",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tyrosine"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 581866
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "2-Amino-4-chloropyridine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 80,
            "CooccurrenceScore": 185830,
            "Article": [
              {
                "PCLID": 13614015,
                "RelevanceScore": 309363,
                "PMID": 34118198,
                "DOI": "10.1016/s2213-8587(21)00120-0",
                "PublicationDate": "2021-08-01",
                "IsReview": false,
                "Title": "Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study",
                "Author": "Vivek Subbiah, Mimi I Hu, Lori J Wirth, Martin Schuler, Aaron S Mansfield, Giuseppe Curigliano, Marcia S Brose, Viola W Zhu, Sophie Leboulleux, Daniel W Bowles, Christina S Baik, Douglas Adkins, Bhumsuk Keam, Ignacio Matos, Elena Garralda, Justin F Gainor, Gilberto Lopes, Chia-Chi Lin, Yann Godbert, Debashis Sarker, Stephen G Miller, Corinne Clifford, Hui Zhang, Christopher D Turner, Matthew H Taylor",
                "Journal": "The lancet. Diabetes & endocrinology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 13614013,
                "RelevanceScore": 309363,
                "PMID": 34118197,
                "DOI": "10.1016/s1470-2045(21)00247-3",
                "PublicationDate": "2021-07-01",
                "IsReview": false,
                "Title": "Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study",
                "Author": "Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe A Cassier, Gilberto Lopes, Daniel S W Tan, Elena Garralda, Luis G Paz-Ares, Byoung Chul Cho, Shirish M Gadgeel, Michael Thomas, Stephen V Liu, Matthew H Taylor, Aaron S Mansfield, Viola W Zhu, Corinne Clifford, Hui Zhang, Michael Palmer, Jennifer Green, Christopher D Turner, Vivek Subbiah",
                "Journal": "The Lancet. Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 19676353,
                "RelevanceScore": 309363,
                "PMID": 33161056,
                "DOI": "10.1016/j.annonc.2020.10.599",
                "PublicationDate": "2021-02-01",
                "IsReview": false,
                "Title": "Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations",
                "Author": "V. Subbiah, T. Shen, S.S. Terzyan, X. Liu, X. Hu, K.P. Patel, M. Hu, M. Cabanillas, A. Behrang, F. Meric-Bernstam, P.T.T. Vo, B.H.M. Mooers, J. Wu",
                "Journal": "Annals of oncology : official journal of the European Society for Medical Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 25085533,
                "RelevanceScore": 309363,
                "PMID": 33512366,
                "DOI": "10.1701/3525.35131",
                "PublicationDate": "2021-01-01",
                "IsReview": false,
                "Title": "[Detection of novel driver mutations in liquid biopsy: case report of a RET-positive lung adenocarcinoma treated with pralsetinib.]",
                "Author": "Marco Russano",
                "Journal": "Recenti progressi in medicina",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 25150569,
                "RelevanceScore": 309363,
                "PMID": 34702125,
                "DOI": "10.1080/17460441.2022.1995351",
                "PublicationDate": "2021-10-27",
                "IsReview": true,
                "Title": "Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancer",
                "Author": "Pietro Locantore, Roberto Novizio, Andrea Corsello, Rosa Maria Paragliola, Alfredo Pontecorvi, Salvatore Maria Corsello",
                "Journal": "Expert Opinion on Drug Discovery",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 9823820
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Lenvatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 97,
            "CooccurrenceScore": 146635,
            "Article": [
              {
                "PCLID": 5424281,
                "RelevanceScore": 747783,
                "PMID": 34733735,
                "DOI": "10.21037/gs-21-469",
                "PublicationDate": "2021-09-01",
                "IsReview": false,
                "Title": "Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma",
                "Author": "Jia Ma, Baosheng Wang, Erhong Meng, Xiangpeng Meng",
                "Journal": "Gland Surgery",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lenvatinib"
              },
              {
                "PCLID": 35092322,
                "RelevanceScore": 598226,
                "PMID": 36451418,
                "DOI": "10.1097/md.0000000000031480",
                "PublicationDate": "2022-11-25",
                "IsReview": false,
                "Title": "Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report",
                "Author": "Linping Gu, Wenxiang Ji, Yunhua Xu, Yuchen Han, Hong Jian",
                "Journal": "Medicine",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lenvatinib"
              },
              {
                "PCLID": 34172184,
                "RelevanceScore": 553913,
                "PMID": 35404189,
                "DOI": "10.1080/17446651.2022.2060819",
                "PublicationDate": "2022-03-04",
                "IsReview": true,
                "Title": "Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions",
                "Author": "Mariantonia Nacchio, Pasquale Pisapia, Francesco Pepe, Gianluca Russo, Elena Vigliar, Tommaso Porcelli, Cristina Luongo, Antonino Iaccarino, Fabio Pagni, Domenico Salvatore, Giancarlo Troncone, Umberto Malapelle, Claudio Bellevicine",
                "Journal": "Expert Review of Endocrinology & Metabolism",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lenvatinib"
              },
              {
                "PCLID": 34354127,
                "RelevanceScore": 553913,
                "PMID": 35788405,
                "DOI": "10.1016/j.jtho.2022.06.008",
                "PublicationDate": "2022-09-01",
                "IsReview": false,
                "Title": "Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy",
                "Author": "Or Kalchiem-Dekel, Christina J. Falcon, Christine M. Bestvina, Dazhi Liu, Lauren A. Kaplanis, Clare Wilhelm, Jordan Eichholz, Guilherme Harada, Lori J. Wirth, Subba R. Digumarthy, Robert P. Lee, David Kadosh, Robin B. Mendelsohn, Jessica Donington, Justin F. Gainor, Alexander Drilon, Jessica J. Lin",
                "Journal": "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lenvatinib"
              },
              {
                "PCLID": 26484719,
                "RelevanceScore": 529679,
                "PMID": 34726500,
                "DOI": "10.18553/jmcp.2021.21308",
                "PublicationDate": "2022-02-01",
                "IsReview": false,
                "Title": "The budget impact of adding pralsetinib to a US health plan formulary for treatment of non-small cell lung cancer and thyroid cancer with RET alterations",
                "Author": "Steve Duff, Francesca Bargiacchi, Chelsea Norregaard, Melanie Brener, Erin Sullivan",
                "Journal": "Journal of Managed Care & Specialty Pharmacy",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lenvatinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 25141092
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Entrectinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 113,
            "CooccurrenceScore": 119058,
            "Article": [
              {
                "PCLID": 39179011,
                "RelevanceScore": 615372,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "entrectinib"
              },
              {
                "PCLID": 35573623,
                "RelevanceScore": 517872,
                "PMID": 37086377,
                "DOI": "10.1007/s12010-023-04541-7",
                "PublicationDate": "2023-04-22",
                "IsReview": false,
                "Title": "Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer—Integrated Bioinformatic Approach",
                "Author": "Pavan Kumar Poleboyina, Manikandan Alagumuthu, Akbar Pasha, Doneti Ravinder, Deepthi Pasumarthi, Smita C. Pawar",
                "Journal": "Applied Biochemistry and Biotechnology",
                "ChemicalName_2": "entrectinib"
              },
              {
                "PCLID": 34903339,
                "RelevanceScore": 462385,
                "PMID": 36275786,
                "DOI": "10.2147/cmar.s340967",
                "PublicationDate": "2022-10-01",
                "IsReview": true,
                "Title": "Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective",
                "Author": "Alice Nervo, Francesca Retta, Alberto Ragni, Alessandro Piovesan, Marco Gallo, Emanuela Arvat",
                "Journal": "Cancer Management and Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "entrectinib"
              },
              {
                "PCLID": 36897636,
                "RelevanceScore": 461529,
                "PMID": 38438731,
                "DOI": "10.1038/s41698-024-00563-4",
                "PublicationDate": "2024-03-04",
                "IsReview": false,
                "Title": "Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer",
                "Author": "Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "entrectinib"
              },
              {
                "PCLID": 24447163,
                "RelevanceScore": 419572,
                "PMID": 34553354,
                "DOI": "10.1055/a-1393-7697",
                "PublicationDate": "2021-10-01",
                "IsReview": false,
                "Title": "[Advances in Lung Cancer Treatment]",
                "Author": "Christian Schulz",
                "Journal": "Deutsche medizinische Wochenschrift (1946)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "entrectinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 46188928
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Larotrectinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 98,
            "CooccurrenceScore": 105049,
            "Article": [
              {
                "PCLID": 39179011,
                "RelevanceScore": 622644,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "larotrectinib"
              },
              {
                "PCLID": 34903339,
                "RelevanceScore": 467849,
                "PMID": 36275786,
                "DOI": "10.2147/cmar.s340967",
                "PublicationDate": "2022-10-01",
                "IsReview": true,
                "Title": "Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective",
                "Author": "Alice Nervo, Francesca Retta, Alberto Ragni, Alessandro Piovesan, Marco Gallo, Emanuela Arvat",
                "Journal": "Cancer Management and Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "larotrectinib"
              },
              {
                "PCLID": 36897636,
                "RelevanceScore": 466983,
                "PMID": 38438731,
                "DOI": "10.1038/s41698-024-00563-4",
                "PublicationDate": "2024-03-04",
                "IsReview": false,
                "Title": "Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer",
                "Author": "Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "larotrectinib"
              },
              {
                "PCLID": 24447163,
                "RelevanceScore": 424530,
                "PMID": 34553354,
                "DOI": "10.1055/a-1393-7697",
                "PublicationDate": "2021-10-01",
                "IsReview": false,
                "Title": "[Advances in Lung Cancer Treatment]",
                "Author": "Christian Schulz",
                "Journal": "Deutsche medizinische Wochenschrift (1946)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "larotrectinib"
              },
              {
                "PCLID": 14943928,
                "RelevanceScore": 311900,
                "PMID": 33707664,
                "DOI": "10.1038/s41379-021-00757-2",
                "PublicationDate": "2021-03-12",
                "IsReview": false,
                "Title": "Abstracts from USCAP 2021: Endocrine Pathology (296-310)",
                "Journal": "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 44462760
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Dabrafenib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 95,
            "CooccurrenceScore": 74235,
            "Article": [
              {
                "PCLID": 37225707,
                "RelevanceScore": 532293,
                "PMID": 38770091,
                "DOI": "10.1177/17588359241253113",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series",
                "Author": "Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar",
                "Journal": "Therapeutic Advances in Medical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "dabrafenib"
              },
              {
                "PCLID": 38504091,
                "RelevanceScore": 511001,
                "PMID": 40063337,
                "DOI": "10.1080/07391102.2025.2472231",
                "PublicationDate": "2025-03-10",
                "IsReview": false,
                "Title": "Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer",
                "Author": "Darakhshan Parveen, Faizul Azam, M. Mumtaz Alam, Ruhi Ali, Mymoona Akhter, Suhel Parvez, Mohammad Ahmed Khan, Shyama Charan, Suruchi Khanna, Mohd. Parvez, Mohammad Shaquiquzzaman",
                "Journal": "Journal of Biomolecular Structure and Dynamics",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "dabrafenib"
              },
              {
                "PCLID": 36220807,
                "RelevanceScore": 260715,
                "PMID": 38001324,
                "DOI": "10.1007/s12020-023-03610-5",
                "PublicationDate": "2023-11-25",
                "IsReview": true,
                "Title": "Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe",
                "Author": "Christelle de la Fouchardière, Laura Fugazzola, Laura D. Locati, Clara V. Alvarez, Robin P. Peeters, Pilar Camacho, Iris M. Simon, Barbara Jarząb, Romana Netea-Maier",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 760032657,
                "RelevanceScore": 260715,
                "DOI": "10.1007/978-981-99-6782-7_79",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Experience in Molecular Testing Using FNA Cytology in EU Countries",
                "Author": "Sara Coluccelli, Thais Maloberti, Federico Chiarucci, Antonio De Leo, Dario de Biase, Giovanni Tallini",
                "Journal": "Thyroid FNA Cytology"
              },
              {
                "PCLID": 10250207,
                "RelevanceScore": 242831,
                "PMID": 35328215,
                "DOI": "10.3390/diagnostics12030662",
                "PublicationDate": "2022-03-09",
                "IsReview": true,
                "Title": "Update on International Medical Taxonomies of Biomarkers and Their Applications in Management of Thyroid Cancers",
                "Author": "Maria Trovato",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "dabrafenib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 71496458
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Osimertinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 68,
            "CooccurrenceScore": 72516,
            "Article": [
              {
                "PCLID": 34128838,
                "RelevanceScore": 1251324,
                "PMID": 35711719,
                "DOI": "10.1016/j.jtocrr.2022.100343",
                "PublicationDate": "2022-06-01",
                "IsReview": false,
                "Title": "Response to Pralsetinib Observed in Meningeal-Metastatic EGFR-Mutant NSCLC With Acquired RET Fusion: A Brief Report",
                "Author": "Zichen Zhao, Chao Su, Weigang Xiu, Weiya Wang, Shasha Zeng, Meijuan Huang, Youling Gong, You Lu, Yan Zhang",
                "Journal": "JTO Clinical and Research Reports",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "osimertinib"
              },
              {
                "PCLID": 34246786,
                "RelevanceScore": 900953,
                "PMID": 35797511,
                "DOI": "10.1200/po.22.00040",
                "PublicationDate": "2022-07-01",
                "IsReview": false,
                "Title": "Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel IntergenicANK3-RETFusion inEGFR-Mutated Non–Small-Cell Lung Cancer",
                "Author": "Edyta M. Urbanska, Jens B. Sørensen, Linea C. Melchior, Junia C. Costa, Eric Santoni-Rugiu",
                "Journal": "JCO Precision Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "osimertinib"
              },
              {
                "PCLID": 37225707,
                "RelevanceScore": 521385,
                "PMID": 38770091,
                "DOI": "10.1177/17588359241253113",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series",
                "Author": "Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar",
                "Journal": "Therapeutic Advances in Medical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "osimertinib"
              },
              {
                "PCLID": 38889347,
                "RelevanceScore": 500530,
                "PMID": 40452844,
                "DOI": "10.3389/fonc.2025.1477910",
                "PublicationDate": "2025-05-16",
                "IsReview": false,
                "Title": "RET fusion driven (RETfus+) non-small cell lung cancer: a comprehensive genomic profiling study with histologic correlation",
                "Author": "Prashanth Ashok Kumar, Michael Connolly, Alina Basnet, Dean Pavlick, Richard Huang, Steven Graziano, Jeffrey Ross",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "osimertinib"
              },
              {
                "PCLID": 37038083,
                "RelevanceScore": 429025,
                "PMID": 38584556,
                "DOI": "10.2174/0118715206290110240326071909",
                "PublicationDate": "2024-07-01",
                "IsReview": false,
                "Title": "Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS)",
                "Author": "Zichen Zhao, Qianlun Pu, Tonglin Sun, Qian Huang, Liping Tong, Ting Fan, Jingyue Kang, Yuhong Chen, Yan Zhang",
                "Journal": "Anti-Cancer Agents in Medicinal Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "osimertinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 135565230
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Pemetrexed, (R)-",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 40,
            "CooccurrenceScore": 64829,
            "Article": [
              {
                "PCLID": 36334624,
                "RelevanceScore": 418363,
                "PMID": 37603207,
                "DOI": "10.1007/s10637-023-01390-3",
                "PublicationDate": "2023-08-21",
                "IsReview": true,
                "Title": "The efficacy and safety of selective RET inhibitors in RET fusion-positive non-small cell lung cancer: a meta-analysis",
                "Author": "Jun-yi Ke, Shu Huang, Zhi-tao Jing, Min-chao Duan",
                "Journal": "Investigational New Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 37948268,
                "RelevanceScore": 325393,
                "PMID": 39497173,
                "DOI": "10.1186/s12890-024-03371-5",
                "PublicationDate": "2024-11-04",
                "IsReview": false,
                "Title": "Evolution of treatment strategies for solid tumors with RET rearrangement in China and real-world treatment status of Non-small Cell Lung Cancer (NSCLC)",
                "Author": "An Wang, Tao Li, Yun-ye Mao, Ming Gao, Sheng Shu, Chang-hong Xia, Yi Dong, Min Liu, Jin-liang Wang, Jun-xun Ma, Yi Hu",
                "Journal": "BMC Pulmonary Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34840771,
                "RelevanceScore": 319477,
                "PMID": 36757608,
                "DOI": "10.1007/s40273-023-01247-w",
                "PublicationDate": "2023-02-09",
                "IsReview": true,
                "Title": "Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
                "Author": "Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt",
                "Journal": "PharmacoEconomics",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 201348149,
                "RelevanceScore": 271664,
                "DOI": "10.1007/s40278-021-05013-6",
                "PublicationDate": "2021-11-06",
                "IsReview": false,
                "Title": "Erlotinib/osimertinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 206778158,
                "RelevanceScore": 271664,
                "DOI": "10.1007/s40278-021-99416-2",
                "PublicationDate": "2021-07-24",
                "IsReview": false,
                "Title": "Carboplatin/pemetrexed/pralsetinib",
                "Journal": "Reactions Weekly"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 11626560
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Crizotinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 85,
            "CooccurrenceScore": 62300,
            "Article": [
              {
                "PCLID": 38969075,
                "RelevanceScore": 546374,
                "PMID": 40502048,
                "DOI": "10.1101/2025.06.04.657911",
                "PublicationDate": "2025-06-07",
                "IsReview": false,
                "Title": "Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma",
                "Author": "Trista K Hinz, Anh T Le, Tristan Doan, Abby Ast, Sophia Jaramillo, Samantha Haines, Andre Navarro, Tejas Patil, Raphael A Nemenoff, Lynn E Heasley",
                "Journal": "bioRxiv : the preprint server for biology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "crizotinib"
              },
              {
                "PCLID": 37038083,
                "RelevanceScore": 425746,
                "PMID": 38584556,
                "DOI": "10.2174/0118715206290110240326071909",
                "PublicationDate": "2024-07-01",
                "IsReview": false,
                "Title": "Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS)",
                "Author": "Zichen Zhao, Qianlun Pu, Tonglin Sun, Qian Huang, Liping Tong, Ting Fan, Jingyue Kang, Yuhong Chen, Yan Zhang",
                "Journal": "Anti-Cancer Agents in Medicinal Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "crizotinib"
              },
              {
                "PCLID": 17674211,
                "RelevanceScore": 354788,
                "PMID": 34156585,
                "DOI": "10.1007/s11060-021-03789-5",
                "PublicationDate": "2021-06-22",
                "IsReview": true,
                "Title": "US Food and Drug Administration regulatory updates in neuro-oncology",
                "Author": "Gautam U. Mehta, Amy K. Barone, Diana Bradford, Erin Larkins, Janice Kim, Lee Pai-Scherf, Adnan Jaigirdar, Mirat Shah, Suparna Wedam, Laleh Amiri-Kordestani, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Harpreet Singh",
                "Journal": "Journal of Neuro-Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34278014,
                "RelevanceScore": 278762,
                "PMID": 35816666,
                "DOI": "10.1200/jco.22.00824",
                "PublicationDate": "2022-10-01",
                "IsReview": false,
                "Title": "Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline",
                "Author": "Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew G. Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael A. Jaiyesimi",
                "Journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "crizotinib"
              },
              {
                "PCLID": 36558058,
                "RelevanceScore": 259640,
                "PMID": 37748692,
                "DOI": "10.1016/j.jtho.2023.09.1444",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function",
                "Author": "Monica F. Chen, Guilherme Harada, Dazhi Liu, Ray DeMatteo, Christina Falcon, Clare Wilhelm, Mark G. Kris, Alexander Drilon, Victoria Gutgarts",
                "Journal": "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "crizotinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 23939
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Platinum",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 22,
            "CooccurrenceScore": 62096,
            "Article": [
              {
                "PCLID": 13614013,
                "RelevanceScore": 697442,
                "PMID": 34118197,
                "DOI": "10.1016/s1470-2045(21)00247-3",
                "PublicationDate": "2021-07-01",
                "IsReview": false,
                "Title": "Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study",
                "Author": "Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe A Cassier, Gilberto Lopes, Daniel S W Tan, Elena Garralda, Luis G Paz-Ares, Byoung Chul Cho, Shirish M Gadgeel, Michael Thomas, Stephen V Liu, Matthew H Taylor, Aaron S Mansfield, Viola W Zhu, Corinne Clifford, Hui Zhang, Michael Palmer, Jennifer Green, Christopher D Turner, Vivek Subbiah",
                "Journal": "The Lancet. Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "platinum"
              },
              {
                "PCLID": 35717910,
                "RelevanceScore": 697442,
                "PMID": 37282666,
                "DOI": "10.1002/cncr.34897",
                "PublicationDate": "2023-06-06",
                "IsReview": false,
                "Title": "Efficacy and safety of pralsetinib in patients with advanced RET fusion‐positive non–small cell lung cancer",
                "Author": "Qing Zhou, Jun Zhao, Jianhua Chang, Huijie Wang, Yun Fan, Ke Wang, Gang Wu, Weiqi Nian, Yuping Sun, Meili Sun, Xiangcai Wang, Huaqiu Shi, Xiangqian Zheng, Sheng Yao, Mengmeng Qin, Zhenwei Shen, Jason Yang, Yi‐Long Wu",
                "Journal": "Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "platinum"
              },
              {
                "PCLID": 5449121,
                "RelevanceScore": 697442,
                "PMID": 34864862,
                "DOI": "10.1093/ajhp/zxab462",
                "PublicationDate": "2021-12-05",
                "IsReview": true,
                "Title": "Pralsetinib: Treatment of metastatic RET fusion–positive non–small cell lung cancer",
                "Author": "Ly Nguyen, Shanada Monestime",
                "Journal": "American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "platinum"
              },
              {
                "PCLID": 34037745,
                "RelevanceScore": 592825,
                "PMID": 35587858,
                "DOI": "10.1007/s40265-022-01720-4",
                "PublicationDate": "2022-05-19",
                "IsReview": true,
                "Title": "Pralsetinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Yahiya Y. Syed",
                "Journal": "Drugs",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "platinum"
              },
              {
                "PCLID": 37691657,
                "RelevanceScore": 592825,
                "PMID": 39233920,
                "DOI": "10.3389/fchem.2024.1450692",
                "PublicationDate": "2024-08-21",
                "IsReview": false,
                "Title": "Development and validation of a novel high-performance liquid chromatography (HPLC) method for the detection of related substances of pralsetinib, a new anti-lung cancer drug",
                "Author": "Yonghong Zhu, Jisu Qin, Wenyi Wu, Liangliang Cai",
                "Journal": "Frontiers in Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "platinum"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 50992434
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Trametinib Dimethyl Sulfoxide",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 84,
            "CooccurrenceScore": 60850,
            "Article": [
              {
                "PCLID": 35437836,
                "RelevanceScore": 278701,
                "PMID": 36959606,
                "DOI": "10.1186/s12967-023-04057-y",
                "PublicationDate": "2023-03-23",
                "IsReview": false,
                "Title": "The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach",
                "Author": "Veronica Villani, Beatrice Casini, Antonio Tanzilli, Mario Lecce, Fabrizio Rasile, Stefano Telera, Andrea Pace, Francesca Piludu, Irene Terrenato, Francesca Rollo, Francesca De Nicola, Maurizio Fanciulli, Matteo Pallocca, Gennaro Ciliberto, Mariantonia Carosi",
                "Journal": "Journal of Translational Medicine"
              },
              {
                "PCLID": 36220807,
                "RelevanceScore": 278701,
                "PMID": 38001324,
                "DOI": "10.1007/s12020-023-03610-5",
                "PublicationDate": "2023-11-25",
                "IsReview": true,
                "Title": "Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe",
                "Author": "Christelle de la Fouchardière, Laura Fugazzola, Laura D. Locati, Clara V. Alvarez, Robin P. Peeters, Pilar Camacho, Iris M. Simon, Barbara Jarząb, Romana Netea-Maier",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 760032657,
                "RelevanceScore": 278701,
                "DOI": "10.1007/978-981-99-6782-7_79",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Experience in Molecular Testing Using FNA Cytology in EU Countries",
                "Author": "Sara Coluccelli, Thais Maloberti, Federico Chiarucci, Antonio De Leo, Dario de Biase, Giovanni Tallini",
                "Journal": "Thyroid FNA Cytology"
              },
              {
                "PCLID": 36137688,
                "RelevanceScore": 213380,
                "PMID": 37902897,
                "DOI": "10.1007/s11154-023-09842-0",
                "PublicationDate": "2023-10-30",
                "IsReview": true,
                "Title": "Molecular testing for thyroid nodules: Where are we now?",
                "Author": "Carolina Ferraz",
                "Journal": "Reviews in Endocrine and Metabolic Disorders"
              },
              {
                "PCLID": 36261002,
                "RelevanceScore": 213380,
                "PMID": 38049644,
                "DOI": "10.1038/s41574-023-00920-6",
                "PublicationDate": "2023-12-04",
                "IsReview": true,
                "Title": "Genomic alterations in thyroid cancer: biological and clinical insights",
                "Author": "Iñigo Landa, Maria E. Cabanillas",
                "Journal": "Nature reviews. Endocrinology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 406563
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Sorafenib Tosylate",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 60,
            "CooccurrenceScore": 53618,
            "Article": [
              {
                "PCLID": 34506511,
                "RelevanceScore": 249572,
                "PMID": 36198171,
                "DOI": "10.1080/13543776.2022.2132851",
                "PublicationDate": "2022-10-03",
                "IsReview": true,
                "Title": "An updated patent review of rearranged during transfection (RET) kinase inhibitors (2016–present)",
                "Author": "Baku Acharya, Brendan Frett",
                "Journal": "Expert Opinion on Therapeutic Patents",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34100617,
                "RelevanceScore": 226884,
                "PMID": 35462671,
                "DOI": "10.1007/s13193-021-01381-x",
                "PublicationDate": "2021-08-15",
                "IsReview": false,
                "Title": "An Audit of Systemic Therapy in Medullary Carcinoma Thyroid",
                "Author": "Aditya Pavan Kumar Kanteti, George Abraham, Vijay M. Patil, Nandini Menon, Tanmoy Mandal, Sobin V. Jacob, Keshav Garg, Anbarasan Sekar, Rup Jyoti Sarma, Laxma Reddy Mekala, Dipti Nakti, Neha Mittal, Munita Bal, Swapnil Rane, Nilendu C. Purandare, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Vanita Noronha, Kumar Prabhash",
                "Journal": "Indian Journal of Surgical Oncology"
              },
              {
                "PCLID": 35116142,
                "RelevanceScore": 226884,
                "PMID": 36626081,
                "DOI": "10.1007/s12020-022-03296-1",
                "PublicationDate": "2023-01-10",
                "IsReview": false,
                "Title": "Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance",
                "Author": "Katerina Saltiki, George Simeakis, Olga Karapanou, Stavroula A. Paschou, Maria Alevizaki",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 35901532,
                "RelevanceScore": 226884,
                "PMID": 37195581,
                "DOI": "10.1007/s12020-023-03368-w",
                "PublicationDate": "2023-05-17",
                "IsReview": true,
                "Title": "Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing",
                "Author": "Rossella Elisei, Cristina Romei",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 37574502,
                "RelevanceScore": 226884,
                "PMID": 39120655,
                "DOI": "10.1007/s00428-024-03890-w",
                "PublicationDate": "2024-08-09",
                "IsReview": false,
                "Title": "High success rate of first proficiency testing for RET fusions and RET mutations in lung and thyroid cancer samples by various methods",
                "Author": "Udo Siebolts, Roberto Pappesch, Marcus Bauer, Wolfgang Dietmaier, Mareike Ernst, Anja Haak, Nils Hartmann, Katharina Ilm, Stavros Kalbourtzis, Thomas Krause, Daniel Kazdal, Hubert Schorle, Kirsten Utpatel, Sabine Merkelbach-Bruse",
                "Journal": "Virchows Archiv : an international journal of pathology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 71731823
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Lorlatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 61,
            "CooccurrenceScore": 50059,
            "Article": [
              {
                "PCLID": 34847774,
                "RelevanceScore": 1975870,
                "PMID": 36941218,
                "DOI": "10.1002/bmc.5628",
                "PublicationDate": "2023-04-12",
                "IsReview": false,
                "Title": "Development and validation of an HPLC–MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2‐EDTA plasma",
                "Author": "Judith L. Gulikers, Ard J. van Veelen, Elishia M. J. Sinkiewicz, Yvo M. de Beer, Mariëlle Slikkerveer, Leo M. L. Stolk, Vivianne C. G. Tjan‐Heijnen, Lizza E. L. Hendriks, Sander Croes, Robin M. J. M. van Geel",
                "Journal": "Biomedical chromatography : BMC",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lorlatinib"
              },
              {
                "PCLID": 38356789,
                "RelevanceScore": 1017873,
                "PMID": 39907599,
                "DOI": "10.18632/oncotarget.28682",
                "PublicationDate": "2025-02-05",
                "IsReview": false,
                "Title": "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report",
                "Author": "Jenny L. Wu, Wade T. Iams",
                "Journal": "Oncotarget",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lorlatinib"
              },
              {
                "PCLID": 34244735,
                "RelevanceScore": 658623,
                "PMID": 35612671,
                "DOI": "10.1007/s10637-022-01259-x",
                "PublicationDate": "2022-05-25",
                "IsReview": false,
                "Title": "The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046",
                "Author": "Matteo Repetto, Edoardo Crimini, Liliana Ascione, Luca Boscolo Bielo, Carmen Belli, Giuseppe Curigliano",
                "Journal": "Investigational New Drugs",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lorlatinib"
              },
              {
                "PCLID": 39179011,
                "RelevanceScore": 609836,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lorlatinib"
              },
              {
                "PCLID": 34278014,
                "RelevanceScore": 397129,
                "PMID": 35816666,
                "DOI": "10.1200/jco.22.00824",
                "PublicationDate": "2022-10-01",
                "IsReview": false,
                "Title": "Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline",
                "Author": "Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew G. Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael A. Jaiyesimi",
                "Journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "lorlatinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 53239799
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Alectinib Hydrochloride",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 58,
            "CooccurrenceScore": 45069,
            "Article": [
              {
                "PCLID": 37948268,
                "RelevanceScore": 361694,
                "PMID": 39497173,
                "DOI": "10.1186/s12890-024-03371-5",
                "PublicationDate": "2024-11-04",
                "IsReview": false,
                "Title": "Evolution of treatment strategies for solid tumors with RET rearrangement in China and real-world treatment status of Non-small Cell Lung Cancer (NSCLC)",
                "Author": "An Wang, Tao Li, Yun-ye Mao, Ming Gao, Sheng Shu, Chang-hong Xia, Yi Dong, Min Liu, Jin-liang Wang, Jun-xun Ma, Yi Hu",
                "Journal": "BMC Pulmonary Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 205261158,
                "RelevanceScore": 301970,
                "DOI": "10.1007/s15004-021-8867-4",
                "PublicationDate": "2021-01-01",
                "IsReview": false,
                "Title": "Molekulare Targets therapeutisch nutzen",
                "Journal": "InFo Hämatologie + Onkologie"
              },
              {
                "PCLID": 214363188,
                "RelevanceScore": 301970,
                "DOI": "10.1007/s40278-022-16856-0",
                "PublicationDate": "2022-06-11",
                "IsReview": false,
                "Title": "Alectinib/pralsetinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 36286750,
                "RelevanceScore": 301970,
                "PMID": 37932425,
                "DOI": "10.1007/s00262-023-03560-x",
                "PublicationDate": "2023-11-06",
                "IsReview": false,
                "Title": "The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer",
                "Author": "Ziyun Shen, Meixin Teng, Lu Han, Dongliang Bian, Jing Zhang, Xinsheng Zhu, Yang Qing, Shiqi Hu, Yan Chen, Wangchao Yao, Huansha Yu, Lele Zhang, Peng Zhang",
                "Journal": "Cancer immunology, immunotherapy : CII"
              },
              {
                "PCLID": 37299098,
                "RelevanceScore": 301970,
                "PMID": 38847983,
                "DOI": "10.1245/s10434-024-15500-9",
                "PublicationDate": "2024-06-07",
                "IsReview": false,
                "Title": "Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET Fusions",
                "Author": "Daniel W. Scholfield, Conall W. R. Fitzgerald, Lillian A. Boe, Alana Eagan, Helena Levyn, Bin Xu, R. Michael Tuttle, James A. Fagin, Ashok R. Shaha, Jatin P. Shah, Richard J. Wong, Snehal G. Patel, Ronald Ghossein, Ian Ganly",
                "Journal": "Annals of Surgical Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 25145656
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Capmatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 57,
            "CooccurrenceScore": 44361,
            "Article": [
              {
                "PCLID": 34443588,
                "RelevanceScore": 1031841,
                "PMID": 36467260,
                "DOI": "10.1007/s11224-022-02072-1",
                "PublicationDate": "2022-11-25",
                "IsReview": false,
                "Title": "Identification of FDA-approved drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) through computational virtual screening",
                "Author": "Dhananjay Jade, Areej Alzahrani, William Critchley, Sreenivasan Ponnambalam, Michael A. Harrison",
                "Journal": "Structural Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "capmatinib"
              },
              {
                "PCLID": 36114199,
                "RelevanceScore": 710625,
                "PMID": 37876974,
                "DOI": "10.3389/fonc.2023.1264231",
                "PublicationDate": "2023-10-09",
                "IsReview": false,
                "Title": "Selpercatinib and capmatinib combination promotes sustained complete response in novel ISOC1-RET fusion lung cancer after resistance to RET inhibitor via MET amplification: Case Report",
                "Author": "Caio Abner Leite, Raíssa Pierri Carvalho, Felipe Marques da Costa, Augusto Kreling Medeiros, Fabio Augusto Schutz, William Nassib William",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "capmatinib"
              },
              {
                "PCLID": 37225707,
                "RelevanceScore": 672940,
                "PMID": 38770091,
                "DOI": "10.1177/17588359241253113",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series",
                "Author": "Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar",
                "Journal": "Therapeutic Advances in Medical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "capmatinib"
              },
              {
                "PCLID": 39179011,
                "RelevanceScore": 657986,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "capmatinib"
              },
              {
                "PCLID": 36558058,
                "RelevanceScore": 337694,
                "PMID": 37748692,
                "DOI": "10.1016/j.jtho.2023.09.1444",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function",
                "Author": "Monica F. Chen, Guilherme Harada, Dazhi Liu, Ray DeMatteo, Christina Falcon, Clare Wilhelm, Mark G. Kris, Alexander Drilon, Victoria Gutgarts",
                "Journal": "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "capmatinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 38904
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 45,
            "CooccurrenceScore": 43021,
            "Article": [
              {
                "PCLID": 34840771,
                "RelevanceScore": 240461,
                "PMID": 36757608,
                "DOI": "10.1007/s40273-023-01247-w",
                "PublicationDate": "2023-02-09",
                "IsReview": true,
                "Title": "Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
                "Author": "Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt",
                "Journal": "PharmacoEconomics",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 201348149,
                "RelevanceScore": 204474,
                "DOI": "10.1007/s40278-021-05013-6",
                "PublicationDate": "2021-11-06",
                "IsReview": false,
                "Title": "Erlotinib/osimertinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 206778158,
                "RelevanceScore": 204474,
                "DOI": "10.1007/s40278-021-99416-2",
                "PublicationDate": "2021-07-24",
                "IsReview": false,
                "Title": "Carboplatin/pemetrexed/pralsetinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 210139580,
                "RelevanceScore": 204474,
                "DOI": "10.1007/s40278-020-87760-6",
                "PublicationDate": "2020-12-19",
                "IsReview": false,
                "Title": "Pembrolizumab",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 36294801,
                "RelevanceScore": 204474,
                "PMID": 38057798,
                "DOI": "10.1186/s12890-023-02799-5",
                "PublicationDate": "2023-12-06",
                "IsReview": false,
                "Title": "Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report",
                "Author": "Yan Peng, Zhu Zheng, Wang Zewen, Liu Yanan, Zhang Mingyan, Sun Meili",
                "Journal": "BMC Pulmonary Medicine"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 68165256
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Brigatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 48,
            "CooccurrenceScore": 35321,
            "Article": [
              {
                "PCLID": 34847774,
                "RelevanceScore": 2015144,
                "PMID": 36941218,
                "DOI": "10.1002/bmc.5628",
                "PublicationDate": "2023-04-12",
                "IsReview": false,
                "Title": "Development and validation of an HPLC–MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2‐EDTA plasma",
                "Author": "Judith L. Gulikers, Ard J. van Veelen, Elishia M. J. Sinkiewicz, Yvo M. de Beer, Mariëlle Slikkerveer, Leo M. L. Stolk, Vivianne C. G. Tjan‐Heijnen, Lizza E. L. Hendriks, Sander Croes, Robin M. J. M. van Geel",
                "Journal": "Biomedical chromatography : BMC",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "brigatinib"
              },
              {
                "PCLID": 17674211,
                "RelevanceScore": 915975,
                "PMID": 34156585,
                "DOI": "10.1007/s11060-021-03789-5",
                "PublicationDate": "2021-06-22",
                "IsReview": true,
                "Title": "US Food and Drug Administration regulatory updates in neuro-oncology",
                "Author": "Gautam U. Mehta, Amy K. Barone, Diana Bradford, Erin Larkins, Janice Kim, Lee Pai-Scherf, Adnan Jaigirdar, Mirat Shah, Suparna Wedam, Laleh Amiri-Kordestani, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Harpreet Singh",
                "Journal": "Journal of Neuro-Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "brigatinib"
              },
              {
                "PCLID": 34278014,
                "RelevanceScore": 405023,
                "PMID": 35816666,
                "DOI": "10.1200/jco.22.00824",
                "PublicationDate": "2022-10-01",
                "IsReview": false,
                "Title": "Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline",
                "Author": "Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew G. Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael A. Jaiyesimi",
                "Journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "brigatinib"
              },
              {
                "PCLID": 36558058,
                "RelevanceScore": 319203,
                "PMID": 37748692,
                "DOI": "10.1016/j.jtho.2023.09.1444",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function",
                "Author": "Monica F. Chen, Guilherme Harada, Dazhi Liu, Ray DeMatteo, Christina Falcon, Clare Wilhelm, Mark G. Kris, Alexander Drilon, Victoria Gutgarts",
                "Journal": "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "brigatinib"
              },
              {
                "PCLID": 36365086,
                "RelevanceScore": 189251,
                "PMID": 37979367,
                "DOI": "10.1016/j.jchromb.2023.123918",
                "PublicationDate": "2023-12-01",
                "IsReview": false,
                "Title": "Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs",
                "Author": "Paul D. Kruithof, Yvo M. de Beer, Judith L. Gulikers, Leo M.L. Stolk, Lizza E.L. Hendriks, Sander Croes, Robin M.J.M. van Geel",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "brigatinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 176870
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Erlotinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 50,
            "CooccurrenceScore": 30776,
            "Article": [
              {
                "PCLID": 37225707,
                "RelevanceScore": 455285,
                "PMID": 38770091,
                "DOI": "10.1177/17588359241253113",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series",
                "Author": "Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar",
                "Journal": "Therapeutic Advances in Medical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "erlotinib"
              },
              {
                "PCLID": 38889347,
                "RelevanceScore": 437073,
                "PMID": 40452844,
                "DOI": "10.3389/fonc.2025.1477910",
                "PublicationDate": "2025-05-16",
                "IsReview": false,
                "Title": "RET fusion driven (RETfus+) non-small cell lung cancer: a comprehensive genomic profiling study with histologic correlation",
                "Author": "Prashanth Ashok Kumar, Michael Connolly, Alina Basnet, Dean Pavlick, Richard Huang, Steven Graziano, Jeffrey Ross",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "erlotinib"
              },
              {
                "PCLID": 29773356,
                "RelevanceScore": 291382,
                "PMID": 32416592,
                "DOI": "10.1016/j.jchromb.2020.122131",
                "PublicationDate": "2020-06-15",
                "IsReview": false,
                "Title": "Quantitative bioanalytical assay for the selective RET inhibitors selpercatinib and pralsetinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry",
                "Author": "Rahime Şentürk, Yaogeng Wang, Alfred H. Schinkel, Jos H. Beijnen, Rolf W. Sparidans",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "erlotinib"
              },
              {
                "PCLID": 34746821,
                "RelevanceScore": 238404,
                "PMID": 35962206,
                "DOI": "10.1038/s41591-022-01931-y",
                "PublicationDate": "2022-08-12",
                "IsReview": false,
                "Title": "Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial",
                "Author": "Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Giuseppe Curigliano",
                "Journal": "Nature Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 201348149,
                "RelevanceScore": 222996,
                "DOI": "10.1007/s40278-021-05013-6",
                "PublicationDate": "2021-11-06",
                "IsReview": false,
                "Title": "Erlotinib/osimertinib",
                "Journal": "Reactions Weekly"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5329102
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Sunitinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 38,
            "CooccurrenceScore": 30429,
            "Article": [
              {
                "PCLID": 34100617,
                "RelevanceScore": 315577,
                "PMID": 35462671,
                "DOI": "10.1007/s13193-021-01381-x",
                "PublicationDate": "2021-08-15",
                "IsReview": false,
                "Title": "An Audit of Systemic Therapy in Medullary Carcinoma Thyroid",
                "Author": "Aditya Pavan Kumar Kanteti, George Abraham, Vijay M. Patil, Nandini Menon, Tanmoy Mandal, Sobin V. Jacob, Keshav Garg, Anbarasan Sekar, Rup Jyoti Sarma, Laxma Reddy Mekala, Dipti Nakti, Neha Mittal, Munita Bal, Swapnil Rane, Nilendu C. Purandare, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Vanita Noronha, Kumar Prabhash",
                "Journal": "Indian Journal of Surgical Oncology",
                "ChemicalName_2": "sunitinib"
              },
              {
                "PCLID": 10232769,
                "RelevanceScore": 276130,
                "PMID": 35151352,
                "DOI": "10.1186/s13044-021-00119-9",
                "PublicationDate": "2022-02-12",
                "IsReview": false,
                "Title": "Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer",
                "Author": "Rohan Parikh, Lisa M. Hess, Elizabeth Esterberg, Naleen Raj Bhandari, James A. Kaye",
                "Journal": "Thyroid Research",
                "ChemicalName_2": "sunitinib"
              },
              {
                "PCLID": 37948268,
                "RelevanceScore": 269994,
                "PMID": 39497173,
                "DOI": "10.1186/s12890-024-03371-5",
                "PublicationDate": "2024-11-04",
                "IsReview": false,
                "Title": "Evolution of treatment strategies for solid tumors with RET rearrangement in China and real-world treatment status of Non-small Cell Lung Cancer (NSCLC)",
                "Author": "An Wang, Tao Li, Yun-ye Mao, Ming Gao, Sheng Shu, Chang-hong Xia, Yi Dong, Min Liu, Jin-liang Wang, Jun-xun Ma, Yi Hu",
                "Journal": "BMC Pulmonary Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 35116142,
                "RelevanceScore": 225412,
                "PMID": 36626081,
                "DOI": "10.1007/s12020-022-03296-1",
                "PublicationDate": "2023-01-10",
                "IsReview": false,
                "Title": "Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance",
                "Author": "Katerina Saltiki, George Simeakis, Olga Karapanou, Stavroula A. Paschou, Maria Alevizaki",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 760354020,
                "RelevanceScore": 225412,
                "DOI": "10.1007/978-3-031-38605-3_15",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Surgery for Medullary Thyroid Cancer",
                "Author": "E. Gréant, A. R. Shaha, I. J. Nixon",
                "Journal": "Practical Management of Thyroid Cancer"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 118984394
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Calcitonin",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 9,
            "CooccurrenceScore": 30388,
            "Article": [
              {
                "PCLID": 38041910,
                "RelevanceScore": 486561,
                "PMID": 39600647,
                "DOI": "10.3389/fonc.2024.1491167",
                "PublicationDate": "2024-11-12",
                "IsReview": false,
                "Title": "A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib",
                "Author": "Yi Yin, Fengli Sun, Youpeng Jin",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "calcitonin"
              },
              {
                "PCLID": 38728102,
                "RelevanceScore": 486561,
                "PMID": 40285824,
                "DOI": "10.1007/s11096-025-01917-z",
                "PublicationDate": "2025-04-26",
                "IsReview": false,
                "Title": "Post-marketing safety of pralsetinib: a real-world disproportionality analysis based on the FDA adverse event reporting system database",
                "Author": "Zheng Shi, Keda Shao, Ke Wang, Manyi Xu, Xiayao Yu, Chunwei Xu, Qin Li, Zhengbo Song",
                "Journal": "International Journal of Clinical Pharmacy",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "calcitonin"
              },
              {
                "PCLID": 39554926,
                "RelevanceScore": 486561,
                "PMID": 41145564,
                "DOI": "10.1038/s41598-025-17627-5",
                "PublicationDate": "2025-10-27",
                "IsReview": false,
                "Title": "Real-world FAERS safety analysis of Pralsetinib",
                "Author": "Dongdong Zhang, Yixin Sun, Ying Cai, Peiji Zeng, Yue Wang, Ming Cai, Chengfu Cai",
                "Journal": "Scientific Reports",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "calcitonin"
              },
              {
                "PCLID": 38533325,
                "RelevanceScore": 405467,
                "PMID": 40084047,
                "DOI": "10.1530/eo-24-0077",
                "PublicationDate": "2025-02-18",
                "IsReview": true,
                "Title": "Overview of management and therapeutic advances in medullary thyroid cancer",
                "Author": "Mark A Jara, Luciana Audi Castroneves",
                "Journal": "Endocrine oncology (Bristol, England)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "calcitonin"
              },
              {
                "PCLID": 38986615,
                "RelevanceScore": 405467,
                "PMID": 40552871,
                "DOI": "10.1097/js9.0000000000002816",
                "PublicationDate": "2025-06-24",
                "IsReview": true,
                "Title": "Dynamic risk stratification-guided management of medullary thyroid carcinoma: integrating surgical precision with RET-targeted therapies and molecular surveillance",
                "Author": "Jiao Zhang, Gianlorenzo Dionigi, Hoon Yub Kim, Hui Sun, Changlin Li",
                "Journal": "International journal of surgery (London, England)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "calcitonin"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 10184653
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Afatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 43,
            "CooccurrenceScore": 29335,
            "Article": [
              {
                "PCLID": 37936126,
                "RelevanceScore": 823815,
                "PMID": 39495173,
                "DOI": "10.1158/1078-0432.ccr-24-1762",
                "PublicationDate": "2024-11-04",
                "IsReview": false,
                "Title": "YAP Regulates HER3 Signaling–Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers",
                "Author": "Yuki Katayama, Tadaaki Yamada, Keiko Tanimura, Hayato Kawachi, Masaki Ishida, Yohei Matsui, Soichi Hirai, Ryota Nakamura, Kenji Morimoto, Naoki Furuya, Sachiko Arai, Yasuhiro Goto, Yoshihiko Sakata, Kazumi Nishino, Michiko Tsuchiya, Akihiro Tamiya, Go Saito, Satoshi Muto, Takayuki Takeda, Koji Date, Yasuhito Fujisaka, Satoshi Watanabe, Daichi Fujimoto, Hisanori Uehara, Mano Horinaka, Toshiyuki Sakai, Seiji Yano, Shinsaku Tokuda, Koichi Takayama",
                "Journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "afatinib"
              },
              {
                "PCLID": 36397716,
                "RelevanceScore": 441329,
                "PMID": 37924363,
                "DOI": "10.1007/s00520-023-08125-3",
                "PublicationDate": "2023-11-04",
                "IsReview": false,
                "Title": "Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer",
                "Author": "Ming Gao, Xia Zhang, Huan Yan, Decong Sun, Xuejiao Yang, Fang Yuan, Yanfang Ju, Lijie Wang, Jinliang Wang, Wei Zhao, Dong Zhang, Lin Li, Xiaoyun Xu, Junxun Ma, Yi Hu, Xiaotao Zhang",
                "Journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 37038083,
                "RelevanceScore": 441329,
                "PMID": 38584556,
                "DOI": "10.2174/0118715206290110240326071909",
                "PublicationDate": "2024-07-01",
                "IsReview": false,
                "Title": "Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS)",
                "Author": "Zichen Zhao, Qianlun Pu, Tonglin Sun, Qian Huang, Liping Tong, Ting Fan, Jingyue Kang, Yuhong Chen, Yan Zhang",
                "Journal": "Anti-Cancer Agents in Medicinal Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "afatinib"
              },
              {
                "PCLID": 6157098,
                "RelevanceScore": 201127,
                "PMID": 34083237,
                "DOI": "10.1158/1078-0432.ccr-20-5026",
                "PublicationDate": "2021-06-03",
                "IsReview": false,
                "Title": "Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma",
                "Author": "Seok-Young Kim, Sang-Min Kim, Sumin Lim, Ji Yeon Lee, Su-Jin Choi, San-Duk Yang, Mi Ran Yun, Chang Gon Kim, Seo Rin Gu, Chaewon Park, A-Young Park, Sun Min Lim, Seong Gu Heo, HyunKi Kim, Byoung Chul Cho",
                "Journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "afatinib"
              },
              {
                "PCLID": 38843277,
                "RelevanceScore": 171628,
                "PMID": 40405293,
                "DOI": "10.1186/s13046-025-03392-w",
                "PublicationDate": "2025-05-22",
                "IsReview": false,
                "Title": "AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors",
                "Author": "Daniela Esposito, Claudia Maria Ascione, Stefania Belli, Fabiana Napolitano, Alberto Servetto, Felice Pepe, Umberto Malapelle, Antonino Iaccarino, Giancarlo Troncone, Diletta Barone, Emilio Bria, Roberto Ferrara, Daniele Lorenzini, Giuseppe Lo Russo, Maria Rosa Ghigna, Arianna Marinello, Mihaela Aldea, Benjamin Besse, Luigi Formisano, Roberto Bianco",
                "Journal": "Journal of experimental & clinical cancer research : CR",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 36314
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Paclitaxel",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 41,
            "CooccurrenceScore": 28497,
            "Article": [
              {
                "PCLID": 34840771,
                "RelevanceScore": 201705,
                "PMID": 36757608,
                "DOI": "10.1007/s40273-023-01247-w",
                "PublicationDate": "2023-02-09",
                "IsReview": true,
                "Title": "Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
                "Author": "Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt",
                "Journal": "PharmacoEconomics",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34746821,
                "RelevanceScore": 183368,
                "PMID": 35962206,
                "DOI": "10.1038/s41591-022-01931-y",
                "PublicationDate": "2022-08-12",
                "IsReview": false,
                "Title": "Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial",
                "Author": "Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Giuseppe Curigliano",
                "Journal": "Nature Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 210139580,
                "RelevanceScore": 171518,
                "DOI": "10.1007/s40278-020-87760-6",
                "PublicationDate": "2020-12-19",
                "IsReview": false,
                "Title": "Pembrolizumab",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 214149620,
                "RelevanceScore": 171518,
                "DOI": "10.1007/s40278-022-19950-2",
                "PublicationDate": "2022-07-30",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 742107349,
                "RelevanceScore": 171518,
                "DOI": "10.1007/s40278-023-32181-x",
                "PublicationDate": "2023-01-21",
                "IsReview": false,
                "Title": "Multiple drugs",
                "Journal": "Reactions Weekly"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 24826799
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Ponatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 22,
            "CooccurrenceScore": 26221,
            "Article": [
              {
                "PCLID": 34443588,
                "RelevanceScore": 879004,
                "PMID": 36467260,
                "DOI": "10.1007/s11224-022-02072-1",
                "PublicationDate": "2022-11-25",
                "IsReview": false,
                "Title": "Identification of FDA-approved drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) through computational virtual screening",
                "Author": "Dhananjay Jade, Areej Alzahrani, William Critchley, Sreenivasan Ponnambalam, Michael A. Harrison",
                "Journal": "Structural Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "ponatinib"
              },
              {
                "PCLID": 6111396,
                "RelevanceScore": 471714,
                "PMID": 33136236,
                "DOI": "10.1007/s40265-020-01427-4",
                "PublicationDate": "2020-11-02",
                "IsReview": true,
                "Title": "Pralsetinib: First Approval",
                "Author": "Anthony Markham",
                "Journal": "Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 35057669,
                "RelevanceScore": 280782,
                "PMID": 36422787,
                "DOI": "10.1007/s11523-022-00935-5",
                "PublicationDate": "2022-11-24",
                "IsReview": true,
                "Title": "Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Tina Nie, Yahiya Y. Syed",
                "Journal": "Targeted Oncology"
              },
              {
                "PCLID": 37800222,
                "RelevanceScore": 211667,
                "PMID": 39342195,
                "DOI": "10.1186/s12964-024-01837-x",
                "PublicationDate": "2024-09-28",
                "IsReview": true,
                "Title": "Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives",
                "Author": "Ying Zhang, Wei-Hui Zheng, Shi-Hong Zhou, Jia-Lei Gu, Qing Yu, Yi-Zhou Zhu, Yu-Jie Yan, Zhi Zhu, Jin-Biao Shang",
                "Journal": "Cell communication and signaling : CCS",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 38545972,
                "RelevanceScore": 211667,
                "PMID": 40102263,
                "DOI": "10.1007/978-3-031-80396-3_12",
                "PublicationDate": "2025-01-01",
                "IsReview": true,
                "Title": "Systemic Therapies for Advanced Medullary Thyroid Carcinoma",
                "Author": "Marco Ruiz Santillan, Ramona Dadu, Robert F Gagel, Elizabeth G Grubbs, Mimi I Hu",
                "Journal": "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 42611257
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Vemurafenib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 45,
            "CooccurrenceScore": 24792,
            "Article": [
              {
                "PCLID": 36286750,
                "RelevanceScore": 254904,
                "PMID": 37932425,
                "DOI": "10.1007/s00262-023-03560-x",
                "PublicationDate": "2023-11-06",
                "IsReview": false,
                "Title": "The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer",
                "Author": "Ziyun Shen, Meixin Teng, Lu Han, Dongliang Bian, Jing Zhang, Xinsheng Zhu, Yang Qing, Shiqi Hu, Yan Chen, Wangchao Yao, Huansha Yu, Lele Zhang, Peng Zhang",
                "Journal": "Cancer immunology, immunotherapy : CII"
              },
              {
                "PCLID": 36366594,
                "RelevanceScore": 205884,
                "PMID": 38011864,
                "DOI": "10.1055/s-0043-1776782",
                "PublicationDate": "2023-11-27",
                "IsReview": true,
                "Title": "Management of Brain Metastases: A Review of Novel Therapies",
                "Author": "Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W. McDermott, Manmeet S. Ahluwalia",
                "Journal": "Seminars in Neurology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "vemurafenib"
              },
              {
                "PCLID": 36137688,
                "RelevanceScore": 195161,
                "PMID": 37902897,
                "DOI": "10.1007/s11154-023-09842-0",
                "PublicationDate": "2023-10-30",
                "IsReview": true,
                "Title": "Molecular testing for thyroid nodules: Where are we now?",
                "Author": "Carolina Ferraz",
                "Journal": "Reviews in Endocrine and Metabolic Disorders"
              },
              {
                "PCLID": 36261002,
                "RelevanceScore": 195161,
                "PMID": 38049644,
                "DOI": "10.1038/s41574-023-00920-6",
                "PublicationDate": "2023-12-04",
                "IsReview": true,
                "Title": "Genomic alterations in thyroid cancer: biological and clinical insights",
                "Author": "Iñigo Landa, Maria E. Cabanillas",
                "Journal": "Nature reviews. Endocrinology"
              },
              {
                "PCLID": 38005529,
                "RelevanceScore": 154201,
                "PMID": 39560781,
                "DOI": "10.1007/s00259-024-06991-5",
                "PublicationDate": "2024-11-19",
                "IsReview": false,
                "Title": "Radioiodine-refractory thyroid cancer—is it time to change the definition in light of novel redifferentiation therapies?",
                "Author": "Petra Petranović Ovčariček, Bart de Keizer, Alfredo Campennì, Michael C. Kreissl, Desiree Deandreis, Murat Tuncel, Luca Giovanella",
                "Journal": "European Journal of Nuclear Medicine and Molecular Imaging"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 10127622
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Selumetinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 25,
            "CooccurrenceScore": 24560,
            "Article": [
              {
                "PCLID": 17674211,
                "RelevanceScore": 566514,
                "PMID": 34156585,
                "DOI": "10.1007/s11060-021-03789-5",
                "PublicationDate": "2021-06-22",
                "IsReview": true,
                "Title": "US Food and Drug Administration regulatory updates in neuro-oncology",
                "Author": "Gautam U. Mehta, Amy K. Barone, Diana Bradford, Erin Larkins, Janice Kim, Lee Pai-Scherf, Adnan Jaigirdar, Mirat Shah, Suparna Wedam, Laleh Amiri-Kordestani, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Harpreet Singh",
                "Journal": "Journal of Neuro-Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "selumetinib"
              },
              {
                "PCLID": 37270700,
                "RelevanceScore": 485583,
                "PMID": 38807449,
                "DOI": "10.1111/cts.13818",
                "PublicationDate": "2024-05-28",
                "IsReview": false,
                "Title": "Impact of P‐gp inhibition on systemic exposure of pralsetinib and dosing considerations",
                "Author": "Julia Suchomel, Priya Agarwal, Doreen Anders, Kevin Hughes, Yang Tang, Rucha Sane, Astrid Scalori, Sunil Sharma, Sravanthi Cheeti",
                "Journal": "Clinical and Translational Science",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34630677,
                "RelevanceScore": 289038,
                "PMID": 36646803,
                "DOI": "10.1038/s41591-022-02160-z",
                "PublicationDate": "2023-01-01",
                "IsReview": true,
                "Title": "The next generation of evidence-based medicine",
                "Author": "Vivek Subbiah",
                "Journal": "Nature Medicine"
              },
              {
                "PCLID": 37864145,
                "RelevanceScore": 289038,
                "PMID": 39417878,
                "DOI": "10.1007/s00424-024-03024-w",
                "PublicationDate": "2024-10-17",
                "IsReview": true,
                "Title": "Challenges and applications in generative AI for clinical tabular data in physiology",
                "Author": "Chaithra Umesh, Manjunath Mahendra, Saptarshi Bej, Olaf Wolkenhauer, Markus Wolfien",
                "Journal": "Pflügers Archiv - European Journal of Physiology"
              },
              {
                "PCLID": 38005529,
                "RelevanceScore": 174850,
                "PMID": 39560781,
                "DOI": "10.1007/s00259-024-06991-5",
                "PublicationDate": "2024-11-19",
                "IsReview": false,
                "Title": "Radioiodine-refractory thyroid cancer—is it time to change the definition in light of novel redifferentiation therapies?",
                "Author": "Petra Petranović Ovčariček, Bart de Keizer, Alfredo Campennì, Michael C. Kreissl, Desiree Deandreis, Murat Tuncel, Luca Giovanella",
                "Journal": "European Journal of Nuclear Medicine and Molecular Imaging"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5702198
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "azane;dichloroplatinum",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 34,
            "CooccurrenceScore": 23970,
            "Article": [
              {
                "PCLID": 34840771,
                "RelevanceScore": 179786,
                "PMID": 36757608,
                "DOI": "10.1007/s40273-023-01247-w",
                "PublicationDate": "2023-02-09",
                "IsReview": true,
                "Title": "Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
                "Author": "Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt",
                "Journal": "PharmacoEconomics",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34746821,
                "RelevanceScore": 163442,
                "PMID": 35962206,
                "DOI": "10.1038/s41591-022-01931-y",
                "PublicationDate": "2022-08-12",
                "IsReview": false,
                "Title": "Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial",
                "Author": "Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Giuseppe Curigliano",
                "Journal": "Nature Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 206778158,
                "RelevanceScore": 152880,
                "DOI": "10.1007/s40278-021-99416-2",
                "PublicationDate": "2021-07-24",
                "IsReview": false,
                "Title": "Carboplatin/pemetrexed/pralsetinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 214149620,
                "RelevanceScore": 152880,
                "DOI": "10.1007/s40278-022-19950-2",
                "PublicationDate": "2022-07-30",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 36470598,
                "RelevanceScore": 152880,
                "PMID": 37653509,
                "DOI": "10.1186/s13019-023-02349-4",
                "PublicationDate": "2023-08-31",
                "IsReview": true,
                "Title": "Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature",
                "Author": "Zirui Zhu, You Liu, Hengliang Xu, Haoyong Ning, Yanmin Xia, Leilei Shen",
                "Journal": "Journal of Cardiothoracic Surgery"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 60750
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Gemcitabine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 28,
            "CooccurrenceScore": 21666,
            "Article": [
              {
                "PCLID": 34840771,
                "RelevanceScore": 228105,
                "PMID": 36757608,
                "DOI": "10.1007/s40273-023-01247-w",
                "PublicationDate": "2023-02-09",
                "IsReview": true,
                "Title": "Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
                "Author": "Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt",
                "Journal": "PharmacoEconomics",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34746821,
                "RelevanceScore": 207368,
                "PMID": 35962206,
                "DOI": "10.1038/s41591-022-01931-y",
                "PublicationDate": "2022-08-12",
                "IsReview": false,
                "Title": "Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial",
                "Author": "Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Giuseppe Curigliano",
                "Journal": "Nature Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 36470598,
                "RelevanceScore": 193967,
                "PMID": 37653509,
                "DOI": "10.1186/s13019-023-02349-4",
                "PublicationDate": "2023-08-31",
                "IsReview": true,
                "Title": "Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature",
                "Author": "Zirui Zhu, You Liu, Hengliang Xu, Haoyong Ning, Yanmin Xia, Leilei Shen",
                "Journal": "Journal of Cardiothoracic Surgery"
              },
              {
                "PCLID": 750895473,
                "RelevanceScore": 193967,
                "DOI": "10.1007/s40278-023-40875-z",
                "PublicationDate": "2023-06-10",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 754912770,
                "RelevanceScore": 193967,
                "DOI": "10.1007/s40278-023-49412-z",
                "PublicationDate": "2023-11-18",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 25171648
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Tepotinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 42,
            "CooccurrenceScore": 21025,
            "Article": [
              {
                "PCLID": 38066819,
                "RelevanceScore": 339612,
                "PMID": 39614301,
                "DOI": "10.1186/s13023-024-03377-6",
                "PublicationDate": "2024-11-29",
                "IsReview": true,
                "Title": "Navigating health policies and programs in India: exploring opportunities to improve rare disease management and orphan drug research",
                "Author": "Sangita Mishra, Deepa Bhat, M. P. Venkatesh",
                "Journal": "Orphanet Journal of Rare Diseases"
              },
              {
                "PCLID": 36558058,
                "RelevanceScore": 316316,
                "PMID": 37748692,
                "DOI": "10.1016/j.jtho.2023.09.1444",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function",
                "Author": "Monica F. Chen, Guilherme Harada, Dazhi Liu, Ray DeMatteo, Christina Falcon, Clare Wilhelm, Mark G. Kris, Alexander Drilon, Victoria Gutgarts",
                "Journal": "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tepotinib"
              },
              {
                "PCLID": 35033898,
                "RelevanceScore": 115562,
                "PMID": 36639452,
                "DOI": "10.1038/s41571-022-00718-x",
                "PublicationDate": "2023-01-13",
                "IsReview": true,
                "Title": "At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC",
                "Author": "Itziar Otano, Alvaro C. Ucero, Jon Zugazagoitia, Luis Paz-Ares",
                "Journal": "Nature reviews. Clinical oncology"
              },
              {
                "PCLID": 38512201,
                "RelevanceScore": 115562,
                "PMID": 40065316,
                "DOI": "10.1186/s12885-025-13786-w",
                "PublicationDate": "2025-03-11",
                "IsReview": true,
                "Title": "Efficacy of liquid biopsy for genetic mutations determination in non-small cell lung cancer: a systematic review on literatures",
                "Author": "Mohammad Mehdi Jahani, Parisa Mashayekhi, Mir Davood Omrani, Azita Azimi Meibody",
                "Journal": "BMC Cancer"
              },
              {
                "PCLID": 678163806,
                "RelevanceScore": 98467,
                "DOI": "10.1007/978-3-030-56051-5_4",
                "PublicationDate": "2021-01-01",
                "IsReview": false,
                "Title": "Biomarkers",
                "Author": "Fiorella Guadagni, Sofia Cutaia, Giorgio Madonia, Valerio Gristina, Lorena Incorvaia, Lidia Rita Corsini, Daniele Fanale, Claudio Longhitano, Federica Martorana, Juan Lucio Iovanna, Viviana Bazan, Paolo Vigneri",
                "Journal": "Practical Medical Oncology Textbook"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 108157
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "GlyTouCan:G91391XS",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 20972,
            "Article": [
              {
                "PCLID": 39141314,
                "RelevanceScore": 615595,
                "PMID": 40702584,
                "DOI": "10.1186/s40364-025-00809-8",
                "PublicationDate": "2025-07-23",
                "IsReview": false,
                "Title": "Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study",
                "Author": "Chang Lu, Chong-Rui Xu, Yi-Chen Zhang, E-E Ke, Yue-Li Sun, Xiao-Yan Bai, Zhi-Hong Chen, Jian Su, Yu Deng, Ting Hou, Fei Zhao, Min Li, Bin-Chao Wang, Hai-Yan Tu, Zhen Wang, Xu-Chao Zhang, Hua-Jun Chen, Jin-Ji Yang, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu",
                "Journal": "Biomarker Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "pfs"
              },
              {
                "PCLID": 36397716,
                "RelevanceScore": 568242,
                "PMID": 37924363,
                "DOI": "10.1007/s00520-023-08125-3",
                "PublicationDate": "2023-11-04",
                "IsReview": false,
                "Title": "Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer",
                "Author": "Ming Gao, Xia Zhang, Huan Yan, Decong Sun, Xuejiao Yang, Fang Yuan, Yanfang Ju, Lijie Wang, Jinliang Wang, Wei Zhao, Dong Zhang, Lin Li, Xiaoyun Xu, Junxun Ma, Yi Hu, Xiaotao Zhang",
                "Journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "pfs"
              },
              {
                "PCLID": 33989076,
                "RelevanceScore": 520888,
                "PMID": 35692799,
                "DOI": "10.3389/fonc.2022.864367",
                "PublicationDate": "2022-05-24",
                "IsReview": false,
                "Title": "The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research",
                "Author": "Yan Meng, Yilin Yang, Yujia Fang, Xinqing Lin, Xiaohong Xie, Haiyi Deng, Jianhui Wu, Maolin Zhou, Ni Sun, Zhanhong Xie, Ming Liu, Ming Ouyang, Yinyin Qin, Chunxia Su, Chengzhi Zhou",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "pfs"
              },
              {
                "PCLID": 34100617,
                "RelevanceScore": 372063,
                "PMID": 35462671,
                "DOI": "10.1007/s13193-021-01381-x",
                "PublicationDate": "2021-08-15",
                "IsReview": false,
                "Title": "An Audit of Systemic Therapy in Medullary Carcinoma Thyroid",
                "Author": "Aditya Pavan Kumar Kanteti, George Abraham, Vijay M. Patil, Nandini Menon, Tanmoy Mandal, Sobin V. Jacob, Keshav Garg, Anbarasan Sekar, Rup Jyoti Sarma, Laxma Reddy Mekala, Dipti Nakti, Neha Mittal, Munita Bal, Swapnil Rane, Nilendu C. Purandare, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Vanita Noronha, Kumar Prabhash",
                "Journal": "Indian Journal of Surgical Oncology",
                "ChemicalName_2": "pfs"
              },
              {
                "PCLID": 35116142,
                "RelevanceScore": 372063,
                "PMID": 36626081,
                "DOI": "10.1007/s12020-022-03296-1",
                "PublicationDate": "2023-01-10",
                "IsReview": false,
                "Title": "Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance",
                "Author": "Katerina Saltiki, George Simeakis, Olga Karapanou, Stavroula A. Paschou, Maria Alevizaki",
                "Journal": "Endocrine",
                "ChemicalName_2": "pfs"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 57379345
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Ceritinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 39,
            "CooccurrenceScore": 20223,
            "Article": [
              {
                "PCLID": 34278014,
                "RelevanceScore": 328889,
                "PMID": 35816666,
                "DOI": "10.1200/jco.22.00824",
                "PublicationDate": "2022-10-01",
                "IsReview": false,
                "Title": "Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline",
                "Author": "Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew G. Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael A. Jaiyesimi",
                "Journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "ceritinib"
              },
              {
                "PCLID": 38421735,
                "RelevanceScore": 298990,
                "PMID": 39982551,
                "DOI": "10.1007/s12022-025-09850-7",
                "PublicationDate": "2025-02-21",
                "IsReview": false,
                "Title": "Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation",
                "Author": "Yixuan Liu, Longnv Bao, Guangqi Li, Weimao Kong, Xueqing Li, Jingnan Wang, Xingzhu Pan, Zhen Zhang, Jigang Wang",
                "Journal": "Endocrine Pathology"
              },
              {
                "PCLID": 35590248,
                "RelevanceScore": 180871,
                "PMID": 37197619,
                "DOI": "10.21037/tlcr-22-566",
                "PublicationDate": "2023-04-28",
                "IsReview": true,
                "Title": "Clinical characteristics and targeted therapy of different gene fusions in non-small cell lung cancer: a narrative review",
                "Author": "Jiayan Chen, Chunwei Xu, Jiawen Lv, Wanjun Lu, Yixue Zhang, Dong Wang, Yong Song",
                "Journal": "Translational Lung Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "ceritinib"
              },
              {
                "PCLID": 12938073,
                "RelevanceScore": 146505,
                "PMID": 34508169,
                "DOI": "10.1038/s41698-021-00221-z",
                "PublicationDate": "2021-09-10",
                "IsReview": false,
                "Title": "Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions",
                "Author": "Binghao Li, Hao Qu, Jing Zhang, Weibo Pan, Meng Liu, Xiaobo Yan, Xin Huang, Xuexin He, Dong Lin, Sisi Liu, Ruting Guan, Yong Wu, Qiuxiang Ou, Hua Bao, Youbin Xu, Xue Wu, Yang Shao, Nong Lin",
                "Journal": "npj Precision Oncology"
              },
              {
                "PCLID": 34100593,
                "RelevanceScore": 146505,
                "PMID": 35462645,
                "DOI": "10.1007/s13193-021-01401-w",
                "PublicationDate": "2021-08-02",
                "IsReview": false,
                "Title": "Revisiting Combination Chemotherapy as a Single Modality Palliative Therapy for Advanced Anaplastic Thyroid Carcinoma—a Single Institution Experience",
                "Author": "Surabhi Garg, Sasi Mouli, Kul Ranjan Singh, Pooja Ramakant, Anand K. Mishra, Chanchal Rana",
                "Journal": "Indian Journal of Surgical Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 135565923
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Repotrectinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 31,
            "CooccurrenceScore": 18838,
            "Article": [
              {
                "PCLID": 34244735,
                "RelevanceScore": 495260,
                "PMID": 35612671,
                "DOI": "10.1007/s10637-022-01259-x",
                "PublicationDate": "2022-05-25",
                "IsReview": false,
                "Title": "The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046",
                "Author": "Matteo Repetto, Edoardo Crimini, Liliana Ascione, Luca Boscolo Bielo, Carmen Belli, Giuseppe Curigliano",
                "Journal": "Investigational New Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 775675085,
                "RelevanceScore": 180095,
                "DOI": "10.1007/s44272-025-00036-0",
                "PublicationDate": "2025-05-20",
                "IsReview": false,
                "Title": "Guideline of precisional testing in intrahepatic cholangiocarcinoma: an international expert consensus",
                "Author": "Xin Zhang, Jing Han, Ruoyu Shi, Bing Yu, Xuchen Zhang, Bin Li, Xia Sheng, Zengshan Li, Yining Zou, Huichuan Sun, Guoming Shi, Hanlin L. Wang, Jian Zhou, Jia Fan, Wenming Cong, Yuan Ji",
                "Journal": "Clinical Cancer Bulletin"
              },
              {
                "PCLID": 36897636,
                "RelevanceScore": 166754,
                "PMID": 38438731,
                "DOI": "10.1038/s41698-024-00563-4",
                "PublicationDate": "2024-03-04",
                "IsReview": false,
                "Title": "Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer",
                "Author": "Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 776812680,
                "RelevanceScore": 106565,
                "DOI": "10.1186/s42047-025-00177-5",
                "PublicationDate": "2025-07-10",
                "IsReview": false,
                "Title": "A panorama of lung cancer biomarkers",
                "Author": "Ana Sofia Silva Mesquita, Maire Iumi Maeda, Juliana Cabral Duarte Brandão, Nicolle Cavalcante Gaglionone, Igor Campos da Silva, Milena Perez Mak, Ellen Caroline Toledo do Nascimento",
                "Journal": "Surgical and Experimental Pathology"
              },
              {
                "PCLID": 35285560,
                "RelevanceScore": 91885,
                "PMID": 36395392,
                "DOI": "10.1021/acs.jmedchem.2c01361",
                "PublicationDate": "2022-11-17",
                "IsReview": true,
                "Title": "Targeting Gatekeeper Mutations for Kinase Drug Discovery",
                "Author": "Yang Zhou, Shuang Xiang, Fang Yang, Xiaoyun Lu",
                "Journal": "Journal of Medicinal Chemistry"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 148124
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Docetaxel",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 22,
            "CooccurrenceScore": 18397,
            "Article": [
              {
                "PCLID": 34840771,
                "RelevanceScore": 458610,
                "PMID": 36757608,
                "DOI": "10.1007/s40273-023-01247-w",
                "PublicationDate": "2023-02-09",
                "IsReview": true,
                "Title": "Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
                "Author": "Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt",
                "Journal": "PharmacoEconomics",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "docetaxel"
              },
              {
                "PCLID": 36470598,
                "RelevanceScore": 272982,
                "PMID": 37653509,
                "DOI": "10.1186/s13019-023-02349-4",
                "PublicationDate": "2023-08-31",
                "IsReview": true,
                "Title": "Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature",
                "Author": "Zirui Zhu, You Liu, Hengliang Xu, Haoyong Ning, Yanmin Xia, Leilei Shen",
                "Journal": "Journal of Cardiothoracic Surgery",
                "ChemicalName_2": "docetaxel"
              },
              {
                "PCLID": 214149620,
                "RelevanceScore": 194987,
                "DOI": "10.1007/s40278-022-19950-2",
                "PublicationDate": "2022-07-30",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 742107349,
                "RelevanceScore": 194987,
                "DOI": "10.1007/s40278-023-32181-x",
                "PublicationDate": "2023-01-21",
                "IsReview": false,
                "Title": "Multiple drugs",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 754912770,
                "RelevanceScore": 194987,
                "DOI": "10.1007/s40278-023-49412-z",
                "PublicationDate": "2023-11-18",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 86705695
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Pemigatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 22,
            "CooccurrenceScore": 16934,
            "Article": [
              {
                "PCLID": 34296446,
                "RelevanceScore": 336982,
                "PMID": 35796778,
                "DOI": "10.1007/s00432-022-04165-0",
                "PublicationDate": "2022-07-07",
                "IsReview": true,
                "Title": "Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board",
                "Author": "Kathrin Heinrich, Lisa Miller-Phillips, Frank Ziemann, Korbinian Hasselmann, Katharina Rühlmann, Madeleine Flach, Dorottya Biro, Michael von Bergwelt-Baildon, Julian Holch, Tobias Herold, Louisa von Baumgarten, Philipp A. Greif, Irmela Jeremias, Rachel Wuerstlein, Jozefina Casuscelli, Christine Spitzweg, Max Seidensticker, Bernhard Renz, Stefanie Corradini, Philipp Baumeister, Elisabetta Goni, Amanda Tufman, Andreas Jung, Jörg Kumbrink, Thomas Kirchner, Frederick Klauschen, Klaus H. Metzeler, Volker Heinemann, C. Benedikt Westphalen",
                "Journal": "Journal of Cancer Research and Clinical Oncology"
              },
              {
                "PCLID": 35292415,
                "RelevanceScore": 336982,
                "PMID": 36167530,
                "DOI": "10.1186/s12885-022-09922-5",
                "PublicationDate": "2022-09-27",
                "IsReview": false,
                "Title": "Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers",
                "Author": "Huita Wu, Haonan Ji, Wenhui Yang, Min Zhang, Yifang Guo, Bangkai Li, Jiayin Wang, Rongrong Chen, Yuan Chen, Xin Wang",
                "Journal": "BMC Cancer"
              },
              {
                "PCLID": 20367522,
                "RelevanceScore": 198642,
                "PMID": 33513356,
                "DOI": "10.1016/j.phrs.2021.105463",
                "PublicationDate": "2021-03-01",
                "IsReview": true,
                "Title": "Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update",
                "Author": "Robert Roskoski",
                "Journal": "Pharmacological Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "pemigatinib"
              },
              {
                "PCLID": 35304373,
                "RelevanceScore": 181633,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "pemigatinib"
              },
              {
                "PCLID": 775675085,
                "RelevanceScore": 165121,
                "DOI": "10.1007/s44272-025-00036-0",
                "PublicationDate": "2025-05-20",
                "IsReview": false,
                "Title": "Guideline of precisional testing in intrahepatic cholangiocarcinoma: an international expert consensus",
                "Author": "Xin Zhang, Jing Han, Ruoyu Shi, Bing Yu, Xuchen Zhang, Bin Li, Xia Sheng, Zengshan Li, Yining Zou, Huichuan Sun, Guoming Shi, Hanlin L. Wang, Jian Zhou, Jia Fan, Wenming Cong, Yuan Ji",
                "Journal": "Clinical Cancer Bulletin"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 9999
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Cyanogen",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 14,
            "CooccurrenceScore": 15444,
            "Article": [
              {
                "PCLID": 36397716,
                "RelevanceScore": 383559,
                "PMID": 37924363,
                "DOI": "10.1007/s00520-023-08125-3",
                "PublicationDate": "2023-11-04",
                "IsReview": false,
                "Title": "Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer",
                "Author": "Ming Gao, Xia Zhang, Huan Yan, Decong Sun, Xuejiao Yang, Fang Yuan, Yanfang Ju, Lijie Wang, Jinliang Wang, Wei Zhao, Dong Zhang, Lin Li, Xiaoyun Xu, Junxun Ma, Yi Hu, Xiaotao Zhang",
                "Journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34100617,
                "RelevanceScore": 228309,
                "PMID": 35462671,
                "DOI": "10.1007/s13193-021-01381-x",
                "PublicationDate": "2021-08-15",
                "IsReview": false,
                "Title": "An Audit of Systemic Therapy in Medullary Carcinoma Thyroid",
                "Author": "Aditya Pavan Kumar Kanteti, George Abraham, Vijay M. Patil, Nandini Menon, Tanmoy Mandal, Sobin V. Jacob, Keshav Garg, Anbarasan Sekar, Rup Jyoti Sarma, Laxma Reddy Mekala, Dipti Nakti, Neha Mittal, Munita Bal, Swapnil Rane, Nilendu C. Purandare, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Vanita Noronha, Kumar Prabhash",
                "Journal": "Indian Journal of Surgical Oncology"
              },
              {
                "PCLID": 666217974,
                "RelevanceScore": 228309,
                "DOI": "10.1007/978-3-030-61919-0_38",
                "PublicationDate": "2020-12-16",
                "IsReview": false,
                "Title": "Medical Treatment Decision-Making for Advanced Medullary Thyroid Cancer",
                "Author": "Ramona Dadu, Mimi I. Hu",
                "Journal": "Thyroid Cancer"
              },
              {
                "PCLID": 760354020,
                "RelevanceScore": 228309,
                "DOI": "10.1007/978-3-031-38605-3_15",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Surgery for Medullary Thyroid Cancer",
                "Author": "E. Gréant, A. R. Shaha, I. J. Nixon",
                "Journal": "Practical Management of Thyroid Cancer"
              },
              {
                "PCLID": 36324511,
                "RelevanceScore": 138113,
                "PMID": 38102498,
                "DOI": "10.1007/s12020-023-03638-7",
                "PublicationDate": "2023-12-16",
                "IsReview": false,
                "Title": "Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States",
                "Author": "Francis Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang",
                "Journal": "Endocrine"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 167196
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Iodine Radioisotopes",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 11,
            "CooccurrenceScore": 15170,
            "Article": [
              {
                "PCLID": 36227874,
                "RelevanceScore": 329552,
                "PMID": 38009200,
                "DOI": "10.1089/thy.2023.0363",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study",
                "Author": "Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schuler, Viola W. Zhu, Julien Hadoux, Giuseppe Curigliano, Lori Wirth, Justin F. Gainor, Guzman Alonso, Douglas Adkins, Yann Godbert, Myung-Ju Ahn, Philippe A. Cassier, Byoung Chul Cho, Chia-Chi Lin, Alena Zalutskaya, Teresa Barata, Peter Trask, Astrid Scalori, Walter Bordogna, Sebastian Heinzmann, Marcia S. Brose",
                "Journal": "Thyroid : official journal of the American Thyroid Association",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 35171699,
                "RelevanceScore": 302089,
                "PMID": 36327463,
                "DOI": "10.1097/rlu.0000000000004475",
                "PublicationDate": "2022-11-11",
                "IsReview": false,
                "Title": "Reversing \"Flip-Flop\" Phenomenon of 131 I and Glucose Avidity in RET-Fusion Positive Radioiodine-Refractory Thyroid Cancer Lesions After Treatment of Pralsetinib",
                "Author": "Hung-Pin Chan, I-Feng Chen, Fu-Ren Tsai, Chun-Hao Kao, Daniel Hueng-Yuan Shen",
                "Journal": "Clinical Nuclear Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 9572982,
                "RelevanceScore": 274626,
                "PMID": 34583388,
                "DOI": "10.1055/a-1580-7327",
                "PublicationDate": "2022-04-01",
                "IsReview": false,
                "Title": "[Treatment strategy by radioiodine refractory differentiated thyroid cancer]",
                "Author": "Konstantinos Mantsopoulos, Sarina K Mueller, Marianne Pavel, Torsten Kuwert, Norbert Meidenbauer, Rainer Fietkau, Matti Sievert, Heinrich Iro",
                "Journal": "Laryngo- rhino- otologie",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 36041619,
                "RelevanceScore": 152570,
                "PMID": 37257629,
                "DOI": "10.1016/j.bbcan.2023.188928",
                "PublicationDate": "2023-07-01",
                "IsReview": true,
                "Title": "Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities",
                "Author": "Lizhuo Zhang, Qingqing Feng, Jiafeng Wang, Zhuo Tan, Qinglin Li, Minghua Ge",
                "Journal": "Biochimica et Biophysica Acta (BBA) - Reviews on Cancer",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 36324511,
                "RelevanceScore": 118666,
                "PMID": 38102498,
                "DOI": "10.1007/s12020-023-03638-7",
                "PublicationDate": "2023-12-16",
                "IsReview": false,
                "Title": "Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States",
                "Author": "Francis Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang",
                "Journal": "Endocrine"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 56960363
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Ensartinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 12,
            "CooccurrenceScore": 14700,
            "Article": [
              {
                "PCLID": 37161097,
                "RelevanceScore": 1613433,
                "PMID": 38698976,
                "DOI": "10.1016/j.heliyon.2024.e29928",
                "PublicationDate": "2024-05-15",
                "IsReview": false,
                "Title": "RET rearrangement as a mechanism of resistance to ALK-TKI in non-small cell lung cancer patient with EML4-ALK fusion: A case report",
                "Author": "Huan Yan, Liang Zeng, Yongchang Zhang",
                "Journal": "Heliyon",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "ensartinib"
              },
              {
                "PCLID": 39179011,
                "RelevanceScore": 714483,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "ensartinib"
              },
              {
                "PCLID": 35590248,
                "RelevanceScore": 216510,
                "PMID": 37197619,
                "DOI": "10.21037/tlcr-22-566",
                "PublicationDate": "2023-04-28",
                "IsReview": true,
                "Title": "Clinical characteristics and targeted therapy of different gene fusions in non-small cell lung cancer: a narrative review",
                "Author": "Jiayan Chen, Chunwei Xu, Jiawen Lv, Wanjun Lu, Yixue Zhang, Dong Wang, Yong Song",
                "Journal": "Translational Lung Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "ensartinib"
              },
              {
                "PCLID": 36366594,
                "RelevanceScore": 155657,
                "PMID": 38011864,
                "DOI": "10.1055/s-0043-1776782",
                "PublicationDate": "2023-11-27",
                "IsReview": true,
                "Title": "Management of Brain Metastases: A Review of Novel Therapies",
                "Author": "Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W. McDermott, Manmeet S. Ahluwalia",
                "Journal": "Seminars in Neurology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "ensartinib"
              },
              {
                "PCLID": 35436076,
                "RelevanceScore": 54128,
                "PMID": 36806787,
                "DOI": "10.1038/s41571-023-00733-6",
                "PublicationDate": "2023-02-20",
                "IsReview": true,
                "Title": "Rare molecular subtypes of lung cancer",
                "Author": "Guilherme Harada, Soo-Ryum Yang, Emiliano Cocco, Alexander Drilon",
                "Journal": "Nature reviews. Clinical oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 135423438
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Nintedanib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 13,
            "CooccurrenceScore": 14597,
            "Article": [
              {
                "PCLID": 34840771,
                "RelevanceScore": 633729,
                "PMID": 36757608,
                "DOI": "10.1007/s40273-023-01247-w",
                "PublicationDate": "2023-02-09",
                "IsReview": true,
                "Title": "Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
                "Author": "Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt",
                "Journal": "PharmacoEconomics",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "nintedanib"
              },
              {
                "PCLID": 754912770,
                "RelevanceScore": 269443,
                "DOI": "10.1007/s40278-023-49412-z",
                "PublicationDate": "2023-11-18",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 35829919,
                "RelevanceScore": 242049,
                "PMID": 37131086,
                "DOI": "10.1007/s11684-023-0985-y",
                "PublicationDate": "2023-04-01",
                "IsReview": true,
                "Title": "Progress and challenges in RET-targeted cancer therapy",
                "Author": "Xueqing Hu, Ujjwol Khatri, Tao Shen, Jie Wu",
                "Journal": "Frontiers of Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 775900487,
                "RelevanceScore": 132027,
                "DOI": "10.1007/s40278-025-82673-x",
                "PublicationDate": "2025-05-17",
                "IsReview": false,
                "Title": "Dacarbazine/temozolomide",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 34104558,
                "RelevanceScore": 96020,
                "PMID": 35598228,
                "DOI": "10.1007/s12272-022-01385-3",
                "PublicationDate": "2022-05-22",
                "IsReview": true,
                "Title": "Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers",
                "Author": "Faraat Ali, Kumari Neha, Garima Chauhan",
                "Journal": "Archives of Pharmacal Research",
                "ChemicalName_1": "pralsetinib; prl"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 123631
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Gefitinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 39,
            "CooccurrenceScore": 14509,
            "Article": [
              {
                "PCLID": 762631631,
                "RelevanceScore": 222146,
                "DOI": "10.1007/s40278-024-57175-9",
                "PublicationDate": "2024-04-27",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 35829919,
                "RelevanceScore": 199561,
                "PMID": 37131086,
                "DOI": "10.1007/s11684-023-0985-y",
                "PublicationDate": "2023-04-01",
                "IsReview": true,
                "Title": "Progress and challenges in RET-targeted cancer therapy",
                "Author": "Xueqing Hu, Ujjwol Khatri, Tao Shen, Jie Wu",
                "Journal": "Frontiers of Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 771524598,
                "RelevanceScore": 134385,
                "DOI": "10.1007/s11696-025-03894-z",
                "PublicationDate": "2025-02-10",
                "IsReview": false,
                "Title": "Computational insights and predictive models for lung cancer molecular structures",
                "Author": "Yeliz Kara, Yeşim Sağlam Özkan, Micheal Arockiaraj",
                "Journal": "Chemical Papers"
              },
              {
                "PCLID": 35304373,
                "RelevanceScore": 119737,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "gefitinib"
              },
              {
                "PCLID": 12938073,
                "RelevanceScore": 108852,
                "PMID": 34508169,
                "DOI": "10.1038/s41698-021-00221-z",
                "PublicationDate": "2021-09-10",
                "IsReview": false,
                "Title": "Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions",
                "Author": "Binghao Li, Hao Qu, Jing Zhang, Weibo Pan, Meng Liu, Xiaobo Yan, Xin Huang, Xuexin He, Dong Lin, Sisi Liu, Ruting Guan, Yong Wu, Qiuxiang Ou, Hua Bao, Youbin Xu, Xue Wu, Yang Shao, Nong Lin",
                "Journal": "npj Precision Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 44237242
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Piperidines",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 6,
            "CooccurrenceScore": 14328,
            "Article": [
              {
                "PCLID": 36227874,
                "RelevanceScore": 330225,
                "PMID": 38009200,
                "DOI": "10.1089/thy.2023.0363",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study",
                "Author": "Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schuler, Viola W. Zhu, Julien Hadoux, Giuseppe Curigliano, Lori Wirth, Justin F. Gainor, Guzman Alonso, Douglas Adkins, Yann Godbert, Myung-Ju Ahn, Philippe A. Cassier, Byoung Chul Cho, Chia-Chi Lin, Alena Zalutskaya, Teresa Barata, Peter Trask, Astrid Scalori, Walter Bordogna, Sebastian Heinzmann, Marcia S. Brose",
                "Journal": "Thyroid : official journal of the American Thyroid Association",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34364823,
                "RelevanceScore": 302706,
                "PMID": 36768635,
                "DOI": "10.3390/ijms24032312",
                "PublicationDate": "2023-01-24",
                "IsReview": true,
                "Title": "Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect",
                "Author": "Linnea Højer Wang, Markus Wehland, Petra M. Wise, Manfred Infanger, Daniela Grimm, Michael C. Kreissl",
                "Journal": "International Journal of Molecular Sciences",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 37607276,
                "RelevanceScore": 302706,
                "PMID": 39137926,
                "DOI": "10.1080/14740338.2024.2392003",
                "PublicationDate": "2024-08-19",
                "IsReview": false,
                "Title": "Cardiovascular toxicities of selective ret-specific tyrosine kinase inhibitors: a pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database",
                "Author": "Yinjing Hou, Xiayang Ren, Ying Chen, Yanfeng Wang",
                "Journal": "Expert Opinion on Drug Safety",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 32529201,
                "RelevanceScore": 235438,
                "PMID": 34598787,
                "DOI": "10.1016/j.bulcan.2021.05.009",
                "PublicationDate": "2021-11-01",
                "IsReview": false,
                "Title": "[Drug approval: Selpercatinib and pralsetinib - RET-altered thyroid cancer]",
                "Author": "Baudouin Courtier, Julien Hadoux",
                "Journal": "Bulletin du cancer",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 25114163,
                "RelevanceScore": 196563,
                "PMID": 34826838,
                "DOI": "10.1055/a-1495-2991",
                "PublicationDate": "2021-11-01",
                "IsReview": false,
                "Title": "[Medullary thyroid carcinoma: current clinical progress]",
                "Author": "Matthias Kroiss, Viktoria Florentine Koehler, Christine Spitzweg",
                "Journal": "Deutsche medizinische Wochenschrift (1946)",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 586
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Creatine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 14145,
            "Article": [
              {
                "PCLID": 34883454,
                "RelevanceScore": 601140,
                "PMID": 35973665,
                "DOI": "10.1016/j.annonc.2022.08.002",
                "PublicationDate": "2022-11-01",
                "IsReview": false,
                "Title": "Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial",
                "Author": "F. Griesinger, G. Curigliano, M. Thomas, V. Subbiah, C.S. Baik, D.S.W. Tan, D.H. Lee, D. Misch, E. Garralda, D.-W. Kim, A.J. van der Wekken, J.F. Gainor, L. Paz-Ares, S.V. Liu, G.P. Kalemkerian, Y. Houvras, D.W. Bowles, A.S. Mansfield, J.J. Lin, V. Smoljanovic, A. Rahman, S. Kong, A. Zalutskaya, M. Louie-Gao, A.L. Boral, J. Mazières",
                "Journal": "Annals of oncology : official journal of the European Society for Medical Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "creatine"
              },
              {
                "PCLID": 38263308,
                "RelevanceScore": 601140,
                "PMID": 37916501,
                "DOI": "10.2217/fon-2023-0155",
                "PublicationDate": "2023-11-02",
                "IsReview": false,
                "Title": "Pralsetinib in Patients with RET Fusion–Positive Non-Small-Cell Lung Cancer: A Plain Language Summary of the ARROW Study",
                "Author": "Frank Griesinger, Giuseppe Curigliano, Vivek Subbiah, Christina S Baik, Daniel SW Tan, Dae H Lee, Daniel Misch, Elena Garralda, Dong-Wan Kim, Anthonie J van der Wekken, Justin F Gainor, Luis Paz-Ares, Stephen V Liu, Gregory P Kalemkerian, Daniel W Bowles, Aaron S Mansfield, Jessica J Lin, Vlatka Smoljanovic, Ahmadur Rahman, Alena Zalutskaya, Melinda Louie-Gao, Andy L Boral, Julien Mazières",
                "Journal": "Future oncology (London, England)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "creatine"
              },
              {
                "PCLID": 36667151,
                "RelevanceScore": 424334,
                "PMID": 38261313,
                "DOI": "10.1530/erc-23-0134",
                "PublicationDate": "2024-01-23",
                "IsReview": false,
                "Title": "Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients",
                "Author": "Xiangqian Zheng, Meiyu Fang, Yun Fan, Yuping Sun, Meili Sun, Ankui Yang, Bin Zhang, Qinjiang Liu, Hui Liu, Xiaohong Zhou, Tao Huang, Jianwu Qin, Zhaohui Wang, Mengmeng Qin, Zhenwei Shen, Sheng Yao, Jason Yang, Yu Wang, Ming Gao",
                "Journal": "Endocrine-Related Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "creatine"
              },
              {
                "PCLID": 37696267,
                "RelevanceScore": 424334,
                "PMID": 39241296,
                "DOI": "10.1016/j.lungcan.2024.107936",
                "PublicationDate": "2024-10-01",
                "IsReview": false,
                "Title": "Efficacy and safety of pralsetinib in patients with RET fusion positive non–small cell lung cancer: An observational real world study",
                "Author": "Dehua Liao, Minghui Long, Jiwen Zhang, Xingyu Wei, Fei Li, Ting Yan, Desong Yang",
                "Journal": "Lung cancer (Amsterdam, Netherlands)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "creatine"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5394
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Temozolomide",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 11,
            "CooccurrenceScore": 13759,
            "Article": [
              {
                "PCLID": 39667339,
                "RelevanceScore": 1068259,
                "PMID": 41244832,
                "DOI": "10.3389/fphar.2025.1671798",
                "PublicationDate": "2025-10-31",
                "IsReview": false,
                "Title": "The RET inhibitor pralsetinib suppresses TMZ-resistant glioma growth by regulating spermine production",
                "Author": "Lingyun Ma, Hang Gong, Wei Sun, Jialing Deng, Qinghua Zhang, Jianzhao Niu, Huimin Sun, Xue Han, Tingting Du, Nina Xue, Ming Ji, Qian Liu",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "temozolomide; tmz"
              },
              {
                "PCLID": 35437836,
                "RelevanceScore": 218012,
                "PMID": 36959606,
                "DOI": "10.1186/s12967-023-04057-y",
                "PublicationDate": "2023-03-23",
                "IsReview": false,
                "Title": "The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach",
                "Author": "Veronica Villani, Beatrice Casini, Antonio Tanzilli, Mario Lecce, Fabrizio Rasile, Stefano Telera, Andrea Pace, Francesca Piludu, Irene Terrenato, Francesca Rollo, Francesca De Nicola, Maurizio Fanciulli, Matteo Pallocca, Gennaro Ciliberto, Mariantonia Carosi",
                "Journal": "Journal of Translational Medicine"
              },
              {
                "PCLID": 35768166,
                "RelevanceScore": 218012,
                "PMID": 37219741,
                "DOI": "10.1007/s10585-023-10208-8",
                "PublicationDate": "2023-05-23",
                "IsReview": false,
                "Title": "Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer",
                "Author": "Ladislaia Wolff, Ariane Steindl, Petar Popov, Karin Dieckmann, Brigitte Gatterbauer, Georg Widhalm, Anna Sophie Berghoff, Matthias Preusser, Markus Raderer, Barbara Kiesewetter",
                "Journal": "Clinical & Experimental Metastasis"
              },
              {
                "PCLID": 768182292,
                "RelevanceScore": 218012,
                "DOI": "10.1007/s40278-024-70355-7",
                "PublicationDate": "2024-11-09",
                "IsReview": false,
                "Title": "Selpercatinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 775900487,
                "RelevanceScore": 106826,
                "DOI": "10.1007/s40278-025-82673-x",
                "PublicationDate": "2025-05-17",
                "IsReview": false,
                "Title": "Dacarbazine/temozolomide",
                "Journal": "Reactions Weekly"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 10509
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Tetranitromethane",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 13678,
            "Article": [
              {
                "PCLID": 37809521,
                "RelevanceScore": 537134,
                "PMID": 39354540,
                "DOI": "10.1186/s13019-024-03092-0",
                "PublicationDate": "2024-10-01",
                "IsReview": false,
                "Title": "A case of neoadjuvant targeted therapy with pralsetinib for locally advanced lung adenocarcinoma with RET fusion mutation",
                "Author": "Wang Chunmao, Cheng Haijie, Wang Zitong, Yang Zhi",
                "Journal": "Journal of Cardiothoracic Surgery",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tnm"
              },
              {
                "PCLID": 22385182,
                "RelevanceScore": 492373,
                "PMID": 35223529,
                "DOI": "10.3389/fonc.2022.848779",
                "PublicationDate": "2022-09-08",
                "IsReview": false,
                "Title": "Use of savolitinib as neoadjuvant therapy for non–small cell lung cancer patient with MET exon 14 skipping alterations: A case report",
                "Author": "Ning Zhou, Tong Li, Maoli Liang, Fan Ren, Hong Ni, Wei Liu, Tao Shi, Dongbo Xu, Qiusong Chen, Haonan Yu, Zuoqing Song, Lingling Zu, Shuo Li, Song Xu",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tnm"
              },
              {
                "PCLID": 38545970,
                "RelevanceScore": 248673,
                "PMID": 40102262,
                "DOI": "10.1007/978-3-031-80396-3_11",
                "PublicationDate": "2025-01-01",
                "IsReview": true,
                "Title": "Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients",
                "Author": "Friedhelm Raue, Karin Frank-Raue",
                "Journal": "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer",
                "ChemicalName_2": "tnm"
              },
              {
                "PCLID": 37736596,
                "RelevanceScore": 223806,
                "PMID": 39278941,
                "DOI": "10.1186/s13044-024-00209-4",
                "PublicationDate": "2024-09-16",
                "IsReview": false,
                "Title": "Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements",
                "Author": "Daisuke Uno, Kazuhira Endo, Tomomi Yoshikawa, Nobuyuki Hirai, Eiji Kobayashi, Yosuke Nakanishi, Satoru Kondo, Tomokazu Yoshizaki",
                "Journal": "Thyroid Research",
                "ChemicalName_2": "tnm"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 16097729
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Motesanib Diphosphate",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 13590,
            "Article": [
              {
                "PCLID": 35207674,
                "RelevanceScore": 371705,
                "PMID": 36131239,
                "DOI": "10.1186/s12885-022-10081-w",
                "PublicationDate": "2022-09-21",
                "IsReview": false,
                "Title": "Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer",
                "Author": "Alicja Rączkowska, Iwona Paśnik, Michał Kukiełka, Marcin Nicoś, Magdalena A. Budzinska, Tomasz Kucharczyk, Justyna Szumiło, Paweł Krawczyk, Nicola Crosetto, Ewa Szczurek",
                "Journal": "BMC Cancer"
              },
              {
                "PCLID": 6134017,
                "RelevanceScore": 371705,
                "PMID": 33594641,
                "DOI": "10.1007/s40618-020-01491-3",
                "PublicationDate": "2021-02-17",
                "IsReview": false,
                "Title": "Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer",
                "Author": "A. Matrone, A. Prete, A. Nervo, A. Ragni, L. Agate, E. Molinaro, C. Giani, L. Valerio, E. Minaldi, A. Piovesan, R. Elisei",
                "Journal": "Journal of Endocrinological Investigation"
              },
              {
                "PCLID": 724809745,
                "RelevanceScore": 371705,
                "DOI": "10.1007/978-3-030-61919-0_37",
                "PublicationDate": "2020-12-16",
                "IsReview": false,
                "Title": "A Patient with an Advanced Medullary Thyroid Cancer and Progressive, Symptomatic Distant Metastases: When to Start Systemic Therapy",
                "Author": "Carlotta Giani, Antonio Matrone, Rossella Elisei",
                "Journal": "Thyroid Cancer"
              },
              {
                "PCLID": 38545970,
                "RelevanceScore": 224859,
                "PMID": 40102262,
                "DOI": "10.1007/978-3-031-80396-3_11",
                "PublicationDate": "2025-01-01",
                "IsReview": true,
                "Title": "Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients",
                "Author": "Friedhelm Raue, Karin Frank-Raue",
                "Journal": "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer"
              },
              {
                "PCLID": 38273201,
                "RelevanceScore": 18953,
                "PMID": 39836286,
                "DOI": "10.1007/s10143-025-03204-x",
                "PublicationDate": "2025-01-21",
                "IsReview": true,
                "Title": "The efficacy and safety of tyrosine kinase inhibitors in the treatment of advanced or metastatic chordoma: a single-arm meta-analysis",
                "Author": "Hongfeng Meng, Boyan Zhang, Penghao Liu, Yueqi Du, Can Zhang, Wanru Duan, Zan Chen",
                "Journal": "Neurosurgical Review"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 53716604
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Fluorodeoxyglucose",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 8,
            "CooccurrenceScore": 13307,
            "Article": [
              {
                "PCLID": 37726549,
                "RelevanceScore": 463532,
                "PMID": 39272672,
                "DOI": "10.3390/diagnostics14171886",
                "PublicationDate": "2024-08-28",
                "IsReview": false,
                "Title": "Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis",
                "Author": "Kalevi Kairemo, Homer A. Macapinlac, Mohammed Gouda, Vivek Subbiah",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "fluorodeoxyglucose"
              },
              {
                "PCLID": 38800716,
                "RelevanceScore": 263371,
                "PMID": 40350419,
                "DOI": "10.1186/s12957-025-03758-6",
                "PublicationDate": "2025-05-11",
                "IsReview": false,
                "Title": "An uncommon site for papillary thyroid carcinoma metastasis: a case of breast involvement",
                "Author": "Lovenish Bains, Uday Kumar Katuri, Chaitanya Polisetty, Pawan Lal, Meeta Singh",
                "Journal": "World Journal of Surgical Oncology",
                "ChemicalName_2": "fdg; fluorodeoxyglucose"
              },
              {
                "PCLID": 752904040,
                "RelevanceScore": 214996,
                "DOI": "10.1007/978-981-99-0938-4_82",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Aggressive Sporadic Medullary Thyroid Cancer",
                "Author": "Amit Agarwal, Ranil Fernando, Rajeev Parameswaran, Anand Mishra, Roma Pradhan",
                "Journal": "Case Studies in Thyroid and Parathyroid Tumors"
              },
              {
                "PCLID": 36694585,
                "RelevanceScore": 164607,
                "PMID": 38175464,
                "DOI": "10.1007/s11912-023-01490-6",
                "PublicationDate": "2024-01-01",
                "IsReview": true,
                "Title": "Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies",
                "Author": "Mandy Jongbloed, Atulya A. Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh, Dirk K.M. De Ruysscher, Lizza E.L. Hendriks, Aakash Desai",
                "Journal": "Current Oncology Reports"
              },
              {
                "PCLID": 37736596,
                "RelevanceScore": 105348,
                "PMID": 39278941,
                "DOI": "10.1186/s13044-024-00209-4",
                "PublicationDate": "2024-09-16",
                "IsReview": false,
                "Title": "Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements",
                "Author": "Daisuke Uno, Kazuhira Endo, Tomomi Yoshikawa, Nobuyuki Hirai, Eiji Kobayashi, Yosuke Nakanishi, Satoru Kondo, Tomokazu Yoshizaki",
                "Journal": "Thyroid Research"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 6569
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Methyl Ethyl Ketone",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 6,
            "CooccurrenceScore": 13199,
            "Article": [
              {
                "PCLID": 34758948,
                "RelevanceScore": 409193,
                "PMID": 35978072,
                "DOI": "10.1038/s41598-022-17791-y",
                "PublicationDate": "2022-08-17",
                "IsReview": false,
                "Title": "An integrative pan cancer analysis of RET aberrations and their potential clinical implications",
                "Author": "Lei Zhou, Juanni Li, Xiaofang Zhang, Zhijie Xu, Yuanliang Yan, Kuan Hu",
                "Journal": "Scientific Reports",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "mek"
              },
              {
                "PCLID": 38969075,
                "RelevanceScore": 409193,
                "PMID": 40502048,
                "DOI": "10.1101/2025.06.04.657911",
                "PublicationDate": "2025-06-07",
                "IsReview": false,
                "Title": "Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma",
                "Author": "Trista K Hinz, Anh T Le, Tristan Doan, Abby Ast, Sophia Jaramillo, Samantha Haines, Andre Navarro, Tejas Patil, Raphael A Nemenoff, Lynn E Heasley",
                "Journal": "bioRxiv : the preprint server for biology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "mek"
              },
              {
                "PCLID": 36466339,
                "RelevanceScore": 170497,
                "PMID": 37648897,
                "DOI": "10.1007/s11154-023-09833-1",
                "PublicationDate": "2023-08-31",
                "IsReview": true,
                "Title": "Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease",
                "Author": "Inés Califano, Anabella Smulever, Fernando Jerkovich, Fabian Pitoia",
                "Journal": "Reviews in Endocrine and Metabolic Disorders",
                "ChemicalName_2": "mek"
              },
              {
                "PCLID": 35850340,
                "RelevanceScore": 126294,
                "PMID": 37434642,
                "DOI": "10.1530/eo-22-0062",
                "PublicationDate": "2023-01-16",
                "IsReview": true,
                "Title": "Kinase inhibitors in thyroid cancers",
                "Author": "Vineeth Sukrithan, Prachi Jain, Manisha H Shah, Bhavana Konda",
                "Journal": "Endocrine oncology (Bristol, England)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "mek"
              },
              {
                "PCLID": 35210090,
                "RelevanceScore": 102298,
                "PMID": 36605433,
                "DOI": "10.3389/fonc.2022.1099280",
                "PublicationDate": "2022-12-20",
                "IsReview": true,
                "Title": "Molecular features of aggressive thyroid cancer",
                "Author": "Giusy Elia, Armando Patrizio, Francesca Ragusa, Sabrina Rosaria Paparo, Valeria Mazzi, Eugenia Balestri, Chiara Botrini, Licia Rugani, Salvatore Benvenga, Gabriele Materazzi, Claudio Spinelli, Alessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "mek"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5460541
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "l-aspartic acid, sodium salt",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 12332,
            "Article": [
              {
                "PCLID": 37823775,
                "RelevanceScore": 398392,
                "PMID": 39372206,
                "DOI": "10.3389/fphar.2024.1424980",
                "PublicationDate": "2024-09-20",
                "IsReview": false,
                "Title": "Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system",
                "Author": "Qiong Jie, Yuanyuan Li, Li Jing, Jinjin Chen, Yang Li",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "aspartate"
              },
              {
                "PCLID": 38373198,
                "RelevanceScore": 398392,
                "PMID": 39926433,
                "DOI": "10.3389/fmed.2025.1467871",
                "PublicationDate": "2025-01-24",
                "IsReview": false,
                "Title": "Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer",
                "Author": "Lei Wang, Yafei You, Wenzhuo He, Yu Hou, Lan Li, Li Wang, Chang Jiang, Jiahong Yi, Yaoxiong Xia, Liangping Xia",
                "Journal": "Frontiers in Medicine",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "aspartate"
              },
              {
                "PCLID": 38084636,
                "RelevanceScore": 331993,
                "PMID": 39630530,
                "DOI": "10.1089/thy.2024.0495",
                "PublicationDate": "2025-01-01",
                "IsReview": false,
                "Title": "Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma",
                "Author": "Sarah Hamidi, Sireesha Yedururi, Mimi I. Hu, Naifa L. Busaidy, Steven I. Sherman, Camilo Jimenez, Elizabeth G. Grubbs, Anastasios Maniakas, Mark E. Zafereo, Vivek Subbiah, Steven G. Waguespack",
                "Journal": "Thyroid : official journal of the American Thyroid Association",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "aspartate"
              },
              {
                "PCLID": 35057669,
                "RelevanceScore": 237138,
                "PMID": 36422787,
                "DOI": "10.1007/s11523-022-00935-5",
                "PublicationDate": "2022-11-24",
                "IsReview": true,
                "Title": "Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Tina Nie, Yahiya Y. Syed",
                "Journal": "Targeted Oncology",
                "ChemicalName_2": "aspartate"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5819
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Thyroxine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 11,
            "CooccurrenceScore": 11864,
            "Article": [
              {
                "PCLID": 34176639,
                "RelevanceScore": 375260,
                "PMID": 35704797,
                "DOI": "10.1200/po.21.00496",
                "PublicationDate": "2022-06-01",
                "IsReview": false,
                "Title": "Selpercatinib-Induced Hypothyroidism Through Off-Target Inhibition of Type 2 Iodothyronine Deiodinase",
                "Author": "Laura Boucai, Federico Salas-Lucia, Gnana P. Krishnamoorthy, Eric Sherman, Charles M. Rudin, Alexander Drilon, Antonio C. Bianco, James A. Fagin",
                "Journal": "JCO Precision Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "levothyroxine"
              },
              {
                "PCLID": 724809745,
                "RelevanceScore": 174054,
                "DOI": "10.1007/978-3-030-61919-0_37",
                "PublicationDate": "2020-12-16",
                "IsReview": false,
                "Title": "A Patient with an Advanced Medullary Thyroid Cancer and Progressive, Symptomatic Distant Metastases: When to Start Systemic Therapy",
                "Author": "Carlotta Giani, Antonio Matrone, Rossella Elisei",
                "Journal": "Thyroid Cancer"
              },
              {
                "PCLID": 38800716,
                "RelevanceScore": 133260,
                "PMID": 40350419,
                "DOI": "10.1186/s12957-025-03758-6",
                "PublicationDate": "2025-05-11",
                "IsReview": false,
                "Title": "An uncommon site for papillary thyroid carcinoma metastasis: a case of breast involvement",
                "Author": "Lovenish Bains, Uday Kumar Katuri, Chaitanya Polisetty, Pawan Lal, Meeta Singh",
                "Journal": "World Journal of Surgical Oncology"
              },
              {
                "PCLID": 37450737,
                "RelevanceScore": 113715,
                "PMID": 38997570,
                "DOI": "10.1007/s40265-024-02040-5",
                "PublicationDate": "2024-07-13",
                "IsReview": true,
                "Title": "RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future",
                "Author": "Monica F. Chen, Matteo Repetto, Clare Wilhelm, Alexander Drilon",
                "Journal": "Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 36324511,
                "RelevanceScore": 105292,
                "PMID": 38102498,
                "DOI": "10.1007/s12020-023-03638-7",
                "PublicationDate": "2023-12-16",
                "IsReview": false,
                "Title": "Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States",
                "Author": "Francis Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang",
                "Journal": "Endocrine"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 60953
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Capecitabine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 16,
            "CooccurrenceScore": 11689,
            "Article": [
              {
                "PCLID": 17674211,
                "RelevanceScore": 302760,
                "PMID": 34156585,
                "DOI": "10.1007/s11060-021-03789-5",
                "PublicationDate": "2021-06-22",
                "IsReview": true,
                "Title": "US Food and Drug Administration regulatory updates in neuro-oncology",
                "Author": "Gautam U. Mehta, Amy K. Barone, Diana Bradford, Erin Larkins, Janice Kim, Lee Pai-Scherf, Adnan Jaigirdar, Mirat Shah, Suparna Wedam, Laleh Amiri-Kordestani, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Harpreet Singh",
                "Journal": "Journal of Neuro-Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34746821,
                "RelevanceScore": 231198,
                "PMID": 35962206,
                "DOI": "10.1038/s41591-022-01931-y",
                "PublicationDate": "2022-08-12",
                "IsReview": false,
                "Title": "Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial",
                "Author": "Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Giuseppe Curigliano",
                "Journal": "Nature Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 775110353,
                "RelevanceScore": 216257,
                "DOI": "10.1007/s40278-025-82479-1",
                "PublicationDate": "2025-05-10",
                "IsReview": false,
                "Title": "Multiple drugs",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 775900487,
                "RelevanceScore": 105966,
                "DOI": "10.1007/s40278-025-82673-x",
                "PublicationDate": "2025-05-17",
                "IsReview": false,
                "Title": "Dacarbazine/temozolomide",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 767579102,
                "RelevanceScore": 73587,
                "DOI": "10.1186/s42047-024-00162-4",
                "PublicationDate": "2024-09-27",
                "IsReview": false,
                "Title": "Advancements and challenges in gastric cancer: epidemiology, biomarkers, and therapeutic strategies",
                "Author": "Marina Nishimuni, Laura Carolina Lopez Claro, Maria Ignez Freitas Melro Braghiroli",
                "Journal": "Surgical and Experimental Pathology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 36462
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Etoposide",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 13,
            "CooccurrenceScore": 11679,
            "Article": [
              {
                "PCLID": 34919368,
                "RelevanceScore": 440444,
                "PMID": 36437214,
                "DOI": "10.1016/j.cllc.2022.10.005",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Small-Cell Lung Cancer Transformation as a Mechanism of Resistance to Pralsetinib in RET-Rearranged Lung Adenocarcinoma: A Case Report",
                "Author": "Alexia Gazeu, Mylena Aubert, Daniel Pissaloux, Sylvie Lantuejoul, Maurice Pérol, Nadia Ikhlef, Amine Bouhamama, Tatiana Franceschi, Aurélie Swalduz",
                "Journal": "Clinical Lung Cancer",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "etoposide"
              },
              {
                "PCLID": 36294801,
                "RelevanceScore": 262169,
                "PMID": 38057798,
                "DOI": "10.1186/s12890-023-02799-5",
                "PublicationDate": "2023-12-06",
                "IsReview": false,
                "Title": "Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report",
                "Author": "Yan Peng, Zhu Zheng, Wang Zewen, Liu Yanan, Zhang Mingyan, Sun Meili",
                "Journal": "BMC Pulmonary Medicine",
                "ChemicalName_2": "etoposide"
              },
              {
                "PCLID": 756919212,
                "RelevanceScore": 187264,
                "DOI": "10.1007/s40278-023-48977-z",
                "PublicationDate": "2023-11-11",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 38341885,
                "RelevanceScore": 141168,
                "PMID": 39893475,
                "DOI": "10.1186/s12957-025-03687-4",
                "PublicationDate": "2025-02-01",
                "IsReview": true,
                "Title": "Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy",
                "Author": "Shuai Wang, Yongsen Wang, Xuan Wu, Li Yang, Xiaoju Zhang",
                "Journal": "World Journal of Surgical Oncology",
                "ChemicalName_2": "etoposide"
              },
              {
                "PCLID": 752977269,
                "RelevanceScore": 54295,
                "DOI": "10.1007/s12312-023-01218-4",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Neuerungen in der aktualisierten S3-Leitlinie „Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms“",
                "Journal": "Forum"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 51039094
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Tucatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 17,
            "CooccurrenceScore": 11404,
            "Article": [
              {
                "PCLID": 17674211,
                "RelevanceScore": 967693,
                "PMID": 34156585,
                "DOI": "10.1007/s11060-021-03789-5",
                "PublicationDate": "2021-06-22",
                "IsReview": true,
                "Title": "US Food and Drug Administration regulatory updates in neuro-oncology",
                "Author": "Gautam U. Mehta, Amy K. Barone, Diana Bradford, Erin Larkins, Janice Kim, Lee Pai-Scherf, Adnan Jaigirdar, Mirat Shah, Suparna Wedam, Laleh Amiri-Kordestani, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Harpreet Singh",
                "Journal": "Journal of Neuro-Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tucatinib"
              },
              {
                "PCLID": 20367522,
                "RelevanceScore": 194024,
                "PMID": 33513356,
                "DOI": "10.1016/j.phrs.2021.105463",
                "PublicationDate": "2021-03-01",
                "IsReview": true,
                "Title": "Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update",
                "Author": "Robert Roskoski",
                "Journal": "Pharmacological Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "tucatinib"
              },
              {
                "PCLID": 38076931,
                "RelevanceScore": 129026,
                "PMID": 39625633,
                "DOI": "10.1007/s11910-024-01388-1",
                "PublicationDate": "2024-12-03",
                "IsReview": true,
                "Title": "Emerging Therapies for Brain Metastases in NSCLC, Breast Cancer, and Melanoma: A Critical Review",
                "Author": "Vivek Podder, Tulika Ranjan, Maya Gowda, Alejandra M. Camacho, Manmeet S. Ahluwalia",
                "Journal": "Current Neurology and Neuroscience Reports",
                "ChemicalName_2": "tucatinib"
              },
              {
                "PCLID": 35780979,
                "RelevanceScore": 49778,
                "PMID": 37188899,
                "DOI": "10.1038/s41571-023-00770-1",
                "PublicationDate": "2023-05-15",
                "IsReview": true,
                "Title": "Cholangiocarcinoma — novel biological insights and therapeutic strategies",
                "Author": "Sumera I. Ilyas, Silvia Affo, Lipika Goyal, Angela Lamarca, Gonzalo Sapisochin, Ju Dong Yang, Gregory J. Gores",
                "Journal": "Nature reviews. Clinical oncology"
              },
              {
                "PCLID": 752836691,
                "RelevanceScore": 28000,
                "DOI": "10.1007/s00761-023-01386-x",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Zielgerichtete Therapie biliärer Tumoren",
                "Journal": "Die Onkologie"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 137278711
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Sotorasib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 7,
            "CooccurrenceScore": 11301,
            "Article": [
              {
                "PCLID": 39179011,
                "RelevanceScore": 647863,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "sotorasib"
              },
              {
                "PCLID": 24447163,
                "RelevanceScore": 441725,
                "PMID": 34553354,
                "DOI": "10.1055/a-1393-7697",
                "PublicationDate": "2021-10-01",
                "IsReview": false,
                "Title": "[Advances in Lung Cancer Treatment]",
                "Author": "Christian Schulz",
                "Journal": "Deutsche medizinische Wochenschrift (1946)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "sotorasib"
              },
              {
                "PCLID": 36365086,
                "RelevanceScore": 346955,
                "PMID": 37979367,
                "DOI": "10.1016/j.jchromb.2023.123918",
                "PublicationDate": "2023-12-01",
                "IsReview": false,
                "Title": "Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs",
                "Author": "Paul D. Kruithof, Yvo M. de Beer, Judith L. Gulikers, Leo M.L. Stolk, Lizza E.L. Hendriks, Sander Croes, Robin M.J.M. van Geel",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "sotorasib"
              },
              {
                "PCLID": 36366594,
                "RelevanceScore": 141143,
                "PMID": 38011864,
                "DOI": "10.1055/s-0043-1776782",
                "PublicationDate": "2023-11-27",
                "IsReview": true,
                "Title": "Management of Brain Metastases: A Review of Novel Therapies",
                "Author": "Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W. McDermott, Manmeet S. Ahluwalia",
                "Journal": "Seminars in Neurology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "sotorasib"
              },
              {
                "PCLID": 34312121,
                "RelevanceScore": 62118,
                "PMID": 35525790,
                "DOI": "10.1016/j.jgo.2022.04.013",
                "PublicationDate": "2022-11-01",
                "IsReview": true,
                "Title": "Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report",
                "Author": "Konstantinos Christofyllakis, Ana Raquel Monteiro, Onur Cetin, Igor Age Kos, Alastair Greystoke, Andrea Luciani",
                "Journal": "Journal of Geriatric Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "sotorasib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 56846693
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Agerafenib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 11207,
            "Article": [
              {
                "PCLID": 25155571,
                "RelevanceScore": 952503,
                "PMID": 35242632,
                "DOI": "10.21037/tlcr-21-571",
                "PublicationDate": "2022-01-01",
                "IsReview": false,
                "Title": "Use of on-therapy ctDNA monitoring in a patient with KIF5B-RET fusion positive advanced non-small cell lung cancer: a case report",
                "Author": "Vincent Yeung, Chul Kim, Lesli A. Kiedrowski, Stephen V. Liu, Joshua E. Reuss",
                "Journal": "Translational Lung Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "rxdx-105"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 254680,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 68614
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Fludeoxyglucose F-18",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 10792,
            "Article": [
              {
                "PCLID": 37726549,
                "RelevanceScore": 400747,
                "PMID": 39272672,
                "DOI": "10.3390/diagnostics14171886",
                "PublicationDate": "2024-08-28",
                "IsReview": false,
                "Title": "Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis",
                "Author": "Kalevi Kairemo, Homer A. Macapinlac, Mohammed Gouda, Vivek Subbiah",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "fdg-pet"
              },
              {
                "PCLID": 35171699,
                "RelevanceScore": 286248,
                "PMID": 36327463,
                "DOI": "10.1097/rlu.0000000000004475",
                "PublicationDate": "2022-11-11",
                "IsReview": false,
                "Title": "Reversing \"Flip-Flop\" Phenomenon of 131 I and Glucose Avidity in RET-Fusion Positive Radioiodine-Refractory Thyroid Cancer Lesions After Treatment of Pralsetinib",
                "Author": "Hung-Pin Chan, I-Feng Chen, Fu-Ren Tsai, Chun-Hao Kao, Daniel Hueng-Yuan Shen",
                "Journal": "Clinical Nuclear Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 37736596,
                "RelevanceScore": 200374,
                "PMID": 39278941,
                "DOI": "10.1186/s13044-024-00209-4",
                "PublicationDate": "2024-09-16",
                "IsReview": false,
                "Title": "Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements",
                "Author": "Daisuke Uno, Kazuhira Endo, Tomomi Yoshikawa, Nobuyuki Hirai, Eiji Kobayashi, Yosuke Nakanishi, Satoru Kondo, Tomokazu Yoshizaki",
                "Journal": "Thyroid Research",
                "ChemicalName_2": "18f-fdg; 18f-fluorodeoxyglucose; fdg"
              },
              {
                "PCLID": 38800716,
                "RelevanceScore": 142311,
                "PMID": 40350419,
                "DOI": "10.1186/s12957-025-03758-6",
                "PublicationDate": "2025-05-11",
                "IsReview": false,
                "Title": "An uncommon site for papillary thyroid carcinoma metastasis: a case of breast involvement",
                "Author": "Lovenish Bains, Uday Kumar Katuri, Chaitanya Polisetty, Pawan Lal, Meeta Singh",
                "Journal": "World Journal of Surgical Oncology"
              },
              {
                "PCLID": 37914743,
                "RelevanceScore": 130113,
                "PMID": 39468677,
                "DOI": "10.1186/s40644-024-00791-8",
                "PublicationDate": "2024-10-28",
                "IsReview": true,
                "Title": "Role of [18F]FDG PET/CT in the management of follicular cell-derived thyroid carcinoma",
                "Author": "Klaudia Zajkowska, Paulina Cegla, Marek Dedecjus",
                "Journal": "Cancer imaging : the official publication of the International Cancer Imaging Society",
                "ChemicalName_2": "2-[18f]fluoro-2-deoxy-d-glucose"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 129103609
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Selitrectinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 12,
            "CooccurrenceScore": 10459,
            "Article": [
              {
                "PCLID": 34244735,
                "RelevanceScore": 528077,
                "PMID": 35612671,
                "DOI": "10.1007/s10637-022-01259-x",
                "PublicationDate": "2022-05-25",
                "IsReview": false,
                "Title": "The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046",
                "Author": "Matteo Repetto, Edoardo Crimini, Liliana Ascione, Luca Boscolo Bielo, Carmen Belli, Giuseppe Curigliano",
                "Journal": "Investigational New Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 37227145,
                "RelevanceScore": 113626,
                "PMID": 38772990,
                "DOI": "10.1007/s12020-024-03867-4",
                "PublicationDate": "2024-05-21",
                "IsReview": false,
                "Title": "Ten years’ real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer",
                "Author": "Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, Fabián Pitoia",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 776812680,
                "RelevanceScore": 113626,
                "DOI": "10.1186/s42047-025-00177-5",
                "PublicationDate": "2025-07-10",
                "IsReview": false,
                "Title": "A panorama of lung cancer biomarkers",
                "Author": "Ana Sofia Silva Mesquita, Maire Iumi Maeda, Juliana Cabral Duarte Brandão, Nicolle Cavalcante Gaglionone, Igor Campos da Silva, Milena Perez Mak, Ellen Caroline Toledo do Nascimento",
                "Journal": "Surgical and Experimental Pathology"
              },
              {
                "PCLID": 35285560,
                "RelevanceScore": 97974,
                "PMID": 36395392,
                "DOI": "10.1021/acs.jmedchem.2c01361",
                "PublicationDate": "2022-11-17",
                "IsReview": true,
                "Title": "Targeting Gatekeeper Mutations for Kinase Drug Discovery",
                "Author": "Yang Zhou, Shuang Xiang, Fang Yang, Xiaoyun Lu",
                "Journal": "Journal of Medicinal Chemistry"
              },
              {
                "PCLID": 35436076,
                "RelevanceScore": 59268,
                "PMID": 36806787,
                "DOI": "10.1038/s41571-023-00733-6",
                "PublicationDate": "2023-02-20",
                "IsReview": true,
                "Title": "Rare molecular subtypes of lung cancer",
                "Author": "Guilherme Harada, Soo-Ryum Yang, Emiliano Cocco, Alexander Drilon",
                "Journal": "Nature reviews. Clinical oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 51038893
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Cobimetinib (racemate)",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 19,
            "CooccurrenceScore": 10351,
            "Article": [
              {
                "PCLID": 36286750,
                "RelevanceScore": 317736,
                "PMID": 37932425,
                "DOI": "10.1007/s00262-023-03560-x",
                "PublicationDate": "2023-11-06",
                "IsReview": false,
                "Title": "The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer",
                "Author": "Ziyun Shen, Meixin Teng, Lu Han, Dongliang Bian, Jing Zhang, Xinsheng Zhu, Yang Qing, Shiqi Hu, Yan Chen, Wangchao Yao, Huansha Yu, Lele Zhang, Peng Zhang",
                "Journal": "Cancer immunology, immunotherapy : CII"
              },
              {
                "PCLID": 36198818,
                "RelevanceScore": 128670,
                "PMID": 37973622,
                "DOI": "10.1007/s00104-023-01993-9",
                "PublicationDate": "2024-03-01",
                "IsReview": true,
                "Title": "[Personalized approach to anaplastic thyroid carcinoma]",
                "Author": "Sabine Wächter, Detlef K Bartsch, Elisabeth Maurer",
                "Journal": "Chirurgie (Heidelberg, Germany)"
              },
              {
                "PCLID": 36466339,
                "RelevanceScore": 108118,
                "PMID": 37648897,
                "DOI": "10.1007/s11154-023-09833-1",
                "PublicationDate": "2023-08-31",
                "IsReview": true,
                "Title": "Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease",
                "Author": "Inés Califano, Anabella Smulever, Fernando Jerkovich, Fabian Pitoia",
                "Journal": "Reviews in Endocrine and Metabolic Disorders"
              },
              {
                "PCLID": 33932930,
                "RelevanceScore": 92125,
                "PMID": 35670980,
                "DOI": "10.1007/978-1-0716-2505-7_17",
                "PublicationDate": "2022-01-01",
                "IsReview": true,
                "Title": "Radioiodine Refractory Differentiated Thyroid Cancer",
                "Author": "Wendy W L Chan, Sonia Chan, Dora L W Kwong",
                "Journal": "Methods in molecular biology (Clifton, N.J.)"
              },
              {
                "PCLID": 760367319,
                "RelevanceScore": 60817,
                "DOI": "10.1007/978-3-031-38605-3_21",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Current Trends in Treatment and New Generation of Trials in Thyroid Cancer",
                "Author": "Priyanka C. Iyer, Samer A. Srour, Marie Claude Hofmann, Maria E. Cabanillas",
                "Journal": "Practical Management of Thyroid Cancer"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 24728625
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Methyl (1R,10S,11R,19R)-11-acetyloxy-12-ethyl-4-[(12R,13S,14S)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 10,
            "CooccurrenceScore": 10235,
            "Article": [
              {
                "PCLID": 34840771,
                "RelevanceScore": 321109,
                "PMID": 36757608,
                "DOI": "10.1007/s40273-023-01247-w",
                "PublicationDate": "2023-02-09",
                "IsReview": true,
                "Title": "Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
                "Author": "Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt",
                "Journal": "PharmacoEconomics",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 206778158,
                "RelevanceScore": 273052,
                "DOI": "10.1007/s40278-021-99416-2",
                "PublicationDate": "2021-07-24",
                "IsReview": false,
                "Title": "Carboplatin/pemetrexed/pralsetinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 772710370,
                "RelevanceScore": 209055,
                "DOI": "10.1007/s40278-025-78875-5",
                "PublicationDate": "2025-03-08",
                "IsReview": false,
                "Title": "Multiple drugs",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 764752361,
                "RelevanceScore": 165180,
                "DOI": "10.1007/s40278-024-62140-x",
                "PublicationDate": "2024-07-06",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 36521014,
                "RelevanceScore": 30339,
                "PMID": 37707774,
                "DOI": "10.1007/s13577-023-00980-w",
                "PublicationDate": "2023-09-14",
                "IsReview": false,
                "Title": "Establishment and characterization of BMC-PDC-019: a novel patient-derived cell line of EGFR-mutant pulmonary adenocarcinoma transformed into small-cell lung cancer",
                "Author": "Mi Young Kim, Seung Yeon Jung, Sungyoul Hong, So Won Oh, Kwang Nam Jin, Ji Eun Kim, Jin-Soo Kim",
                "Journal": "Human Cell"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 57390074
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "5-Chloro-N2-(4-(4-(dimethylamino)-1-piperidinyl)-2-methoxyphenyl)-N4-(2-(dimethylphosphinyl)phenyl)-2,4-pyrimidinediamine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 10197,
            "Article": [
              {
                "PCLID": 34847774,
                "RelevanceScore": 601993,
                "PMID": 36941218,
                "DOI": "10.1002/bmc.5628",
                "PublicationDate": "2023-04-12",
                "IsReview": false,
                "Title": "Development and validation of an HPLC–MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2‐EDTA plasma",
                "Author": "Judith L. Gulikers, Ard J. van Veelen, Elishia M. J. Sinkiewicz, Yvo M. de Beer, Mariëlle Slikkerveer, Leo M. L. Stolk, Vivianne C. G. Tjan‐Heijnen, Lizza E. L. Hendriks, Sander Croes, Robin M. J. M. van Geel",
                "Journal": "Biomedical chromatography : BMC",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34278014,
                "RelevanceScore": 394162,
                "PMID": 35816666,
                "DOI": "10.1200/jco.22.00824",
                "PublicationDate": "2022-10-01",
                "IsReview": false,
                "Title": "Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline",
                "Author": "Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew G. Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael A. Jaiyesimi",
                "Journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 36558058,
                "RelevanceScore": 175581,
                "PMID": 37748692,
                "DOI": "10.1016/j.jtho.2023.09.1444",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function",
                "Author": "Monica F. Chen, Guilherme Harada, Dazhi Liu, Ray DeMatteo, Christina Falcon, Clare Wilhelm, Mark G. Kris, Alexander Drilon, Victoria Gutgarts",
                "Journal": "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 11511120
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Dacomitinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 29,
            "CooccurrenceScore": 10188,
            "Article": [
              {
                "PCLID": 771524598,
                "RelevanceScore": 190913,
                "DOI": "10.1007/s11696-025-03894-z",
                "PublicationDate": "2025-02-10",
                "IsReview": false,
                "Title": "Computational insights and predictive models for lung cancer molecular structures",
                "Author": "Yeliz Kara, Yeşim Sağlam Özkan, Micheal Arockiaraj",
                "Journal": "Chemical Papers"
              },
              {
                "PCLID": 35304373,
                "RelevanceScore": 170104,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "dacomitinib"
              },
              {
                "PCLID": 36468328,
                "RelevanceScore": 78898,
                "PMID": 37651020,
                "DOI": "10.1007/s12094-023-03303-5",
                "PublicationDate": "2023-08-31",
                "IsReview": true,
                "Title": "Difficulties on the access to innovative targeted therapies for lung cancer in Spain",
                "Author": "Virginia Calvo, Carlos Camps, Enric Carcereny, Manuel Cobo, Manuel Dómine, María Rosario García Campelo, José Luis González Larriba, María Guirado, Florentino Hernando-Trancho, Bartomeu Massutí, Ernest Nadal, Delvys Rodríguez-Abreu, Alfredo Sánchez, Ivana Gabriela Sullivan, Mariano Provencio",
                "Journal": "Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"
              },
              {
                "PCLID": 34312121,
                "RelevanceScore": 60406,
                "PMID": 35525790,
                "DOI": "10.1016/j.jgo.2022.04.013",
                "PublicationDate": "2022-11-01",
                "IsReview": true,
                "Title": "Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report",
                "Author": "Konstantinos Christofyllakis, Ana Raquel Monteiro, Onur Cetin, Igor Age Kos, Alastair Greystoke, Andrea Luciani",
                "Journal": "Journal of Geriatric Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "dacomitinib"
              },
              {
                "PCLID": 766422768,
                "RelevanceScore": 60406,
                "DOI": "10.1007/978-981-99-6263-1_64",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Recent Advances in FDA-Approved Kinase Inhibitors Targeting Lung Cancer",
                "Author": "Vivek Panwar, Manini Bhatt, Dheeraj Bisht, Rajeshwar K. K. Arya, Deepak Kumar",
                "Journal": "Handbook of Oncobiology: From Basic to Clinical Sciences"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 92851
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "D-Cysteine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 11,
            "CooccurrenceScore": 10129,
            "Article": [
              {
                "PCLID": 35431431,
                "RelevanceScore": 299023,
                "PMID": 36576611,
                "DOI": "10.1007/s00894-022-05429-9",
                "PublicationDate": "2022-12-28",
                "IsReview": false,
                "Title": "Insights into pralsetinib resistance to the non-gatekeeper RET kinase G810C mutation through molecular dynamics simulations",
                "Author": "Shu Cao, Changbin Tan, Anhua Fei, Gangqiang Hu, Ming Fu, Jun Lv",
                "Journal": "Journal of Molecular Modeling",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 35901532,
                "RelevanceScore": 203417,
                "PMID": 37195581,
                "DOI": "10.1007/s12020-023-03368-w",
                "PublicationDate": "2023-05-17",
                "IsReview": true,
                "Title": "Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing",
                "Author": "Rossella Elisei, Cristina Romei",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 37800222,
                "RelevanceScore": 153345,
                "PMID": 39342195,
                "DOI": "10.1186/s12964-024-01837-x",
                "PublicationDate": "2024-09-28",
                "IsReview": true,
                "Title": "Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives",
                "Author": "Ying Zhang, Wei-Hui Zheng, Shi-Hong Zhou, Jia-Lei Gu, Qing Yu, Yi-Zhou Zhu, Yu-Jie Yan, Zhi Zhu, Jin-Biao Shang",
                "Journal": "Cell communication and signaling : CCS",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 38545972,
                "RelevanceScore": 153345,
                "PMID": 40102263,
                "DOI": "10.1007/978-3-031-80396-3_12",
                "PublicationDate": "2025-01-01",
                "IsReview": true,
                "Title": "Systemic Therapies for Advanced Medullary Thyroid Carcinoma",
                "Author": "Marco Ruiz Santillan, Ramona Dadu, Robert F Gagel, Elizabeth G Grubbs, Mimi I Hu",
                "Journal": "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34104558,
                "RelevanceScore": 72490,
                "PMID": 35598228,
                "DOI": "10.1007/s12272-022-01385-3",
                "PublicationDate": "2022-05-22",
                "IsReview": true,
                "Title": "Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers",
                "Author": "Faraat Ali, Kumari Neha, Garima Chauhan",
                "Journal": "Archives of Pharmacal Research",
                "ChemicalName_1": "pralsetinib; prl"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 68740
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Zoledronic Acid",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 8,
            "CooccurrenceScore": 10084,
            "Article": [
              {
                "PCLID": 214249487,
                "RelevanceScore": 232251,
                "DOI": "10.1007/s40278-022-21448-7",
                "PublicationDate": "2022-08-13",
                "IsReview": false,
                "Title": "Pralsetinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 666217974,
                "RelevanceScore": 232251,
                "DOI": "10.1007/978-3-030-61919-0_38",
                "PublicationDate": "2020-12-16",
                "IsReview": false,
                "Title": "Medical Treatment Decision-Making for Advanced Medullary Thyroid Cancer",
                "Author": "Ramona Dadu, Mimi I. Hu",
                "Journal": "Thyroid Cancer"
              },
              {
                "PCLID": 752904040,
                "RelevanceScore": 232251,
                "DOI": "10.1007/978-981-99-0938-4_82",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Aggressive Sporadic Medullary Thyroid Cancer",
                "Author": "Amit Agarwal, Ranil Fernando, Rajeev Parameswaran, Anand Mishra, Roma Pradhan",
                "Journal": "Case Studies in Thyroid and Parathyroid Tumors"
              },
              {
                "PCLID": 682755491,
                "RelevanceScore": 113803,
                "DOI": "10.1007/978-3-030-84367-0_16",
                "PublicationDate": "2022-01-01",
                "IsReview": false,
                "Title": "Medullary Thyroid Carcinoma",
                "Author": "Payal Paresh Patel Shooliz, Victor Bernet",
                "Journal": "A Case-Based Guide to Clinical Endocrinology"
              },
              {
                "PCLID": 17675648,
                "RelevanceScore": 108384,
                "PMID": 34291429,
                "DOI": "10.1007/s40618-021-01634-0",
                "PublicationDate": "2021-07-21",
                "IsReview": true,
                "Title": "Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates",
                "Author": "L. Lorusso, L. Pieruzzi, M. Gabriele, M. Nisi, D. Viola, E. Molinaro, V. Bottici, R. Elisei, L. Agate",
                "Journal": "Journal of Endocrinological Investigation",
                "ChemicalName_2": "zoledronic acid"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 67462786
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Erdafitinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 20,
            "CooccurrenceScore": 10052,
            "Article": [
              {
                "PCLID": 35292415,
                "RelevanceScore": 324313,
                "PMID": 36167530,
                "DOI": "10.1186/s12885-022-09922-5",
                "PublicationDate": "2022-09-27",
                "IsReview": false,
                "Title": "Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers",
                "Author": "Huita Wu, Haonan Ji, Wenhui Yang, Min Zhang, Yifang Guo, Bangkai Li, Jiayin Wang, Rongrong Chen, Yuan Chen, Xin Wang",
                "Journal": "BMC Cancer"
              },
              {
                "PCLID": 35304373,
                "RelevanceScore": 174805,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "erdafitinib"
              },
              {
                "PCLID": 35736677,
                "RelevanceScore": 141047,
                "PMID": 37513232,
                "DOI": "10.3390/molecules28145359",
                "PublicationDate": "2023-07-12",
                "IsReview": true,
                "Title": "The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies",
                "Author": "George Mihai Nitulescu, Gheorghe Stancov, Oana Cristina Seremet, Georgiana Nitulescu, Dragos Paul Mihai, Cosmina Gabriela Duta-Bratu, Stefania Felicia Barbuceanu, Octavian Tudorel Olaru",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "erdafitinib"
              },
              {
                "PCLID": 35033898,
                "RelevanceScore": 110357,
                "PMID": 36639452,
                "DOI": "10.1038/s41571-022-00718-x",
                "PublicationDate": "2023-01-13",
                "IsReview": true,
                "Title": "At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC",
                "Author": "Itziar Otano, Alvaro C. Ucero, Jon Zugazagoitia, Luis Paz-Ares",
                "Journal": "Nature reviews. Clinical oncology"
              },
              {
                "PCLID": 752596600,
                "RelevanceScore": 54987,
                "DOI": "10.1007/s15036-023-3214-2",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Aktuelle Entwicklungen in der palliativen Therapie biliärer Tumoren",
                "Journal": "Gastro-News"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 6442177
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Everolimus",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 23,
            "CooccurrenceScore": 9769,
            "Article": [
              {
                "PCLID": 37800222,
                "RelevanceScore": 168609,
                "PMID": 39342195,
                "DOI": "10.1186/s12964-024-01837-x",
                "PublicationDate": "2024-09-28",
                "IsReview": true,
                "Title": "Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives",
                "Author": "Ying Zhang, Wei-Hui Zheng, Shi-Hong Zhou, Jia-Lei Gu, Qing Yu, Yi-Zhou Zhu, Yu-Jie Yan, Zhi Zhu, Jin-Biao Shang",
                "Journal": "Cell communication and signaling : CCS",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 38545972,
                "RelevanceScore": 168609,
                "PMID": 40102263,
                "DOI": "10.1007/978-3-031-80396-3_12",
                "PublicationDate": "2025-01-01",
                "IsReview": true,
                "Title": "Systemic Therapies for Advanced Medullary Thyroid Carcinoma",
                "Author": "Marco Ruiz Santillan, Ramona Dadu, Robert F Gagel, Elizabeth G Grubbs, Mimi I Hu",
                "Journal": "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 36897636,
                "RelevanceScore": 101477,
                "PMID": 38438731,
                "DOI": "10.1038/s41698-024-00563-4",
                "PublicationDate": "2024-03-04",
                "IsReview": false,
                "Title": "Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer",
                "Author": "Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 36198818,
                "RelevanceScore": 90575,
                "PMID": 37973622,
                "DOI": "10.1007/s00104-023-01993-9",
                "PublicationDate": "2024-03-01",
                "IsReview": true,
                "Title": "[Personalized approach to anaplastic thyroid carcinoma]",
                "Author": "Sabine Wächter, Detlef K Bartsch, Elisabeth Maurer",
                "Journal": "Chirurgie (Heidelberg, Germany)"
              },
              {
                "PCLID": 12956479,
                "RelevanceScore": 86981,
                "PMID": 34165651,
                "DOI": "10.1007/s11864-021-00867-8",
                "PublicationDate": "2021-06-24",
                "IsReview": true,
                "Title": "Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer",
                "Author": "Fangdi Sun, Caroline E. McCoach",
                "Journal": "Current Treatment Options in Oncology",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5291
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Imatinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 20,
            "CooccurrenceScore": 9651,
            "Article": [
              {
                "PCLID": 34746821,
                "RelevanceScore": 218881,
                "PMID": 35962206,
                "DOI": "10.1038/s41591-022-01931-y",
                "PublicationDate": "2022-08-12",
                "IsReview": false,
                "Title": "Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial",
                "Author": "Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Giuseppe Curigliano",
                "Journal": "Nature Medicine",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 212473112,
                "RelevanceScore": 204736,
                "DOI": "10.1007/s12312-021-00986-1",
                "PublicationDate": "2021-01-01",
                "IsReview": false,
                "Title": "Blueprint Medicines – Ein neues Sektion C Mitglied stellt sich vor",
                "Journal": "Forum"
              },
              {
                "PCLID": 682755491,
                "RelevanceScore": 100321,
                "DOI": "10.1007/978-3-030-84367-0_16",
                "PublicationDate": "2022-01-01",
                "IsReview": false,
                "Title": "Medullary Thyroid Carcinoma",
                "Author": "Payal Paresh Patel Shooliz, Victor Bernet",
                "Journal": "A Case-Based Guide to Clinical Endocrinology"
              },
              {
                "PCLID": 20367522,
                "RelevanceScore": 98058,
                "PMID": 33513356,
                "DOI": "10.1016/j.phrs.2021.105463",
                "PublicationDate": "2021-03-01",
                "IsReview": true,
                "Title": "Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update",
                "Author": "Robert Roskoski",
                "Journal": "Pharmacological Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "imatinib"
              },
              {
                "PCLID": 38273201,
                "RelevanceScore": 71195,
                "PMID": 39836286,
                "DOI": "10.1007/s10143-025-03204-x",
                "PublicationDate": "2025-01-21",
                "IsReview": true,
                "Title": "The efficacy and safety of tyrosine kinase inhibitors in the treatment of advanced or metastatic chordoma: a single-arm meta-analysis",
                "Author": "Hongfeng Meng, Boyan Zhang, Penghao Liu, Yueqi Du, Can Zhang, Wanru Duan, Zan Chen",
                "Journal": "Neurosurgical Review",
                "ChemicalName_2": "imatinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 588
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "creatinine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 9,
            "CooccurrenceScore": 9646,
            "Article": [
              {
                "PCLID": 6111396,
                "RelevanceScore": 230848,
                "PMID": 33136236,
                "DOI": "10.1007/s40265-020-01427-4",
                "PublicationDate": "2020-11-02",
                "IsReview": true,
                "Title": "Pralsetinib: First Approval",
                "Author": "Anthony Markham",
                "Journal": "Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34037745,
                "RelevanceScore": 179548,
                "PMID": 35587858,
                "DOI": "10.1007/s40265-022-01720-4",
                "PublicationDate": "2022-05-19",
                "IsReview": true,
                "Title": "Pralsetinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Yahiya Y. Syed",
                "Journal": "Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 214151830,
                "RelevanceScore": 137409,
                "DOI": "10.1007/s40278-022-21024-4",
                "PublicationDate": "2022-08-13",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 742107349,
                "RelevanceScore": 137409,
                "DOI": "10.1007/s40278-023-32181-x",
                "PublicationDate": "2023-01-21",
                "IsReview": false,
                "Title": "Multiple drugs",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 755498351,
                "RelevanceScore": 137409,
                "DOI": "10.1007/s40278-023-47016-0",
                "PublicationDate": "2023-09-30",
                "IsReview": false,
                "Title": "Pralsetinib",
                "Journal": "Reactions Weekly"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5950
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "L-Alanine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 9607,
            "Article": [
              {
                "PCLID": 37823775,
                "RelevanceScore": 365875,
                "PMID": 39372206,
                "DOI": "10.3389/fphar.2024.1424980",
                "PublicationDate": "2024-09-20",
                "IsReview": false,
                "Title": "Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system",
                "Author": "Qiong Jie, Yuanyuan Li, Li Jing, Jinjin Chen, Yang Li",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "alanine"
              },
              {
                "PCLID": 38084636,
                "RelevanceScore": 304896,
                "PMID": 39630530,
                "DOI": "10.1089/thy.2024.0495",
                "PublicationDate": "2025-01-01",
                "IsReview": false,
                "Title": "Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma",
                "Author": "Sarah Hamidi, Sireesha Yedururi, Mimi I. Hu, Naifa L. Busaidy, Steven I. Sherman, Camilo Jimenez, Elizabeth G. Grubbs, Anastasios Maniakas, Mark E. Zafereo, Vivek Subbiah, Steven G. Waguespack",
                "Journal": "Thyroid : official journal of the American Thyroid Association",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "alanine"
              },
              {
                "PCLID": 35057669,
                "RelevanceScore": 217783,
                "PMID": 36422787,
                "DOI": "10.1007/s11523-022-00935-5",
                "PublicationDate": "2022-11-24",
                "IsReview": true,
                "Title": "Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Tina Nie, Yahiya Y. Syed",
                "Journal": "Targeted Oncology",
                "ChemicalName_2": "alanine"
              },
              {
                "PCLID": 38545972,
                "RelevanceScore": 117268,
                "PMID": 40102263,
                "DOI": "10.1007/978-3-031-80396-3_12",
                "PublicationDate": "2025-01-01",
                "IsReview": true,
                "Title": "Systemic Therapies for Advanced Medullary Thyroid Carcinoma",
                "Author": "Marco Ruiz Santillan, Ramona Dadu, Robert F Gagel, Elizabeth G Grubbs, Mimi I Hu",
                "Journal": "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34465969,
                "RelevanceScore": 15749,
                "PMID": 36571695,
                "DOI": "10.1007/s12094-022-03046-9",
                "PublicationDate": "2022-12-26",
                "IsReview": false,
                "Title": "New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology",
                "Author": "Dolores Isla, Maria D. Lozano, Luis Paz-Ares, Clara Salas, Javier de Castro, Esther Conde, Enriqueta Felip, Javier Gómez-Román, Pilar Garrido, Ana Belén Enguita",
                "Journal": "Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 50922675
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Encorafenib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 19,
            "CooccurrenceScore": 9382,
            "Article": [
              {
                "PCLID": 36137688,
                "RelevanceScore": 236350,
                "PMID": 37902897,
                "DOI": "10.1007/s11154-023-09842-0",
                "PublicationDate": "2023-10-30",
                "IsReview": true,
                "Title": "Molecular testing for thyroid nodules: Where are we now?",
                "Author": "Carolina Ferraz",
                "Journal": "Reviews in Endocrine and Metabolic Disorders"
              },
              {
                "PCLID": 35736677,
                "RelevanceScore": 134258,
                "PMID": 37513232,
                "DOI": "10.3390/molecules28145359",
                "PublicationDate": "2023-07-12",
                "IsReview": true,
                "Title": "The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies",
                "Author": "George Mihai Nitulescu, Gheorghe Stancov, Oana Cristina Seremet, Georgiana Nitulescu, Dragos Paul Mihai, Cosmina Gabriela Duta-Bratu, Stefania Felicia Barbuceanu, Octavian Tudorel Olaru",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "encorafenib"
              },
              {
                "PCLID": 36366594,
                "RelevanceScore": 134258,
                "PMID": 38011864,
                "DOI": "10.1055/s-0043-1776782",
                "PublicationDate": "2023-11-27",
                "IsReview": true,
                "Title": "Management of Brain Metastases: A Review of Novel Therapies",
                "Author": "Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W. McDermott, Manmeet S. Ahluwalia",
                "Journal": "Seminars in Neurology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "encorafenib"
              },
              {
                "PCLID": 36860421,
                "RelevanceScore": 125012,
                "PMID": 38403820,
                "DOI": "10.1007/s12672-024-00904-6",
                "PublicationDate": "2024-02-25",
                "IsReview": true,
                "Title": "Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials",
                "Author": "Ke Wang, Ying Zhang, Yang Xing, Hong Wang, Minghua He, Rui Guo",
                "Journal": "Discover Oncology"
              },
              {
                "PCLID": 39119712,
                "RelevanceScore": 67228,
                "PMID": 40681930,
                "DOI": "10.1038/d41573-025-00123-w",
                "PublicationDate": "2025-07-18",
                "IsReview": false,
                "Title": "The non-small-cell lung cancer drug market",
                "Author": "Charlotte B. Jago, Rachel M. Webster",
                "Journal": "Nature reviews. Drug discovery"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 135398738
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Dacarbazine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 9,
            "CooccurrenceScore": 9362,
            "Article": [
              {
                "PCLID": 214151830,
                "RelevanceScore": 237128,
                "DOI": "10.1007/s40278-022-21024-4",
                "PublicationDate": "2022-08-13",
                "IsReview": false,
                "Title": "Antineoplastics",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 10232769,
                "RelevanceScore": 181551,
                "PMID": 35151352,
                "DOI": "10.1186/s13044-021-00119-9",
                "PublicationDate": "2022-02-12",
                "IsReview": false,
                "Title": "Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer",
                "Author": "Rohan Parikh, Lisa M. Hess, Elizabeth Esterberg, Naleen Raj Bhandari, James A. Kaye",
                "Journal": "Thyroid Research"
              },
              {
                "PCLID": 36527703,
                "RelevanceScore": 181551,
                "PMID": 37715050,
                "DOI": "10.1007/s11154-023-09836-y",
                "PublicationDate": "2023-09-16",
                "IsReview": true,
                "Title": "Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities",
                "Author": "Alessio Imperiale, Valentina Berti, Mickaël Burgy, Roberto Luigi Cazzato, Arnoldo Piccardo, Giorgio Treglia",
                "Journal": "Reviews in Endocrine and Metabolic Disorders"
              },
              {
                "PCLID": 775900487,
                "RelevanceScore": 116193,
                "DOI": "10.1007/s40278-025-82673-x",
                "PublicationDate": "2025-05-17",
                "IsReview": false,
                "Title": "Dacarbazine/temozolomide",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 765080110,
                "RelevanceScore": 59282,
                "DOI": "10.1007/978-3-031-62301-1_17",
                "PublicationDate": "2024-07-25",
                "IsReview": false,
                "Title": "Medical Treatment of Malignant Pheochromocytoma",
                "Author": "Marta Laganà, Deborah Cosentini, Antonella Turla, Valentina Cremaschi, Salvatore Grisanti, Alfredo Berruti",
                "Journal": "Primary Adrenal Malignancies"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 135566046
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "4-(3-Chloro-4-(((cyclopropylamino)carbonyl)amino)phenoxy)-7-hydroxy-6-quinolinecarboxamide",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 9247,
            "Article": [
              {
                "PCLID": 32529201,
                "RelevanceScore": 356542,
                "PMID": 34598787,
                "DOI": "10.1016/j.bulcan.2021.05.009",
                "PublicationDate": "2021-11-01",
                "IsReview": false,
                "Title": "[Drug approval: Selpercatinib and pralsetinib - RET-altered thyroid cancer]",
                "Author": "Baudouin Courtier, Julien Hadoux",
                "Journal": "Bulletin du cancer",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 6134017,
                "RelevanceScore": 297670,
                "PMID": 33594641,
                "DOI": "10.1007/s40618-020-01491-3",
                "PublicationDate": "2021-02-17",
                "IsReview": false,
                "Title": "Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer",
                "Author": "A. Matrone, A. Prete, A. Nervo, A. Ragni, L. Agate, E. Molinaro, C. Giani, L. Valerio, E. Minaldi, A. Piovesan, R. Elisei",
                "Journal": "Journal of Endocrinological Investigation"
              },
              {
                "PCLID": 36324511,
                "RelevanceScore": 180072,
                "PMID": 38102498,
                "DOI": "10.1007/s12020-023-03638-7",
                "PublicationDate": "2023-12-16",
                "IsReview": false,
                "Title": "Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States",
                "Author": "Francis Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 37227145,
                "RelevanceScore": 86307,
                "PMID": 38772990,
                "DOI": "10.1007/s12020-024-03867-4",
                "PublicationDate": "2024-05-21",
                "IsReview": false,
                "Title": "Ten years’ real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer",
                "Author": "Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, Fabián Pitoia",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 37379239,
                "RelevanceScore": 36465,
                "PMID": 38900279,
                "DOI": "10.1007/s00108-024-01728-w",
                "PublicationDate": "2024-07-01",
                "IsReview": false,
                "Title": "[Thyroid carcinomas: the role of systemic therapies in internal medicine]",
                "Author": "Tim Brandenburg, Matthias Kroiß",
                "Journal": "Innere Medizin (Heidelberg, Germany)"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 11048
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Eosin",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 6,
            "CooccurrenceScore": 9101,
            "Article": [
              {
                "PCLID": 37809521,
                "RelevanceScore": 233863,
                "PMID": 39354540,
                "DOI": "10.1186/s13019-024-03092-0",
                "PublicationDate": "2024-10-01",
                "IsReview": false,
                "Title": "A case of neoadjuvant targeted therapy with pralsetinib for locally advanced lung adenocarcinoma with RET fusion mutation",
                "Author": "Wang Chunmao, Cheng Haijie, Wang Zitong, Yang Zhi",
                "Journal": "Journal of Cardiothoracic Surgery",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 35207674,
                "RelevanceScore": 222726,
                "PMID": 36131239,
                "DOI": "10.1186/s12885-022-10081-w",
                "PublicationDate": "2022-09-21",
                "IsReview": false,
                "Title": "Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer",
                "Author": "Alicja Rączkowska, Iwona Paśnik, Michał Kukiełka, Marcin Nicoś, Magdalena A. Budzinska, Tomasz Kucharczyk, Justyna Szumiło, Paweł Krawczyk, Nicola Crosetto, Ewa Szczurek",
                "Journal": "BMC Cancer",
                "ChemicalName_2": "eosin"
              },
              {
                "PCLID": 35043805,
                "RelevanceScore": 159090,
                "PMID": 35920918,
                "DOI": "10.1007/s00428-022-03390-9",
                "PublicationDate": "2022-08-03",
                "IsReview": false,
                "Title": "Clinical significance and interrelations of PD-L1 expression, Ki-67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population",
                "Author": "Yanhua Bai, Ting Guo, Dongfeng Niu, Yanli Zhu, Wenhao Ren, Qian Yao, Xiaozheng Huang, Qin Feng, Tianxiao Wang, Xiuli Ma, Xinqiang Ji",
                "Journal": "Virchows Archiv : an international journal of pathology"
              },
              {
                "PCLID": 36294801,
                "RelevanceScore": 159090,
                "PMID": 38057798,
                "DOI": "10.1186/s12890-023-02799-5",
                "PublicationDate": "2023-12-06",
                "IsReview": false,
                "Title": "Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report",
                "Author": "Yan Peng, Zhu Zheng, Wang Zewen, Liu Yanan, Zhang Mingyan, Sun Meili",
                "Journal": "BMC Pulmonary Medicine"
              },
              {
                "PCLID": 6166176,
                "RelevanceScore": 96240,
                "PMID": 35364706,
                "DOI": "10.1007/s00432-022-03969-4",
                "PublicationDate": "2022-04-02",
                "IsReview": false,
                "Title": "A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing: a case report",
                "Author": "Xiaoyi Xu, Haoyi Wang, Zhaonan Yu, Xianguo Chen",
                "Journal": "Journal of Cancer Research and Clinical Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5330286
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Palbociclib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 15,
            "CooccurrenceScore": 9016,
            "Article": [
              {
                "PCLID": 35947600,
                "RelevanceScore": 774415,
                "PMID": 37071495,
                "DOI": "10.1158/0008-5472.can-22-3484",
                "PublicationDate": "2023-04-18",
                "IsReview": false,
                "Title": "Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer",
                "Author": "Xuxu Gou, Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt, Diana Fandino, Craig T. Vollert, Purba Singh, Mohammad A. Alzubi, Anna Malovannaya, Lacey E. Dobrolecki, Michael T. Lewis, Shunqiang Li, Charles E. Foulds, Matthew J. Ellis",
                "Journal": "Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "palbociclib"
              },
              {
                "PCLID": 12956479,
                "RelevanceScore": 102436,
                "PMID": 34165651,
                "DOI": "10.1007/s11864-021-00867-8",
                "PublicationDate": "2021-06-24",
                "IsReview": true,
                "Title": "Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer",
                "Author": "Fangdi Sun, Caroline E. McCoach",
                "Journal": "Current Treatment Options in Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 34936145,
                "RelevanceScore": 57364,
                "PMID": 36696006,
                "DOI": "10.1007/s13402-023-00771-3",
                "PublicationDate": "2023-01-25",
                "IsReview": true,
                "Title": "The application of patient-derived organoid in the research of lung cancer",
                "Author": "Yin Li, Xinyu Gao, Chao Ni, Bing Zhao, Xinghua Cheng",
                "Journal": "Cellular oncology (Dordrecht, Netherlands)"
              },
              {
                "PCLID": 38216224,
                "RelevanceScore": 50418,
                "PMID": 39762686,
                "DOI": "10.1007/s12029-024-01149-w",
                "PublicationDate": "2025-01-06",
                "IsReview": true,
                "Title": "Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma",
                "Author": "Tuan Hoang, Erica S. Tsang",
                "Journal": "Journal of Gastrointestinal Cancer"
              },
              {
                "PCLID": 760367319,
                "RelevanceScore": 50418,
                "DOI": "10.1007/978-3-031-38605-3_21",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Current Trends in Treatment and New Generation of Trials in Thyroid Cancer",
                "Author": "Priyanka C. Iyer, Samer A. Srour, Marie Claude Hofmann, Maria E. Cabanillas",
                "Journal": "Practical Management of Thyroid Cancer"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 9915743
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Neratinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 17,
            "CooccurrenceScore": 9016,
            "Article": [
              {
                "PCLID": 35573623,
                "RelevanceScore": 299602,
                "PMID": 37086377,
                "DOI": "10.1007/s12010-023-04541-7",
                "PublicationDate": "2023-04-22",
                "IsReview": false,
                "Title": "Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer—Integrated Bioinformatic Approach",
                "Author": "Pavan Kumar Poleboyina, Manikandan Alagumuthu, Akbar Pasha, Doneti Ravinder, Deepthi Pasumarthi, Smita C. Pawar",
                "Journal": "Applied Biochemistry and Biotechnology"
              },
              {
                "PCLID": 35865555,
                "RelevanceScore": 299602,
                "PMID": 37392324,
                "DOI": "10.1007/s12010-023-04608-5",
                "PublicationDate": "2023-07-01",
                "IsReview": false,
                "Title": "Virtual Screening, Molecular Docking, and Dynamic Simulations Revealed TGF-β1 Potential Inhibitors to Curtail Cervical Cancer Progression",
                "Author": "Pavan Kumar Poleboyina, Umakanth Naik, Akbar Pasha, Doneti Ravinder, Shivaji Bhanothu, Sneha Malleswari Poleboyina, Umamaheshwari Amineni, Smita C. Pawar",
                "Journal": "Applied Biochemistry and Biotechnology"
              },
              {
                "PCLID": 36930222,
                "RelevanceScore": 50798,
                "PMID": 38472216,
                "DOI": "10.1038/s41523-024-00626-6",
                "PublicationDate": "2024-03-12",
                "IsReview": true,
                "Title": "Circulating tumor DNA validity and potential uses in metastatic breast cancer",
                "Author": "Ottavia Amato, Nefeli Giannopoulou, Michail Ignatiadis",
                "Journal": "npj Breast Cancer"
              },
              {
                "PCLID": 752596600,
                "RelevanceScore": 50798,
                "DOI": "10.1007/s15036-023-3214-2",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Aktuelle Entwicklungen in der palliativen Therapie biliärer Tumoren",
                "Journal": "Gastro-News"
              },
              {
                "PCLID": 755286143,
                "RelevanceScore": 40666,
                "DOI": "10.1007/978-3-031-35118-1_9",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Molecular Pathology of Lung Tumors",
                "Author": "Ying-Chun Lo, Neal I. Lindeman",
                "Journal": "Molecular Surgical Pathology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 6342
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Acetonitrile",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 7,
            "CooccurrenceScore": 8941,
            "Article": [
              {
                "PCLID": 37691657,
                "RelevanceScore": 396497,
                "PMID": 39233920,
                "DOI": "10.3389/fchem.2024.1450692",
                "PublicationDate": "2024-08-21",
                "IsReview": false,
                "Title": "Development and validation of a novel high-performance liquid chromatography (HPLC) method for the detection of related substances of pralsetinib, a new anti-lung cancer drug",
                "Author": "Yonghong Zhu, Jisu Qin, Wenyi Wu, Liangliang Cai",
                "Journal": "Frontiers in Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "acetonitrile; acn"
              },
              {
                "PCLID": 37038083,
                "RelevanceScore": 283212,
                "PMID": 38584556,
                "DOI": "10.2174/0118715206290110240326071909",
                "PublicationDate": "2024-07-01",
                "IsReview": false,
                "Title": "Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS)",
                "Author": "Zichen Zhao, Qianlun Pu, Tonglin Sun, Qian Huang, Liping Tong, Ting Fan, Jingyue Kang, Yuhong Chen, Yan Zhang",
                "Journal": "Anti-Cancer Agents in Medicinal Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "acetonitrile"
              },
              {
                "PCLID": 29773356,
                "RelevanceScore": 220276,
                "PMID": 32416592,
                "DOI": "10.1016/j.jchromb.2020.122131",
                "PublicationDate": "2020-06-15",
                "IsReview": false,
                "Title": "Quantitative bioanalytical assay for the selective RET inhibitors selpercatinib and pralsetinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry",
                "Author": "Rahime Şentürk, Yaogeng Wang, Alfred H. Schinkel, Jos H. Beijnen, Rolf W. Sparidans",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "acetonitrile"
              },
              {
                "PCLID": 39179011,
                "RelevanceScore": 78670,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "acetonitrile"
              },
              {
                "PCLID": 36365086,
                "RelevanceScore": 68267,
                "PMID": 37979367,
                "DOI": "10.1016/j.jchromb.2023.123918",
                "PublicationDate": "2023-12-01",
                "IsReview": false,
                "Title": "Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs",
                "Author": "Paul D. Kruithof, Yvo M. de Beer, Judith L. Gulikers, Leo M.L. Stolk, Lizza E.L. Hendriks, Sander Croes, Robin M.J.M. van Geel",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "acetonitrile"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 712
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Formaldehyde",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 7,
            "CooccurrenceScore": 8559,
            "Article": [
              {
                "PCLID": 37574502,
                "RelevanceScore": 204738,
                "PMID": 39120655,
                "DOI": "10.1007/s00428-024-03890-w",
                "PublicationDate": "2024-08-09",
                "IsReview": false,
                "Title": "High success rate of first proficiency testing for RET fusions and RET mutations in lung and thyroid cancer samples by various methods",
                "Author": "Udo Siebolts, Roberto Pappesch, Marcus Bauer, Wolfgang Dietmaier, Mareike Ernst, Anja Haak, Nils Hartmann, Katharina Ilm, Stavros Kalbourtzis, Thomas Krause, Daniel Kazdal, Hubert Schorle, Kirsten Utpatel, Sabine Merkelbach-Bruse",
                "Journal": "Virchows Archiv : an international journal of pathology",
                "ChemicalName_2": "formalin"
              },
              {
                "PCLID": 34107943,
                "RelevanceScore": 146241,
                "PMID": 35524867,
                "DOI": "10.1007/s10637-022-01246-2",
                "PublicationDate": "2022-05-07",
                "IsReview": false,
                "Title": "Identifification of a novel LDLR-RET Fusion in Lung Adenocarcinoma",
                "Author": "Guanglin Shi, Yuyan Luo, Zhaonan Yu, Yue Wang, Bojin Zhu",
                "Journal": "Investigational New Drugs"
              },
              {
                "PCLID": 766628438,
                "RelevanceScore": 146241,
                "DOI": "10.1007/s44178-024-00116-6",
                "PublicationDate": "2024-08-30",
                "IsReview": false,
                "Title": "Medullary thyroid cancer: single-cell transcriptome and tumor evolution",
                "Author": "Li-feng Wang, Wen-wen Zhou, Fang Yuan, Kai-wen Fu, Yongpeng He, Rui Chen",
                "Journal": "Holistic Integrative Oncology"
              },
              {
                "PCLID": 4062679,
                "RelevanceScore": 143316,
                "PMID": 35220468,
                "DOI": "10.1007/s00432-022-03959-6",
                "PublicationDate": "2022-02-26",
                "IsReview": false,
                "Title": "The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients",
                "Author": "Guowu Wu, Longhua Guo, Yinfang Gu, Tanxiao Huang, Ming Liu, Xiaofang Zou, Bo Yang, Ping Huang, Chunling Wen, Lilan Yi, Wenting Liao, Dongdong Zhao, Junlin Zhu, Xiaoni Zhang, Yuanyuan Liu, Yan Yin, Shifu Chen",
                "Journal": "Journal of Cancer Research and Clinical Oncology",
                "ChemicalName_2": "formalin"
              },
              {
                "PCLID": 6157098,
                "RelevanceScore": 111966,
                "PMID": 34083237,
                "DOI": "10.1158/1078-0432.ccr-20-5026",
                "PublicationDate": "2021-06-03",
                "IsReview": false,
                "Title": "Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma",
                "Author": "Seok-Young Kim, Sang-Min Kim, Sumin Lim, Ji Yeon Lee, Su-Jin Choi, San-Duk Yang, Mi Ran Yun, Chang Gon Kim, Seo Rin Gu, Chaewon Park, A-Young Park, Sun Min Lim, Seong Gu Heo, HyunKi Kim, Byoung Chul Cho",
                "Journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "formalin"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 25127713
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Poziotinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 10,
            "CooccurrenceScore": 8339,
            "Article": [
              {
                "PCLID": 6157098,
                "RelevanceScore": 408949,
                "PMID": 34083237,
                "DOI": "10.1158/1078-0432.ccr-20-5026",
                "PublicationDate": "2021-06-03",
                "IsReview": false,
                "Title": "Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma",
                "Author": "Seok-Young Kim, Sang-Min Kim, Sumin Lim, Ji Yeon Lee, Su-Jin Choi, San-Duk Yang, Mi Ran Yun, Chang Gon Kim, Seo Rin Gu, Chaewon Park, A-Young Park, Sun Min Lim, Seong Gu Heo, HyunKi Kim, Byoung Chul Cho",
                "Journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "poziotinib"
              },
              {
                "PCLID": 747376264,
                "RelevanceScore": 215414,
                "DOI": "10.1007/16833_2022_78",
                "PublicationDate": "2022-01-01",
                "IsReview": false,
                "Title": "Patient-Derived Organoids as a Stem Cell Model to Study Lung Cancer",
                "Author": "Melissa Acosta-Plasencia, Joan J. Castellano, Alison M. Taylor, Yangyi He, Daniel Martínez, Mariano Monzo, Ramón M. Marrades, Alfons Navarro",
                "Journal": "Lung Cancer Diagnosis and Treatment: An Interdisciplinary Approach"
              },
              {
                "PCLID": 36366594,
                "RelevanceScore": 154868,
                "PMID": 38011864,
                "DOI": "10.1055/s-0043-1776782",
                "PublicationDate": "2023-11-27",
                "IsReview": true,
                "Title": "Management of Brain Metastases: A Review of Novel Therapies",
                "Author": "Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W. McDermott, Manmeet S. Ahluwalia",
                "Journal": "Seminars in Neurology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "poziotinib"
              },
              {
                "PCLID": 34936145,
                "RelevanceScore": 77549,
                "PMID": 36696006,
                "DOI": "10.1007/s13402-023-00771-3",
                "PublicationDate": "2023-01-25",
                "IsReview": true,
                "Title": "The application of patient-derived organoid in the research of lung cancer",
                "Author": "Yin Li, Xinyu Gao, Chao Ni, Bing Zhao, Xinghua Cheng",
                "Journal": "Cellular oncology (Dordrecht, Netherlands)"
              },
              {
                "PCLID": 36278778,
                "RelevanceScore": 43621,
                "PMID": 37592034,
                "DOI": "10.1038/s41571-023-00808-4",
                "PublicationDate": "2023-08-17",
                "IsReview": true,
                "Title": "Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer",
                "Author": "Kelsey Pan, Kyle Concannon, Jing Li, Jianjun Zhang, John V. Heymach, Xiuning Le",
                "Journal": "Nature reviews. Clinical oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 56649450
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Alpelisib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 11,
            "CooccurrenceScore": 8164,
            "Article": [
              {
                "PCLID": 34630677,
                "RelevanceScore": 301978,
                "PMID": 36646803,
                "DOI": "10.1038/s41591-022-02160-z",
                "PublicationDate": "2023-01-01",
                "IsReview": true,
                "Title": "The next generation of evidence-based medicine",
                "Author": "Vivek Subbiah",
                "Journal": "Nature Medicine"
              },
              {
                "PCLID": 35437836,
                "RelevanceScore": 301978,
                "PMID": 36959606,
                "DOI": "10.1186/s12967-023-04057-y",
                "PublicationDate": "2023-03-23",
                "IsReview": false,
                "Title": "The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach",
                "Author": "Veronica Villani, Beatrice Casini, Antonio Tanzilli, Mario Lecce, Fabrizio Rasile, Stefano Telera, Andrea Pace, Francesca Piludu, Irene Terrenato, Francesca Rollo, Francesca De Nicola, Maurizio Fanciulli, Matteo Pallocca, Gennaro Ciliberto, Mariantonia Carosi",
                "Journal": "Journal of Translational Medicine"
              },
              {
                "PCLID": 38078543,
                "RelevanceScore": 87556,
                "PMID": 39627756,
                "DOI": "10.1186/s12885-024-13250-1",
                "PublicationDate": "2024-12-03",
                "IsReview": false,
                "Title": "Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database",
                "Author": "Jiancheng Qian, Shuohan Zhang, Cheng Jiang",
                "Journal": "BMC Cancer"
              },
              {
                "PCLID": 36930222,
                "RelevanceScore": 51200,
                "PMID": 38472216,
                "DOI": "10.1038/s41523-024-00626-6",
                "PublicationDate": "2024-03-12",
                "IsReview": true,
                "Title": "Circulating tumor DNA validity and potential uses in metastatic breast cancer",
                "Author": "Ottavia Amato, Nefeli Giannopoulou, Michail Ignatiadis",
                "Journal": "npj Breast Cancer"
              },
              {
                "PCLID": 36744749,
                "RelevanceScore": 23096,
                "PMID": 38288815,
                "DOI": "10.2174/0118715206259585240105051941",
                "PublicationDate": "2024-05-01",
                "IsReview": true,
                "Title": "An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021)",
                "Author": "S. Vishakha, N. Navneesh, Balak Das Kurmi, Ghanshyam Das Gupta, Sant Kumar Verma, Ankit Jain, Preeti Patel",
                "Journal": "Anti-Cancer Agents in Medicinal Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "alpelisib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 135413535
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Valganciclovir",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 8114,
            "Article": [
              {
                "PCLID": 38128141,
                "RelevanceScore": 913263,
                "PMID": 39692337,
                "DOI": "10.1177/10781552241304000",
                "PublicationDate": "2024-12-18",
                "IsReview": false,
                "Title": "Cytomegalovirus viremia and hepatitis B reactivation in patient with RET fusion-positive non-small cell lung cancer treated with pralsetinib",
                "Author": "Alanna Lehman, Anthony Perissinotti, Sam Aitken",
                "Journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "valganciclovir"
              },
              {
                "PCLID": 906605904,
                "RelevanceScore": 274089,
                "DOI": "10.1007/s40278-025-86615-4",
                "PublicationDate": "2025-01-01",
                "IsReview": false,
                "Title": "Pralsetinib",
                "Journal": "Reactions Weekly"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 284
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Formic Acid",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 7832,
            "Article": [
              {
                "PCLID": 19676353,
                "RelevanceScore": 307535,
                "PMID": 33161056,
                "DOI": "10.1016/j.annonc.2020.10.599",
                "PublicationDate": "2021-02-01",
                "IsReview": false,
                "Title": "Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations",
                "Author": "V. Subbiah, T. Shen, S.S. Terzyan, X. Liu, X. Hu, K.P. Patel, M. Hu, M. Cabanillas, A. Behrang, F. Meric-Bernstam, P.T.T. Vo, B.H.M. Mooers, J. Wu",
                "Journal": "Annals of oncology : official journal of the European Society for Medical Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 37038083,
                "RelevanceScore": 307535,
                "PMID": 38584556,
                "DOI": "10.2174/0118715206290110240326071909",
                "PublicationDate": "2024-07-01",
                "IsReview": false,
                "Title": "Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS)",
                "Author": "Zichen Zhao, Qianlun Pu, Tonglin Sun, Qian Huang, Liping Tong, Ting Fan, Jingyue Kang, Yuhong Chen, Yan Zhang",
                "Journal": "Anti-Cancer Agents in Medicinal Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "formic acid"
              },
              {
                "PCLID": 34847774,
                "RelevanceScore": 239194,
                "PMID": 36941218,
                "DOI": "10.1002/bmc.5628",
                "PublicationDate": "2023-04-12",
                "IsReview": false,
                "Title": "Development and validation of an HPLC–MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2‐EDTA plasma",
                "Author": "Judith L. Gulikers, Ard J. van Veelen, Elishia M. J. Sinkiewicz, Yvo M. de Beer, Mariëlle Slikkerveer, Leo M. L. Stolk, Vivianne C. G. Tjan‐Heijnen, Lizza E. L. Hendriks, Sander Croes, Robin M. J. M. van Geel",
                "Journal": "Biomedical chromatography : BMC",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "formic acid"
              },
              {
                "PCLID": 39179011,
                "RelevanceScore": 106783,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "formic acid"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 135398508
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Entecavir",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 7719,
            "Article": [
              {
                "PCLID": 38128141,
                "RelevanceScore": 1266245,
                "PMID": 39692337,
                "DOI": "10.1177/10781552241304000",
                "PublicationDate": "2024-12-18",
                "IsReview": false,
                "Title": "Cytomegalovirus viremia and hepatitis B reactivation in patient with RET fusion-positive non-small cell lung cancer treated with pralsetinib",
                "Author": "Alanna Lehman, Anthony Perissinotti, Sam Aitken",
                "Journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "entecavir"
              },
              {
                "PCLID": 906605904,
                "RelevanceScore": 258417,
                "DOI": "10.1007/s40278-025-86615-4",
                "PublicationDate": "2025-01-01",
                "IsReview": false,
                "Title": "Pralsetinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 760535234,
                "RelevanceScore": 6848,
                "DOI": "10.1007/s44178-024-00069-w",
                "PublicationDate": "2024-03-14",
                "IsReview": false,
                "Title": "CACA guidelines for holistic integrative management of adult acute myeloid leukemia",
                "Author": "Hui Wei, Yingchang Mi, Ying Wang, Erlie Jiang, Jianda Hu, Xiaojing Yan, Yanqiu Han, Yongrong Lai, Yong You, Sujun Gao, Chunji Gao, Bing Xu, Wenjuan Yu, Jieping Chen, Suning Chen, Tiejun Gong, Linhua Yang, Jianmin Yang, Xin Du, Xin Du, Wei Li, Fei Li, Yan Li, Jian Li, Junmin Li, Jie Jin, Xi Zhang, Mei Zhang, Yu Zhang, Guangsen Zhang, Xianmin Song, Yongping Song, Qian Jiang, Tong Wu, Ting Liu, Zhuogang Liu, Daihong Liu, Hanyun Ren, Ru Feng, Rong Fu, Honghu Zhu, Zimin Sun, Jianmin Wang, Xin Wang, Jishi Wang, Shaoyuan Wang, Meiyun Fang, He Huang, Yu Hu, Qifa Liu, Jun Ma, Zhixiang Shen, Depei Wu, Xiaojun Huang, Jianfeng Zhou, Chunyan Ji, Lugui Qiu, Jianyong Li, Jianxiang Wang",
                "Journal": "Holistic Integrative Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 320930
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Hematoxyline",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 7554,
            "Article": [
              {
                "PCLID": 37809521,
                "RelevanceScore": 257014,
                "PMID": 39354540,
                "DOI": "10.1186/s13019-024-03092-0",
                "PublicationDate": "2024-10-01",
                "IsReview": false,
                "Title": "A case of neoadjuvant targeted therapy with pralsetinib for locally advanced lung adenocarcinoma with RET fusion mutation",
                "Author": "Wang Chunmao, Cheng Haijie, Wang Zitong, Yang Zhi",
                "Journal": "Journal of Cardiothoracic Surgery",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 35043805,
                "RelevanceScore": 174839,
                "PMID": 35920918,
                "DOI": "10.1007/s00428-022-03390-9",
                "PublicationDate": "2022-08-03",
                "IsReview": false,
                "Title": "Clinical significance and interrelations of PD-L1 expression, Ki-67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population",
                "Author": "Yanhua Bai, Ting Guo, Dongfeng Niu, Yanli Zhu, Wenhao Ren, Qian Yao, Xiaozheng Huang, Qin Feng, Tianxiao Wang, Xiuli Ma, Xinqiang Ji",
                "Journal": "Virchows Archiv : an international journal of pathology"
              },
              {
                "PCLID": 36294801,
                "RelevanceScore": 174839,
                "PMID": 38057798,
                "DOI": "10.1186/s12890-023-02799-5",
                "PublicationDate": "2023-12-06",
                "IsReview": false,
                "Title": "Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report",
                "Author": "Yan Peng, Zhu Zheng, Wang Zewen, Liu Yanan, Zhang Mingyan, Sun Meili",
                "Journal": "BMC Pulmonary Medicine"
              },
              {
                "PCLID": 6166176,
                "RelevanceScore": 105767,
                "PMID": 35364706,
                "DOI": "10.1007/s00432-022-03969-4",
                "PublicationDate": "2022-04-02",
                "IsReview": false,
                "Title": "A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing: a case report",
                "Author": "Xiaoyi Xu, Haoyi Wang, Zhaonan Yu, Xianguo Chen",
                "Journal": "Journal of Cancer Research and Clinical Oncology"
              },
              {
                "PCLID": 38654974,
                "RelevanceScore": 85671,
                "PMID": 40214776,
                "DOI": "10.1007/s00428-025-04093-7",
                "PublicationDate": "2025-04-11",
                "IsReview": false,
                "Title": "A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration",
                "Author": "Anna Maria Carillo, Caterina De Luca, Mariantonia Nacchio, Maria Salatiello, Pasquale Pisapia, Vincenzo Damiano, Elena Vigliar, Maria D’Armiento, Giancarlo Troncone, Claudio Bellevicine",
                "Journal": "Virchows Archiv : an international journal of pathology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5280352
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Bilirubin",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 7242,
            "Article": [
              {
                "PCLID": 34037745,
                "RelevanceScore": 217663,
                "PMID": 35587858,
                "DOI": "10.1007/s40265-022-01720-4",
                "PublicationDate": "2022-05-19",
                "IsReview": true,
                "Title": "Pralsetinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Yahiya Y. Syed",
                "Journal": "Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 35057669,
                "RelevanceScore": 166579,
                "PMID": 36422787,
                "DOI": "10.1007/s11523-022-00935-5",
                "PublicationDate": "2022-11-24",
                "IsReview": true,
                "Title": "Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Tina Nie, Yahiya Y. Syed",
                "Journal": "Targeted Oncology"
              },
              {
                "PCLID": 774051013,
                "RelevanceScore": 166579,
                "DOI": "10.1007/s40278-025-80457-9",
                "PublicationDate": "2025-04-05",
                "IsReview": false,
                "Title": "Multiple drugs",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 37450737,
                "RelevanceScore": 108832,
                "PMID": 38997570,
                "DOI": "10.1007/s40265-024-02040-5",
                "PublicationDate": "2024-07-13",
                "IsReview": true,
                "Title": "RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future",
                "Author": "Monica F. Chen, Matteo Repetto, Clare Wilhelm, Alexander Drilon",
                "Journal": "Drugs",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 35580814,
                "RelevanceScore": 100770,
                "PMID": 37543550,
                "DOI": "10.1245/s10434-023-14031-z",
                "PublicationDate": "2023-08-05",
                "IsReview": false,
                "Title": "The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study",
                "Author": "Jia-ying Chen, Nai-si Huang, Wen-jun Wei, Jia-qian Hu, Yi-ming Cao, Qiang Shen, Zhong-wu Lu, Yu-long Wang, Yu Wang, Qing-hai Ji",
                "Journal": "Annals of Surgical Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 11525740
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Pazopanib Hydrochloride",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 18,
            "CooccurrenceScore": 7214,
            "Article": [
              {
                "PCLID": 776483359,
                "RelevanceScore": 164141,
                "DOI": "10.1007/978-3-031-88229-6_6",
                "PublicationDate": "2025-01-01",
                "IsReview": false,
                "Title": "Molecular Testing of Thyroid Nodules",
                "Author": "Marialuisa Sponziello, Leslie Eldeiry, Cosimo Durante",
                "Journal": "Thyroid Ablation"
              },
              {
                "PCLID": 37227145,
                "RelevanceScore": 78671,
                "PMID": 38772990,
                "DOI": "10.1007/s12020-024-03867-4",
                "PublicationDate": "2024-05-21",
                "IsReview": false,
                "Title": "Ten years’ real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer",
                "Author": "Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, Fabián Pitoia",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 765080110,
                "RelevanceScore": 67834,
                "DOI": "10.1007/978-3-031-62301-1_17",
                "PublicationDate": "2024-07-25",
                "IsReview": false,
                "Title": "Medical Treatment of Malignant Pheochromocytoma",
                "Author": "Marta Laganà, Deborah Cosentini, Antonella Turla, Valentina Cremaschi, Salvatore Grisanti, Alfredo Berruti",
                "Journal": "Primary Adrenal Malignancies"
              },
              {
                "PCLID": 36203330,
                "RelevanceScore": 61553,
                "PMID": 37979019,
                "DOI": "10.1007/s11864-023-01145-5",
                "PublicationDate": "2023-11-18",
                "IsReview": true,
                "Title": "The Evolving Treatment Landscape of Medullary Thyroid Cancer",
                "Author": "Marta Laganà, Valentina Cremaschi, Andrea Alberti, Danica M. Vodopivec Kuri, Deborah Cosentini, Alfredo Berruti",
                "Journal": "Current Treatment Options in Oncology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 767699341,
                "RelevanceScore": 51935,
                "DOI": "10.1007/978-981-97-3774-1_15",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "An Update on Medullary Thyroid Carcinoma",
                "Author": "Supriya Sen, Deepak Thomas Abraham",
                "Journal": "Surgical Management of Thyroid and Parathyroid Diseases"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 162786624
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Pyrimidinones",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 7150,
            "Article": [
              {
                "PCLID": 36800119,
                "RelevanceScore": 428940,
                "PMID": 38337106,
                "DOI": "10.1002/jcph.2409",
                "PublicationDate": "2024-02-09",
                "IsReview": false,
                "Title": "Exposure‐Response Relationships for Pralsetinib in Patients with RET‐Altered Thyroid Cancer or RET Fusion‐Positive Nonsmall Cell Lung Cancer",
                "Author": "Nastya Kassir, David McDougall, Denison Kuruvilla, Sean Kim, Shaun Kumar, Ahmadur Rahman, Thorsten Ruf, Sravanthi Cheeti, Wendy Ankrom",
                "Journal": "The Journal of Clinical Pharmacology",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 37535647,
                "RelevanceScore": 428940,
                "PMID": 39057153,
                "DOI": "10.3390/curroncol31070281",
                "PublicationDate": "2024-06-30",
                "IsReview": false,
                "Title": "A Locally Advanced NSCLC Patient Harboring a Rare KIF13A-RET Fusion Benefited from Pralsetinib: A Case Report",
                "Author": "Zenghao Chang, Tengfei Zhu, Hao Jiang, Wei Ou, Siyu Wang",
                "Journal": "Current oncology (Toronto, Ont.)",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 118023034
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Avapritinib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 16,
            "CooccurrenceScore": 7133,
            "Article": [
              {
                "PCLID": 212473112,
                "RelevanceScore": 339140,
                "DOI": "10.1007/s12312-021-00986-1",
                "PublicationDate": "2021-01-01",
                "IsReview": false,
                "Title": "Blueprint Medicines – Ein neues Sektion C Mitglied stellt sich vor",
                "Journal": "Forum"
              },
              {
                "PCLID": 20367522,
                "RelevanceScore": 199914,
                "PMID": 33513356,
                "DOI": "10.1016/j.phrs.2021.105463",
                "PublicationDate": "2021-03-01",
                "IsReview": true,
                "Title": "Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update",
                "Author": "Robert Roskoski",
                "Journal": "Pharmacological Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "avapritinib"
              },
              {
                "PCLID": 35736677,
                "RelevanceScore": 147496,
                "PMID": 37513232,
                "DOI": "10.3390/molecules28145359",
                "PublicationDate": "2023-07-12",
                "IsReview": true,
                "Title": "The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies",
                "Author": "George Mihai Nitulescu, Gheorghe Stancov, Oana Cristina Seremet, Georgiana Nitulescu, Dragos Paul Mihai, Cosmina Gabriela Duta-Bratu, Stefania Felicia Barbuceanu, Octavian Tudorel Olaru",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "avapritinib"
              },
              {
                "PCLID": 36157358,
                "RelevanceScore": 31414,
                "PMID": 37925369,
                "DOI": "10.1007/s10928-023-09896-2",
                "PublicationDate": "2023-11-04",
                "IsReview": true,
                "Title": "Rare oncology therapeutics: review of clinical pharmacology package of drug approvals (2019–2023) by US FDA, best practices and recommendations",
                "Author": "Amitava Mitra, Jong Bong Lee, Douglas Steinbach, Anasuya Hazra, Rajesh Krishna",
                "Journal": "Journal of Pharmacokinetics and Pharmacodynamics"
              },
              {
                "PCLID": 36744749,
                "RelevanceScore": 25938,
                "PMID": 38288815,
                "DOI": "10.2174/0118715206259585240105051941",
                "PublicationDate": "2024-05-01",
                "IsReview": true,
                "Title": "An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021)",
                "Author": "S. Vishakha, N. Navneesh, Balak Das Kurmi, Ghanshyam Das Gupta, Sant Kumar Verma, Ankit Jain, Preeti Patel",
                "Journal": "Anti-Cancer Agents in Medicinal Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "avapritinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 119373
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Elacridar",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 7121,
            "Article": [
              {
                "PCLID": 8246211,
                "RelevanceScore": 1236555,
                "PMID": 34450308,
                "DOI": "10.1016/j.phrs.2021.105850",
                "PublicationDate": "2021-10-01",
                "IsReview": false,
                "Title": "ABCB1 and ABCG2, but not CYP3A4 limit oral availability and brain accumulation of the RET inhibitor pralsetinib",
                "Author": "Yaogeng Wang, Rolf W. Sparidans, Sander Potters, Maria C. Lebre, Jos H. Beijnen, Alfred H. Schinkel",
                "Journal": "Pharmacological Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "elacridar"
              },
              {
                "PCLID": 34104558,
                "RelevanceScore": 112414,
                "PMID": 35598228,
                "DOI": "10.1007/s12272-022-01385-3",
                "PublicationDate": "2022-05-22",
                "IsReview": true,
                "Title": "Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers",
                "Author": "Faraat Ali, Kumari Neha, Garima Chauhan",
                "Journal": "Archives of Pharmacal Research",
                "ChemicalName_1": "pralsetinib; prl"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 807
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Iodine",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 6,
            "CooccurrenceScore": 7085,
            "Article": [
              {
                "PCLID": 25114163,
                "RelevanceScore": 185635,
                "PMID": 34826838,
                "DOI": "10.1055/a-1495-2991",
                "PublicationDate": "2021-11-01",
                "IsReview": false,
                "Title": "[Medullary thyroid carcinoma: current clinical progress]",
                "Author": "Matthias Kroiss, Viktoria Florentine Koehler, Christine Spitzweg",
                "Journal": "Deutsche medizinische Wochenschrift (1946)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "iodine"
              },
              {
                "PCLID": 37679112,
                "RelevanceScore": 165384,
                "PMID": 39225945,
                "DOI": "10.1007/s42000-024-00597-0",
                "PublicationDate": "2024-09-03",
                "IsReview": true,
                "Title": "The value of preoperative molecular testing in the management of Bethesda V and Bethesda VI thyroid tumors",
                "Author": "Anna Paspala, Georgia Bompetsi, Stavroula A. Paschou, Anestis Charalambopoulos, Emmanuil Pikoulis, Melpomeni Peppa, Constantinos Nastos",
                "Journal": "Hormones (Athens, Greece)",
                "ChemicalName_2": "iodine"
              },
              {
                "PCLID": 37689661,
                "RelevanceScore": 107013,
                "PMID": 39231920,
                "DOI": "10.1007/s12020-024-04018-5",
                "PublicationDate": "2024-09-04",
                "IsReview": true,
                "Title": "An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinoma",
                "Author": "Theodora Pappa, Lori Wirth",
                "Journal": "Endocrine",
                "ChemicalName_2": "iodine"
              },
              {
                "PCLID": 37379239,
                "RelevanceScore": 100057,
                "PMID": 38900279,
                "DOI": "10.1007/s00108-024-01728-w",
                "PublicationDate": "2024-07-01",
                "IsReview": false,
                "Title": "[Thyroid carcinomas: the role of systemic therapies in internal medicine]",
                "Author": "Tim Brandenburg, Matthias Kroiß",
                "Journal": "Innere Medizin (Heidelberg, Germany)",
                "ChemicalName_2": "iodine"
              },
              {
                "PCLID": 17675648,
                "RelevanceScore": 86630,
                "PMID": 34291429,
                "DOI": "10.1007/s40618-021-01634-0",
                "PublicationDate": "2021-07-21",
                "IsReview": true,
                "Title": "Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates",
                "Author": "L. Lorusso, L. Pieruzzi, M. Gabriele, M. Nisi, D. Viola, E. Molinaro, V. Bottici, R. Elisei, L. Agate",
                "Journal": "Journal of Endocrinological Investigation",
                "ChemicalName_2": "iodine"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5238
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Sodium Iodide",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 8,
            "CooccurrenceScore": 6996,
            "Article": [
              {
                "PCLID": 35725428,
                "RelevanceScore": 251667,
                "PMID": 37160531,
                "DOI": "10.1007/s12022-023-09764-2",
                "PublicationDate": "2023-05-09",
                "IsReview": true,
                "Title": "Thyroid Nodules and Follicular Cell-Derived Thyroid Carcinomas in Children",
                "Author": "Jonathan C. Slack, Monica Hollowell, Justine A. Barletta",
                "Journal": "Endocrine Pathology"
              },
              {
                "PCLID": 38005529,
                "RelevanceScore": 152243,
                "PMID": 39560781,
                "DOI": "10.1007/s00259-024-06991-5",
                "PublicationDate": "2024-11-19",
                "IsReview": false,
                "Title": "Radioiodine-refractory thyroid cancer—is it time to change the definition in light of novel redifferentiation therapies?",
                "Author": "Petra Petranović Ovčariček, Bart de Keizer, Alfredo Campennì, Michael C. Kreissl, Desiree Deandreis, Murat Tuncel, Luca Giovanella",
                "Journal": "European Journal of Nuclear Medicine and Molecular Imaging"
              },
              {
                "PCLID": 33932930,
                "RelevanceScore": 72969,
                "PMID": 35670980,
                "DOI": "10.1007/978-1-0716-2505-7_17",
                "PublicationDate": "2022-01-01",
                "IsReview": true,
                "Title": "Radioiodine Refractory Differentiated Thyroid Cancer",
                "Author": "Wendy W L Chan, Sonia Chan, Dora L W Kwong",
                "Journal": "Methods in molecular biology (Clifton, N.J.)"
              },
              {
                "PCLID": 37914743,
                "RelevanceScore": 62917,
                "PMID": 39468677,
                "DOI": "10.1186/s40644-024-00791-8",
                "PublicationDate": "2024-10-28",
                "IsReview": true,
                "Title": "Role of [18F]FDG PET/CT in the management of follicular cell-derived thyroid carcinoma",
                "Author": "Klaudia Zajkowska, Paulina Cegla, Marek Dedecjus",
                "Journal": "Cancer imaging : the official publication of the International Cancer Imaging Society"
              },
              {
                "PCLID": 762199688,
                "RelevanceScore": 62917,
                "DOI": "10.1007/978-981-97-1802-3_20",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Thyroid Cancer",
                "Author": "Manasa Desai, Mohammed Qudrathulla Khan Quadri, Hameeda Bee, Prapthi Bathini, Rama Krishna Kancha",
                "Journal": "Biomedical Aspects of Solid Cancers"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 155927613
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "5-[2-(8-amino-1,7-naphthyridin-5-yl)ethynyl]-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]pyridine-3-carboxamide",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6990,
            "Article": [
              {
                "PCLID": 35948128,
                "RelevanceScore": 768783,
                "PMID": 37070927,
                "DOI": "10.1158/1535-7163.mct-22-0629",
                "PublicationDate": "2023-04-18",
                "IsReview": false,
                "Title": "Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors",
                "Author": "Ujjwol Khatri, Neetu Dayal, Xueqing Hu, Elizabeth Larocque, Nimishetti Naganna, Tao Shen, Xuan Liu, Frederick W. Holtsberg, M. Javad Aman, Herman O. Sintim, Jie Wu",
                "Journal": "Molecular Cancer Therapeutics",
                "ChemicalName_1": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 2829715
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "(1,1'-Biphenyl)-3,3',4,4'-tetramine tetrahydrochloride dihydrate",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6869,
            "Article": [
              {
                "PCLID": 38504091,
                "RelevanceScore": 755500,
                "PMID": 40063337,
                "DOI": "10.1080/07391102.2025.2472231",
                "PublicationDate": "2025-03-10",
                "IsReview": false,
                "Title": "Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer",
                "Author": "Darakhshan Parveen, Faizul Azam, M. Mumtaz Alam, Ruhi Ali, Mymoona Akhter, Suhel Parvez, Mohammad Ahmed Khan, Shyama Charan, Suruchi Khanna, Mohd. Parvez, Mohammad Shaquiquzzaman",
                "Journal": "Journal of Biomolecular Structure and Dynamics",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "dab"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 421610
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "2,2'-((Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl)bis(methylene))bis(N,N-dimethylbenzenamine)",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6660,
            "Article": [
              {
                "PCLID": 35656580,
                "RelevanceScore": 799084,
                "PMID": 37301138,
                "DOI": "10.1016/j.biopha.2023.114995",
                "PublicationDate": "2023-08-01",
                "IsReview": false,
                "Title": "Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance",
                "Author": "Sofia Trocchianesi, Agnese Po, Anna Citarella, Zaira Spinello, Aurelia Rughetti, Zein Mersini Besharat, Tanja Milena Autilio, Valeria Pecce, Antonella Verrienti, Rossella Elisei, Cosimo Durante, Giuseppina Catanzaro, Elisabetta Ferretti",
                "Journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "gant61"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 16129706
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Somatostatin",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 6624,
            "Article": [
              {
                "PCLID": 35183605,
                "RelevanceScore": 363726,
                "PMID": 36890425,
                "DOI": "10.1007/s12022-023-09753-5",
                "PublicationDate": "2023-03-01",
                "IsReview": true,
                "Title": "Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma",
                "Author": "Chan Kwon Jung, Shipra Agarwal, Jen-Fan Hang, Dong-Jun Lim, Andrey Bychkov, Ozgur Mete",
                "Journal": "Endocrine Pathology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "somatostatin"
              },
              {
                "PCLID": 36527703,
                "RelevanceScore": 142080,
                "PMID": 37715050,
                "DOI": "10.1007/s11154-023-09836-y",
                "PublicationDate": "2023-09-16",
                "IsReview": true,
                "Title": "Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities",
                "Author": "Alessio Imperiale, Valentina Berti, Mickaël Burgy, Roberto Luigi Cazzato, Arnoldo Piccardo, Giorgio Treglia",
                "Journal": "Reviews in Endocrine and Metabolic Disorders"
              },
              {
                "PCLID": 682755491,
                "RelevanceScore": 90931,
                "DOI": "10.1007/978-3-030-84367-0_16",
                "PublicationDate": "2022-01-01",
                "IsReview": false,
                "Title": "Medullary Thyroid Carcinoma",
                "Author": "Payal Paresh Patel Shooliz, Victor Bernet",
                "Journal": "A Case-Based Guide to Clinical Endocrinology"
              },
              {
                "PCLID": 38047578,
                "RelevanceScore": 40414,
                "PMID": 39609369,
                "DOI": "10.1007/s12020-024-04114-6",
                "PublicationDate": "2024-11-29",
                "IsReview": true,
                "Title": "Is peptide receptor radionuclide therapy still a promising option for medullary thyroid carcinoma?",
                "Author": "Fernanda Accioly de Andrade, Daniel Bulzico, Rossana Corbo, Fernanda Vaisman",
                "Journal": "Endocrine"
              },
              {
                "PCLID": 760174677,
                "RelevanceScore": 25189,
                "DOI": "10.1007/978-3-031-38605-3_16",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Medullary Thyroid Cancer: Diagnosis and Non-surgical Management",
                "Author": "Leslie Cheng, Kate Newbold",
                "Journal": "Practical Management of Thyroid Cancer"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 138611145
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Adagrasib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 6501,
            "Article": [
              {
                "PCLID": 39179011,
                "RelevanceScore": 690797,
                "PMID": 40743983,
                "DOI": "10.1016/j.jpba.2025.117078",
                "PublicationDate": "2025-12-15",
                "IsReview": false,
                "Title": "LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib",
                "Author": "Marinda Meertens, L. Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Alwin D.R. Huitema",
                "Journal": "Journal of Pharmaceutical and Biomedical Analysis",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "adagrasib"
              },
              {
                "PCLID": 36365086,
                "RelevanceScore": 369948,
                "PMID": 37979367,
                "DOI": "10.1016/j.jchromb.2023.123918",
                "PublicationDate": "2023-12-01",
                "IsReview": false,
                "Title": "Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs",
                "Author": "Paul D. Kruithof, Yvo M. de Beer, Judith L. Gulikers, Leo M.L. Stolk, Lizza E.L. Hendriks, Sander Croes, Robin M.J.M. van Geel",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "adagrasib"
              },
              {
                "PCLID": 36366594,
                "RelevanceScore": 150496,
                "PMID": 38011864,
                "DOI": "10.1055/s-0043-1776782",
                "PublicationDate": "2023-11-27",
                "IsReview": true,
                "Title": "Management of Brain Metastases: A Review of Novel Therapies",
                "Author": "Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W. McDermott, Manmeet S. Ahluwalia",
                "Journal": "Seminars in Neurology",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "adagrasib"
              },
              {
                "PCLID": 38339541,
                "RelevanceScore": 48079,
                "PMID": 39881149,
                "DOI": "10.1038/s41598-025-88044-x",
                "PublicationDate": "2025-01-29",
                "IsReview": false,
                "Title": "Comparative study of degree, neighborhood and reverse degree based indices for drugs used in lung cancer treatment through QSPR analysis",
                "Author": "Micheal Arockiaraj, J. J. Jeni Godlin, S. Radha, Tariq Aziz, Mitub Al-harbi",
                "Journal": "Scientific Reports",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "adagrasib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 14888
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Arsenic Trioxide",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 6497,
            "Article": [
              {
                "PCLID": 35656580,
                "RelevanceScore": 992716,
                "PMID": 37301138,
                "DOI": "10.1016/j.biopha.2023.114995",
                "PublicationDate": "2023-08-01",
                "IsReview": false,
                "Title": "Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance",
                "Author": "Sofia Trocchianesi, Agnese Po, Anna Citarella, Zaira Spinello, Aurelia Rughetti, Zein Mersini Besharat, Tanja Milena Autilio, Valeria Pecce, Antonella Verrienti, Rossella Elisei, Cosimo Durante, Giuseppina Catanzaro, Elisabetta Ferretti",
                "Journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "arsenic trioxide; ato"
              },
              {
                "PCLID": 39348705,
                "RelevanceScore": 245115,
                "PMID": 40913959,
                "DOI": "10.1016/j.bioorg.2025.108948",
                "PublicationDate": "2025-10-01",
                "IsReview": true,
                "Title": "Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies",
                "Author": "Ting Wang, Wenjie Jiang, Liyan Yang, Jinqi Li, Yiqi Sun, Jianyou Shi",
                "Journal": "Bioorganic Chemistry",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "arsenic trioxide"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 71657455
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Ivosidenib",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 8,
            "CooccurrenceScore": 6481,
            "Article": [
              {
                "PCLID": 35865555,
                "RelevanceScore": 321837,
                "PMID": 37392324,
                "DOI": "10.1007/s12010-023-04608-5",
                "PublicationDate": "2023-07-01",
                "IsReview": false,
                "Title": "Virtual Screening, Molecular Docking, and Dynamic Simulations Revealed TGF-β1 Potential Inhibitors to Curtail Cervical Cancer Progression",
                "Author": "Pavan Kumar Poleboyina, Umakanth Naik, Akbar Pasha, Doneti Ravinder, Shivaji Bhanothu, Sneha Malleswari Poleboyina, Umamaheshwari Amineni, Smita C. Pawar",
                "Journal": "Applied Biochemistry and Biotechnology"
              },
              {
                "PCLID": 775675085,
                "RelevanceScore": 157700,
                "DOI": "10.1007/s44272-025-00036-0",
                "PublicationDate": "2025-05-20",
                "IsReview": false,
                "Title": "Guideline of precisional testing in intrahepatic cholangiocarcinoma: an international expert consensus",
                "Author": "Xin Zhang, Jing Han, Ruoyu Shi, Bing Yu, Xuchen Zhang, Bin Li, Xia Sheng, Zengshan Li, Yining Zou, Huichuan Sun, Guoming Shi, Hanlin L. Wang, Jian Zhou, Jia Fan, Wenming Cong, Yuan Ji",
                "Journal": "Clinical Cancer Bulletin"
              },
              {
                "PCLID": 752596600,
                "RelevanceScore": 54568,
                "DOI": "10.1007/s15036-023-3214-2",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Aktuelle Entwicklungen in der palliativen Therapie biliärer Tumoren",
                "Journal": "Gastro-News"
              },
              {
                "PCLID": 35780979,
                "RelevanceScore": 48673,
                "PMID": 37188899,
                "DOI": "10.1038/s41571-023-00770-1",
                "PublicationDate": "2023-05-15",
                "IsReview": true,
                "Title": "Cholangiocarcinoma — novel biological insights and therapeutic strategies",
                "Author": "Sumera I. Ilyas, Silvia Affo, Lipika Goyal, Angela Lamarca, Gonzalo Sapisochin, Ju Dong Yang, Gregory J. Gores",
                "Journal": "Nature reviews. Clinical oncology"
              },
              {
                "PCLID": 752836691,
                "RelevanceScore": 27379,
                "DOI": "10.1007/s00761-023-01386-x",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Zielgerichtete Therapie biliärer Tumoren",
                "Journal": "Die Onkologie"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 60838
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Irinotecan",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 12,
            "CooccurrenceScore": 6460,
            "Article": [
              {
                "PCLID": 36470598,
                "RelevanceScore": 209110,
                "PMID": 37653509,
                "DOI": "10.1186/s13019-023-02349-4",
                "PublicationDate": "2023-08-31",
                "IsReview": true,
                "Title": "Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature",
                "Author": "Zirui Zhu, You Liu, Hengliang Xu, Haoyong Ning, Yanmin Xia, Leilei Shen",
                "Journal": "Journal of Cardiothoracic Surgery"
              },
              {
                "PCLID": 742236089,
                "RelevanceScore": 84681,
                "DOI": "10.1007/s40278-023-30396-y",
                "PublicationDate": "2023-01-07",
                "IsReview": false,
                "Title": "Atezolizumab/pralsetinib",
                "Journal": "Reactions Weekly"
              },
              {
                "PCLID": 34443588,
                "RelevanceScore": 75140,
                "PMID": 36467260,
                "DOI": "10.1007/s11224-022-02072-1",
                "PublicationDate": "2022-11-25",
                "IsReview": false,
                "Title": "Identification of FDA-approved drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) through computational virtual screening",
                "Author": "Dhananjay Jade, Areej Alzahrani, William Critchley, Sreenivasan Ponnambalam, Michael A. Harrison",
                "Journal": "Structural Chemistry",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 38289701,
                "RelevanceScore": 71156,
                "PMID": 39856649,
                "DOI": "10.1186/s12887-024-05378-7",
                "PublicationDate": "2025-01-24",
                "IsReview": true,
                "Title": "Pediatric pancreatic acinar cell carcinoma with a non-canonical BRAF-KMT2C fusion and a classic SND1-BRAF fusion: a case report and literature review",
                "Author": "Yaqin Wang, Jiasi Zhang, Dimin Nie, Ai Zhang, Qun Hu, Aiguo Liu",
                "Journal": "BMC Pediatrics"
              },
              {
                "PCLID": 38341885,
                "RelevanceScore": 60630,
                "PMID": 39893475,
                "DOI": "10.1186/s12957-025-03687-4",
                "PublicationDate": "2025-02-01",
                "IsReview": true,
                "Title": "Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy",
                "Author": "Shuai Wang, Yongsen Wang, Xuan Wu, Li Yang, Xiaoju Zhang",
                "Journal": "World Journal of Surgical Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 31703
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Doxorubicin",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 14,
            "CooccurrenceScore": 6374,
            "Article": [
              {
                "PCLID": 35768166,
                "RelevanceScore": 156413,
                "PMID": 37219741,
                "DOI": "10.1007/s10585-023-10208-8",
                "PublicationDate": "2023-05-23",
                "IsReview": false,
                "Title": "Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer",
                "Author": "Ladislaia Wolff, Ariane Steindl, Petar Popov, Karin Dieckmann, Brigitte Gatterbauer, Georg Widhalm, Anna Sophie Berghoff, Matthias Preusser, Markus Raderer, Barbara Kiesewetter",
                "Journal": "Clinical & Experimental Metastasis"
              },
              {
                "PCLID": 10250207,
                "RelevanceScore": 101345,
                "PMID": 35328215,
                "DOI": "10.3390/diagnostics12030662",
                "PublicationDate": "2022-03-09",
                "IsReview": true,
                "Title": "Update on International Medical Taxonomies of Biomarkers and Their Applications in Management of Thyroid Cancers",
                "Author": "Maria Trovato",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "doxorubicin"
              },
              {
                "PCLID": 38545970,
                "RelevanceScore": 94620,
                "PMID": 40102262,
                "DOI": "10.1007/978-3-031-80396-3_11",
                "PublicationDate": "2025-01-01",
                "IsReview": true,
                "Title": "Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients",
                "Author": "Friedhelm Raue, Karin Frank-Raue",
                "Journal": "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer"
              },
              {
                "PCLID": 34100593,
                "RelevanceScore": 76642,
                "PMID": 35462645,
                "DOI": "10.1007/s13193-021-01401-w",
                "PublicationDate": "2021-08-02",
                "IsReview": false,
                "Title": "Revisiting Combination Chemotherapy as a Single Modality Palliative Therapy for Advanced Anaplastic Thyroid Carcinoma—a Single Institution Experience",
                "Author": "Surabhi Garg, Sasi Mouli, Kul Ranjan Singh, Pooja Ramakant, Anand K. Mishra, Chanchal Rana",
                "Journal": "Indian Journal of Surgical Oncology"
              },
              {
                "PCLID": 35910037,
                "RelevanceScore": 53224,
                "PMID": 37076888,
                "DOI": "10.1186/s13014-023-02249-w",
                "PublicationDate": "2023-04-19",
                "IsReview": false,
                "Title": "Prognostic factors in radiotherapy of anaplastic thyroid carcinoma: a single center study over 31 years",
                "Author": "Julia Jacob, Dirk Vordermark, Kerstin Lorenz, Daniel Medenwald",
                "Journal": "Radiation oncology (London, England)"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 166078561
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Lambrolizumab",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 6347,
            "Article": [
              {
                "PCLID": 21724088,
                "RelevanceScore": 370185,
                "PMID": 34166867,
                "DOI": "10.1016/j.ctarc.2021.100423",
                "PublicationDate": "2021-01-01",
                "IsReview": false,
                "Title": "Frontline pembrolizumab for the treatment of RET-rearranged non-small cell lung cancer: A case report",
                "Author": "Sheon Baby, Farah Khalil, Tawee Tanvetyanon",
                "Journal": "Cancer Treatment and Research Communications",
                "ChemicalName_1": "pralsetinib"
              },
              {
                "PCLID": 37800496,
                "RelevanceScore": 264418,
                "PMID": 39352419,
                "DOI": "10.1007/s11096-024-01800-3",
                "PublicationDate": "2024-10-01",
                "IsReview": false,
                "Title": "Cost-effectiveness analysis of selpercatinib versus chemotherapy and pembrolizumab in the first-line treatment of rearranged during transfection fusion–positive non-small cell lung cancer in the United States",
                "Author": "Hongbin Yi, Yingdan Cao, Fenghao Shi, Xiaoxia Wei, Sheng Han",
                "Journal": "International Journal of Clinical Pharmacy"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "CID": 5757
        },
        "Evidence": {
          "ChemicalNeighbor": {
            "NeighborName": "Estradiol",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 6248,
            "Article": [
              {
                "PCLID": 36586242,
                "RelevanceScore": 314341,
                "PMID": 37779428,
                "DOI": "10.1158/0008-5472.can-23-1021",
                "PublicationDate": "2023-10-02",
                "IsReview": false,
                "Title": "RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion–Positive Breast Cancer and Beyond",
                "Author": "Jie Wu, Vivek Subbiah",
                "Journal": "Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "estrogen"
              },
              {
                "PCLID": 35947600,
                "RelevanceScore": 261951,
                "PMID": 37071495,
                "DOI": "10.1158/0008-5472.can-22-3484",
                "PublicationDate": "2023-04-18",
                "IsReview": false,
                "Title": "Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer",
                "Author": "Xuxu Gou, Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt, Diana Fandino, Craig T. Vollert, Purba Singh, Mohammad A. Alzubi, Anna Malovannaya, Lacey E. Dobrolecki, Michael T. Lewis, Shunqiang Li, Charles E. Foulds, Matthew J. Ellis",
                "Journal": "Cancer Research",
                "ChemicalName_1": "pralsetinib",
                "ChemicalName_2": "estrogen"
              },
              {
                "PCLID": 34955359,
                "RelevanceScore": 100750,
                "PMID": 36918928,
                "DOI": "10.1186/s13058-023-01622-7",
                "PublicationDate": "2023-03-14",
                "IsReview": true,
                "Title": "RET signaling in breast cancer therapeutic resistance and metastasis",
                "Author": "Geoffrey Pecar, Simeng Liu, Jagmohan Hooda, Jennifer M. Atkinson, Steffi Oesterreich, Adrian V. Lee",
                "Journal": "Breast cancer research : BCR",
                "ChemicalName_2": "estrogen"
              }
            ]
          }
        }
      }
    ]
  }
}
